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ABSTRACT 
 
Anopheles funestus is a major vector of malaria in the southern African region. Insecticide 
resistance to pyrethroid and carbamate insecticides has been recorded in populations of this 
species in South Africa and Mozambique. This study aimed to determine the relationship 
between pyrethroid resistance and gene expression of two closely related genes, CYP6P9 
and CYP6P13, by age and sex in a resistant strain An. funestus from southern Africa, 
FUMOZ-R. The insecticide susceptibility assays showed that percentage survival in both 
FUMOZ-R sexes significantly decreased as age increased. The mRNA expressions of 
CYP6P9 and CYP6P13 were higher in FUMOZ-R relative to the insecticide susceptible 
strain (FANG). The expression of permethrin resistance varies with age in An. funestus 
FUMOZ-R. The results indicate that other genes may also be involved in insecticide 
resistance. In addition to this, the expression profile of other metabolic genes involved in 
insecticide resistance was also investigated. A microarray based approach was used to 
identify genes differentially expressed in FUMOZ-R and FANG. As the full set of 
detoxification genes in An. funestus are unknown, this study investigated the utility of the 
An. gambiae detox chip to screen for differentially expressed detoxification genes in An. 
funestus. After optimization of the hybridisation conditions, over 90% of the probes 
showed a positive signal. Only three genes were significantly (P<0.001) differentially 
expressed in the females, CYP6P9, COI and CYP6M7. The same genes were also 
significantly differentially expressed in the adult males, together with an additional 21 
transcripts. The third part of this study investigated the gene expression in the first instar, 
fourth instar and 3-day old adults in FUMOZ-R using the An. gambiae detox chip. The 
variation in metabolic enzyme gene transcription at the different developmental stages in 
An. funestus are not known. The identification of differentially transcribed genes at the 
 vi!
different life stages provides some insight into the role and function of these genes. A large 
number of cytochrome P450s (monooxygenases), esterases, glutathione S-transferases 
(GSTs) and other additional genes were differentially expressed in all life stages. This 
study provided vital information regarding genes potentially involved in pyrethroid 
resistant and is the first to provide metabolic or detoxifying transcription gene information 
in An. funestus.  
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CHAPTER ONE 
 
INTRODUCTION 
 
There are approximately 3 450 species and sub species of mosquitoes, consisting of 38 
genera which all belong to the family Culicidae (Service, 1996). The Culicidae family 
consists of three sub families, Toxorhynchitinae, Anophelinae (anophelines) and Culicinae 
(culicines). Mosquitoes are found worldwide in both tropical and temperate regions. They 
are, however, absent from a few islands and Antarctica (Service, 1996). Mosquitoes are 
notorious for the spread of various diseases including filariasis, yellow fever, dengue fever, 
chikungunya, and most importantly malaria.  
 
 
1.1 Malaria 
In 2010, the World Health Organization (WHO) reported that an estimated 765 million 
people were of risk of malaria. Malaria accounts for 10% of Africa’s disease burden and 
causes the greatest suffering and impoverishment amongst the poor (Figure 1.1).  
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 Figure 1.1 Distribution of malaria worldwide and the phases of control in the malarial  
areas, reported at the end of 2008 (WHO, 2009) 
 
Pregnant women and children under five years of age are usually the most vulnerable 
(Okenu, 1999; Tren and Bate, 2004). Most malaria deaths occur in Africa and result from 
both the epidemiological situation on this continent and very limited vector control 
activities during the past decades. The lack of adequate health services often results in 
deficiencies in treatment and this is compounded by an increase in drug resistance (WHO, 
2004). One of the key components of an effective malaria control programme entails 
prompt drug treatment and in more severe cases, admission to hospital (reviewed by 
Hemingway and Bates, 2003). The choice of drug treatment is usually dependant on the 
parasite resistant patterns and the availability of anti-malarial treatment (www.doh.gov.za).  
 
Malaria control programmes aim to prevent transmission of malaria, aid in prompt clinical 
diagnosis of malaria infection and provide adequate drug treatment. This leads to reduced 
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infection as well as morbidity and mortality caused by malaria parasites. The Plasmodium 
falciparum parasite causes about 90% of the malaria cases in most of southern Africa, 
while the remaining 10% are caused by P. vivax, P. malariae and P. ovale (Tren and Bate, 
2004). These parasites are transmitted to humans by a select few mosquito vectors with the 
main vectors in Africa, being Anopheles gambiae Giles, An. arabiensis Patton and An. 
funestus Giles. 
 
 
1.2 Malaria Vectors  
In order to improve our understanding of malaria and the risks involved it is imperative to 
have knowledge of the biology of the malaria vectors and their distribution.  
 
1.2.1 Anopheles gambiae complex 
Members of the An. gambiae complex are amongst the main vectors of malaria in sub-
Saharan Africa (Gillies and Coetzee, 1987). This complex consists of at least seven 
morphologically similar species, that differ in their ecology, behaviour and feeding (Gillies 
and De Meillon, 1968; White, 1985; Gillies and Coetzee, 1987; Hunt et al., 1998). The An. 
gambiae complex consists of seven species and these include An. gambiae s.s., An. 
arabiensis Patton, An. merus Donitz, An. melas Theobald, An. bwambae White and An. 
quadriannulatus Theobald species A and B (Gillies and De Meillon, 1968; Gillies and 
Coetzee, 1987; Hunt et al., 1998). Anopheles gambiae and An. arabiensis, two of the major 
malaria vectors are found in most of Africa (Gillies and Coetzee, 1987). Three of the minor 
vectors include An. merus, a saltwater breeder, found on the eastern side of Africa, An. 
melas found on the west coast and An. bwambae found in only one locality in Uganda 
(Gillies and De Meillon, 1968; White, 1985; Gillies and Coetzee, 1987). Anopheles 
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quadriannulatus, a non-malarial vector, is found in Ethiopia and most of southern Africa 
(Gillies and Coetzee, 1987; Coetzee et al., 2000). 
 
1.2.2 Anopheles funestus group 
The third most well known malarial vector, which is the focus of this study, is An. 
funestus. Anopheles funestus mosquitoes are much smaller and darker in colour than the 
An. gambiae complex mosquitoes. The An. funestus group historically consisted of nine 
species with little morphological variation existing between them except at the larval and 
adult stages. The nine species includes An. funestus Giles, An. rivulorum Leeson, An. 
parensis Gillies, An. vaneedeni Gillies and Coetzee, An. leesoni Evans, An. fuscivenosus 
Leeson, An. aruni Sobti, An. brucei Service and An. confusus Evans and Leeson (Gillies 
and Coetzee, 1987). A new species, An. rivulorum-like sp. (Cohuet et al., 2003) was 
identified in Cameroon and it was found to be very similar to An. rivulorum. Another new 
member in this group was recently discovered in Malawi and is morphologically similar to 
An. funestus but different at the genetic level (Spillings et al., 2009). This species, 
temporarily called An. funestus-like, has not been reported to carry P. falciparum parasites. 
Recently, Harbach (2004) restructured the taxonomic classification of the An. funestus 
group. This group now comprises the An. funestus subgroup (An. funestus, An. vaneedeni, 
An. parensis, An. aruni, An. confusus, An. funestus-like), the An. aconitus subgroup, the 
An. culicifacies subgroup, the An. minimus subgroup (An. leesoni amongst others) and the 
An. rivulorum subgroup (An. brucei, An. rivulorum, An. rivulorum-like and An. 
fuscivenosus). 
 
Anopheles funestus, is highly endophilic and anthropophilic. This implies they feed indoors 
on humans although alternative hosts might be present (Gillies and De Meillon, 1968). 
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Anopheles rivulorum, which is usually zoophilic, is the only other species from the An. 
funestus group, that has been implicated in the transmission of malaria in nature (Tanzania) 
(Wilkes et al., 1996). The other members of this group are zoophilic and do not transmit 
malaria (Gillies and De Meillon, 1968; Gillies and Coetzee, 1987; Cohuet et al., 2003). 
Anopheles vaneedeni has been shown to support malaria parasite development under 
laboratory conditions, but has not been implicated as a malaria vector in nature (De 
Meillon et al., 1977).  
 
1.2.2.1 Distribution 
Anopheles funestus, An. rivulorum and An. leesoni are widespread throughout sub-Saharan 
Africa (Gillies and De Meillon, 1968; Gillies and Coetzee, 1987). Anopheles parensis and 
An. confusus can be found in eastern and southern Africa, An. aruni in Zanzibar, An. 
fuscivenousus in Zimbabwe, An. brucei in Nigeria and An. vaneedeni in the northern areas 
of South Africa (Gillies and De Meillon, 1968; Gillies and Coetzee, 1987). The An. 
funestus group generally inhabits areas that have permanent water such as swamps, weedy 
sides of streams and ponds that are conducive to the breeding of An. funestus larvae. 
Anopheles funestus generally prefers water with shade, usually provided by floating 
vegetation or grass (De Meillon, 1947).  
 
1.2.2.2 Species identification 
Anopheles funestus, An. funestus-like, An. vaneedeni, An. parensis and An. aruni are 
identical morphologically at all life stages (Gillies and De Meillon, 1968). Anopheles 
rivulorum and An. brucei can be distinguished from the other species by their distinctive 
larvae although they are indistinguishable from each other at the adult stage (Gillies and 
De Meillon, 1968). Anopheles leesoni are distinguished from the other African species by 
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its early stages (Gillies and De Meillon, 1968) while An. confusus is distinguished by its 
larval characteristics. Anopheles fuscivenosus is known only from the adult stage and by 
chromosomal banding arrangements (Gillies and De Meillon, 1968; Green, 1982).  
 
The identification of malaria vectors is essential for the implementation of vector control 
strategies. Identification of the different species of the An. funestus group is problematic 
when only adult mosquitoes are available and as a result, molecular methods had to be 
implemented in order to distinguish between them. In 1980, Green and Hunt conducted a 
study on the cytogenetic characteristics of An. funestus. In 1982, Green reported on An. 
funestus chromosome maps of seven of the species. This was the only genetic method 
available at the time to distinguish between species. This method is laborious, time 
consuming and not effective if large samples are to be processed for identification 
(reviewed by Coetzee and Fontenille, 2004). One of the first molecular studies on An. 
funestus was conducted by Koekemoer et al. (1998). In this study, primers were developed 
in the D3 region in the 28S ribosomal gene. The PCR products were digested which 
resulted in two fragments that represented An. funestus and An. vaneedeni. Further studies 
by Koekemoer et al. (1999), used the single-strand confirmation polymorphism technique 
to identify An. funestus, An. rivulorum, An. leesoni and An. vaneedeni. This technique was 
limiting in that only four members of the An. funestus group could be identified.  
 
In 2002, Koekemoer et al. developed a molecular species-specific polymerase chain 
reaction (PCR) assay that identifies five members of the An. funestus group in Africa, and 
these include An. funestus, An. vaneedeni, An. rivulorum, An. leesoni and An. parensis. 
Another species-specific PCR developed a year later (Cohuet et al., 2003) identified An. 
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rivulorum-like. This species from Cameroon differed genetically from the An. rivulorum 
from South Africa as described in the study conducted by Koekemoer et al. (2002).  
 
 
1.3 Malaria Vector Control 
Resurgence of malaria in southern Africa can be attributed to various factors such as: 
parasite drug resistance, mosquito insecticide resistance, climate change, large scale 
population migration and the breakdown of vector control programs (reviewed by Booman 
et al., 2003). The control of malaria cannot be solely by treatment of the disease itself. 
Both the disease (caused by the parasite) and the vector need to be managed in order to 
prevent transmission. The control of malaria in most African countries consists of early 
diagnosis and timeous treatment (Keiser et al., 2004). Most vector control programs use an 
integrated vector management (IVM) plan. IVM incorporates a wide range of tools such as 
environmental management (includes larval control), screening of  windows and doors, 
indoor residual spraying (IRS) and insecticide treated bed nets (ITNs) (Okenu, 1999; 
reviewed by Hemingway and Bates, 2003; Howard et al., 2007).  IRS and ITNs are widely 
used, while other methods mentioned above are used in specific settings. 
 
In Africa, in the 1930’s, IRS involved spraying with chemicals such as pyrethrum. Today, 
pyrethroids are the preferred insecticides of choice due to their low mammalian toxicity 
and their ability to quickly kill and immobilize insects (Roberts and Andre, 1994; Coetzee 
et al., 2006). Around the 1950s, this was replaced by dieldrin and DDT (reviewed in 
Coetzee et al., 1999), which had a much longer life span and therefore had economic 
advantages. Currently pyrethroids, organochlorines, carbamates and organophosphates are 
recommended for vector control (WHO, 2008). Despite environmental concerns about 
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DDT (organochlorines), it is still used for malarial control. The increase in insecticide 
resistance is of major concern where IRS and ITNs are used as control interventions and 
insecticide resistance management is imperative. The only insecticide currently allowed for 
use on ITNs is pyrethroids (reviewed in Coetzee et al., 1999). However, ITNs provide 
limited protection against mosquitoes biting outdoors and have been perceived as being 
irrelevant by users (Roberts and Andre, 1994).  
 
The control of malarial vectors is to an extent a countrywide control intervention. Larval 
control can be achieved by environmental management and community participation. 
Microbial larvicides have been used and Bacillus sphaericus (Bs) and B. thuringiensis var. 
israelensis (Bti) have shown to give excellent control of the major vectors of malaria in 
Africa (Fillinger and Lindsay, 2006; Majambere et al., 2007). The use of biological control 
agents as opposed to chemical larvicides can be attributed to the fact that they are very 
species-specific and environmentally safe (Majambere et al., 2007). Larvivorous fish have 
also been used in the control of mosquitoes for decades and have shown to reduce larvae 
by 75% in ponds (Howard et al., 2007; reviewed by Chandra et al., 2008). However, this 
method will not be suitable in Africa due to the fact that members of the An. gambiae 
complex breed in temporary pools. Due to the harmful effects of chemicals on mosquitoes 
and non-target populations and the occurrence of insecticide resistance in mosquito 
populations, there has been an interest in the use of biological control and biopesticides. 
The use of entomopathogenic fungi, Metarhizium anisopliae and Beauveria bassiana in 
storage clay pots, have been trialled and tested for use against malarial vectors (Farenhorst 
et al., 2008). These insect-pathogenic fungi infect insects by penetrating the cuticle, 
without the need for ingestion, and kill them within a few days (Roy et al., 2006).  
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Despite the use of biocontrol and insecticides over the years, insecticide resistance 
amongst vectors is still a problem. This is, therefore, increasingly impacting on the success 
of malaria control interventions (reviewed by Coetzee et al., 1999; Ranson et al., 2009). 
Insecticide resistance has been reported in many malaria vectors worldwide and the 
understanding of the vector biology, resistance mechanisms and the insecticides in 
question will greatly attribute to the control of malaria.  
 
 
1.4 Insecticide Resistance 
Resistance is defined by the World Health Organization (WHO) as, “the inherited ability 
of a strain of some organism to survive doses of a toxicant that would kill the majority of 
individuals in a normal population of the same species” (WHO, 1957). Insecticide 
resistance can develop through mainly one or more of four mechanisms and these occur 
when (WHO, 1957; Hemingway et al., 2004): 
 
i) Resistant mosquitoes destroy or naturally detoxify the insecticide faster than the 
susceptible ones (metabolic resistance); 
ii) The site at which the insecticide binds in the mosquito has been genetically altered 
to reduce its effects (altered target-site resistance); 
iii) The resistant mosquitoes develop thicker cuticles thus reducing the rate at which 
the insecticide is being absorbed (penetration resistance) or 
iv) Resistant mosquitoes may recognize and detect the threat and avoid the insecticide 
(behavioural resistance). 
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The bulk of insecticide resistance in mosquitoes to date is mainly through metabolic 
resistance and/or target site resistance. The other two mechanisms are more difficult to 
study and very little information is available on them. 
 
1.4.1 Metabolic resistance mechanism/detoxification 
The metabolic resistance mechanisms involve three major enzyme groups, 
carboxylesterases (esterases), P450 monooxygenases (P450s) and glutathione S-
transferases (GSTs). These metabolic enzymes are responsible for the resistance to four 
classes of insecticides: organophosphates, organochlorines, carbamates and pyrethroids 
(Hemingway and Ranson, 2000) which are the only classes of insecticides approved for 
public health usage. Figure 1.2 shows the complex interaction between the insecticides, 
their target sites and metabolic enzymes involved. The monooxygenases and esterases are 
generally involved in organophosphate, carbamate and pyrethroid resistance. The GSTs are 
mainly involved in DDT resistance (Hemingway and Ranson, 2000). 
 
 
 
 
 
   
 
 
 
 
 
 
Figure 1.2 Diagrammatic representation of cross-resistance between commonly used classes 
of insecticides and the affected target site (adapted from Brogdon and McAllister, 
1998) 
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1.4.1.1 Carboxylesterases 
The carboxylesterase (esterase) resistance mechanism is involved in organophosphate 
(OP), carbamate and in some cases pyrethroid insecticide resistance (Hemingway and 
Karunaratne, 1998). Insect esterase genes are subdivided into eight subfamilies according 
to sequence similarity and substrate specificity and these include: !-esterase, ß-esterase, 
juvenile hormone esterase, gliotactins, acetylcholinesterases, neurotactins, neuroligins, and 
glutactin class (Ranson et al., 2002a). The !-esterase, ß-esterase, juvenile hormone 
esterase and acetylcholinesterases account for most of the catalytically active esterases 
whilst the remaining esterases are non-catalytic and are involved in development and 
neurogenesis (Ranson et al., 2002a; Yu et al., 2009). 
 
Esterases are known to play a role in the detoxification and metabolism of xenobiotic 
compounds and insecticides (Russell et al., 1996; Li et al., 2007), hydrolysis of the 
juvenile hormone, neurotransmitter acetylcholine as well as the hydrolysis of carboxylic 
esters (Taylor and Radic, 1994; Hemingway and Karunaratne, 1998; Riddiford et al., 
2003). Esterases have also been reported to play a role in organophosphate resistance in 
Culex quinquefasciatus from Saudi Arabia (Hemingway et al., 1990). 
 
In An. gambiae there are 51 known gene sequences of the esterase family (Ranson et al., 
2002a). To date there have been reports of esterases playing a role in cross-resistance in 
An. funestus using biochemical analysis (Brooke et al., 2001) but there are no reports on 
gene transcription studies done on this enzyme family. 
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1.4.1.2 Cytochrome P450 (monooxygenases) 
Cytochrome P450 or monooxygenases consists of a large, ancient super family of heme-
thiolate proteins and are found in most insects, plants, mammals, birds and bacteria (Scott, 
1999; Alzahrani, 2009). P450s are membrane-bound enzymes and are found mainly in the 
endoplasmic reticulum or in the mitochondrial membrane (Alzahrani, 2009). P450s are 
found in most cell tissues; however, in insects it has been found to be located mainly in the 
midgut, fat bodies and malpighian tubules (Hodgson, 1983). Most eukaryotic P450s 
require the flavoprotein NADPH, cytochrome P450 reductase and cytochrome b5 for 
activity (Hemingway et al., 2004). 
 
Due to P450s comprising a large number of proteins, the naming of each one is imperative. 
Therefore, a standardized naming system was implemented (Nelson et al., 1993). In the 
present system, cytochrome P450 genes are named CYP (Cytochrome P450) followed by a 
number (family name), letter (subfamily) and number (isoform) for example, CYP6P9 
(Nelson et al., 1996; Feyereisen, 1999; Scott, 1999; Ranson et al., 2002b). Members of a 
family share more than 40% identity at the amino acid sequence level and more than 55% 
at the subfamily level (Bergé et al., 1998; Feyereisen, 1999; Werck-Reichhart and 
Feyereisen, 2000; Ranson et al., 2002b).  
 
Due to the large number of P450 gene families, approximately 4000 being discovered 
across living organisms, (Nelson, 2006), blocks of two to four digit numbers were assigned 
for different orders of organisms; CYP1-CYP49, CYP301-CYP499 and CYP3001-
CYP4999 are reserved for animals, CYP71-CYP99, CYP701-CYP999 and CYP7001-
CYP999 for plants, CYP51-CYP69, CYP501-CYP699 and CYP5001-CYP6999 belong to 
lower eukaryotes, CYP101-CYP299 and CYP1001-CYP2999 to bacteria (Nelson, 2006).  
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In insects, as of 2009, there were 1 675 reported P450s in six P450 families. These six 
families include CYP 6, 9, 12, 18 and 28 while the sixth family, CYP4, also includes 
sequences from vertebrates (Bergé et al., 1998; Feyereisen, 1999; Ranson et al., 2002a; 
Alzahrani, 2009). Some CYP4 enzymes are thought to play a role in resistance to 
xenobiotics, mobilization of energy and fatty acids oxidation (Alzahrani, 2009). The CYP6 
and CYP28 families are also thought to play a role in metabolism of xenobiotic 
compounds. The CYP12 P450 family is mitochondrial and plays a role in steroidogenesis 
(Alzahrani, 2009). The CYP12 P450s have also been found at higher levels in insecticide 
resistant strains of insects (Le Goff et al., 2006). The function of CYP9 has not clearly 
been established (Danielson et al., 1997), while the CYP18 enzymes function in C26 
hydroxylation/oxidation (Feyereisen, 2006).  
 
In An. gambiae a total of 111, P450 genes (of which seven are pseudo genes) have been 
identified (Ranson et al., 2002a). In 2005, Amenya et al. identified 31 P450 genes in An. 
funestus. In the Amenya study, a total of 12 CYP4, 12 CYP6 and seven CYP9 partial genes 
were isolated and sequenced.  
 
P450 enzymes function by binding molecular oxygen and receiving electrons from 
NADPH (nicotinamide adenine dinucleotide phosphate). The enzyme in turn adds an 
oxygen atom to the substrate and forms water with the other oxygen atom (Bergé et al., 
1998). This process is represented in Figure 1.3. Electrons are transferred from NADPH on 
the substrate-P450 complex by a NADPH cytochrome P450 reductase. These reactions can 
also occur in the presence of cytochrome b5 (Bergé et al., 1998). 
 
 
 14 
Substrate(S) + (NADPH+H+) + O2 !S(O) + NADP+ + H2O 
 
Figure 1.3 The metabolic reaction of P450 cytochromes 
 
P450s are considered to be an important enzyme group, due to their involvement in the 
detoxification or activation of xenobiotics such as drugs or pesticides and the metabolism 
of compounds (Bergé et al., 1998; Feyereisen, 1999; Scott, 1999; Brown et al., 2003). 
Monooxygenases are known to oxidize a large number of substrates and catalyze a large 
range of reactions (Scott, 1999). They are also known for their involvement in controlling 
the production of compounds such as hormones, fatty acids, pheromones and steroids 
(Scott, 1999; Brown et al., 2003).  
 
Monooxygenases are interesting to study due to their large variation in substrate specificity 
(Scott, 1999). Some P450s display overlapping substrate specificity such that a single 
compound may be subject to metabolism by multiple P450s. In some cases, some P450s 
can produce only one metabolite from a given substrate, whilst other P450s produce 
several metabolites (Scott, 1999). 
 
It is well known that elevated levels of P450s result in insecticide resistance in many insect 
species (Liu and Scott, 1998; Feyereisen, 1999; Kasai et al., 2000; Ranson et al., 2002a; 
David et al., 2005; Djouaka et al., 2008; Müller et al., 2008b; Awolola et al., 2009). 
Subfamilies from monooxyegenase have been reported to be involved in the metabolism of 
all insecticide classes and these include CYP4, CYP6 and CYP12 (Guzov et al., 1998; 
Ranson et al., 2002a; Nikou et al., 2003; Pridgeon et al., 2003; Rongnoparut et al., 2003). 
A study conducted by Nikou et al. (2003) found the CYP6Z1 gene to be overexpressed in a 
pyrethroid resistant An. gambiae strain. These enzymes have also been found to be up-
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regulated in other insects such as the CYP6L1 gene in adult male German cockroaches, 
Blattella germanica (L) (Wen and Scott, 2001), in Drosophila melanogaster (Chung et al., 
2009) and the CYP6A36 and CYP6A37 genes in the house fly, Musca domestica (Zhu et 
al., 2008). 
 
1.4.1.3 Glutathione S-transferases 
Glutathione S-transferases are members of a large family of multifunctional intracellular 
enzymes and are found in most living organisms (Ding et al., 2003; Che-Mendoza et al., 
2009). There are over 40 GST genes and three known groups of GST protein families in 
eukaryotes and these include the microsomals or kappa (!) group (membrane-associated 
proteins), cytosolics (occurs in the cytoplasma) and the mitochondrials (found in the 
mammalian mitochondria and peroxisomes)  (Che-Mendoza et al., 2009).  
 
GSTs that have over a 40% sequence identity, have phylogenetic relationships, share 
immunological properties, tertiary structures and the ability to form heterodimers, are 
assigned to the same class (Hemingway et al., 2004). There are eight cystolic GST classes 
in mammals, Alpha ("), Mu (#), Pi ($), Theta (%), Sigma (&), Zeta ('), Kappa (!) and 
Omega (() and a microsomal class (Ranson et al., 2001). There are six known classes of 
GSTs in insects, Delta ()), Epsilon (*), Omega ((), Sigma (&), Theta (%), Zeta ('), an 
unknown class and a microsomal class. Delta and Epsilon are the largest classes found 
only in insects (Enayati et al., 2005). GSTs are named according to the species they were 
isolated from and the GST class they belong to. They are also assigned a number that 
indicates the order in which they were discovered or genomic organization (Hemingway et 
al., 2004). For example, in the gene AgGSTe4, Ag refers to the species in which it was 
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discovered, An. gambiae, and e4 indicates that it belongs to the Epsilon class and was the 
fourth GST in that class to be identified (Enayati et al., 2005). 
 
In An. gambiae there are 31 known GSTs (Ranson et al., 2002a). Twelve of these genes 
belong to the Delta class, eight to Epsilon, one to Omega, one to Sigma, two to Theta, one 
to Zeta and three to both the unknown and microsomal classes (Claudianos et al., 2006). 
There have been reports on increased GST activity in An. funestus using biochemical 
analysis (Cuamba et al., 2010; Morgan et al., 2010) but no gene transcription studies have 
been conducted on GSTs in this species. 
 
Insect GSTs are of importance due to their involvement in detoxification of a wide range 
of xenobiotic compounds such as insecticides and these include organophosphates, 
organochlorines and pyrethroids (Ortelli et al., 2003; Che-Mendoza et al., 2009). GSTs 
play a role in the transport of proteins and ligans and in signaling processes (Hemingway 
and Ranson, 2000; Ding et al., 2003; Ortelli et al., 2003). They have also been known to 
play a role in protection against oxidative stress (Ding et al., 2003; Che-Mendoza et al., 
2009).  
 
1.4.2 Target-site resistance 
The second most widespread mechanism by which insects are able to resist insecticides is 
through target-site resistance. Target-site insensitivity results when point mutations occur 
at the target sites of insecticides, decreasing the affinity of the insecticide to its receptor 
(Brogdon and McAllister, 1998). Alterations of the sodium ion channel gene knock-down 
resistance (kdr) which is the target site for DDT and pyrethroids, "-aminobutyric acid 
(GABA) receptor which is the target of cyclodiene insecticides and acetylcholinesterase 
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(AChE) which is inhibited by organophosphate and carbamate compounds, result in the 
insecticide not being effective (Hemingway and Ranson, 2000; Djogbenou et al., 2008). 
Details on these different target sites are provided in the following sections.  
 
1.4.2.1 Insensitive acetylcholinesterase 
Acetylcholinesterase (AChE) acts by hydrolyzing the excitory neurotransmitter, 
acetylcholine, on the post-synaptic nerve membrane (Hemingway and Ranson, 2000). 
Organophosphates and carbamates target the acetylcholinesterase and inhibit enzyme 
activity by carbamylating and phosphorylating the serine residue within the active site 
gorge (Hemingway et al., 2004). There have been reports of two types of target-site 
resistance, i.e. one conferring high carbamate and low organophosphate resistance and the 
other, which has a high organophosphate with an equal or low carbamate resistance 
(Russel et al., 2004). To date, all mosquito AChE target site resistance falls within the first 
category (Hemingway et al., 2004). Studies conducted on An. gambiae s.l populations 
from Ivory Coast (N’Guessan et al., 2003) and Burkina Faso (Djogbenou et al., 2008; 
Dabiré et al., 2009) have all shown the presence of the G119S mutation of the ace-1R gene, 
which is responsible for insensitive acetylcholinesterase resistance to organophosphate and 
carbamate insecticides. 
 
1.4.2.2 GABA receptor mutation 
The GABA ("-aminobutyric acid) receptor is a heteromultimeric gated chloride-ion 
channel and an inhibitory neurotransmission channel in an insect’s central nervous system 
and in neuromuscular junctions (Hemingway and Ranson, 2000). It consists of five 
subunits, which are arranged at the central ion channel (Hemingway et al., 2004). The 
GABA receptor is the site for cyclodiene insecticides such as dieldrin (Hemingway and 
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Ranson, 2000; Hemingway et al., 2004). In most dieldrin resistant insects, a single 
mutation occurs from the alanine residue to a serine (Ffrench-Constant et al., 1993). In 
2005, Du et al. carried out one of the first studies which showed that resistance to dieldrin 
in An. arabiensis occurs when this same mutation is present. This mutation has been called 
Rdl. The same study also discovered that a different mutation of alanine to glycine 
occurred in An. gambiae. 
 
1.4.2.3 Mutations in the voltage-gated sodium channel 
This form of resistance occurs when there are mutations in the voltage-gated sodium 
channel and the insecticides, DDT and pyrethroids are prevented from being active at this 
site (Hemingway et al., 2004). The intensive use of insecticides has led to the development 
of knock-down resistance (kdr) in Anopheles mosquitoes (Liu et al., 2000). The knock-
down resistance (kdr) mutation was first detected in houseflies and the German cockroach 
(Knipple et al., 1994; Liu et al., 2000). One type of resistance-associated mutation in kdr 
in An. gambiae and which is predominant in west Africa (kdr-w), results in a leucine-to-
phenylalanine substitution (L1014F) in the S6 hydrophobic segment of domain II 
(Williamson et al., 1996; Martinez-Torres et al., 1998). This mutation is associated with 
kdr to pyrethroids and DDT. Two other different mutations at this position also confer 
resistance to DDT and/or pyrethroids. The first is a leucine–histidine substitution which is 
associated with pyrethroid resistance in Heliothis virescens (Park & Taylor, 1997). The 
second is a leucine–serine substitution (L1014S) which confers DDT resistance and low 
levels of permethrin resistance in An. gambiae s.s from east Africa (kdr-e) (Martinez-
Torres et al., 1998; Ranson et al., 2000). Another type of mutation, the methionine–
threonine mutation, has been detected in the housefly showing high levels of pyrethroid 
resistance (Lee et al., 1999).  
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1.4.3 Behavioural resistance 
Behavioural resistance results when some insecticides cause insects to avoid or leave 
treated surfaces before acquiring a lethal dose of insecticide such that frequent contact is 
necessitated before death occurs (WHO, 1957). Behavioural resistance is divided into two 
categories, contact irritancy and non-contact repellency. Contact irritancy occurs when the 
insect is stimulated to leave an insecticide treated surface after physical contact. Non-
contact repellency results when the insect is stimulated to leave an insecticide treated area 
before contact is made with the treated surface (Georghiou, 1972; Potikasikorn et al., 
2005; Liu et al., 2006). This form of resistance has been reported for many classes of 
insecticides and these include, pyrethroids, carbamates, organochlorines and 
organophosphates.  
 
Behavioural resistance is challenging to control and very little information is available 
regarding the management strategies and the mechanism. However, there have been a few 
studies investigating this form of resistance. The An. minimus complex species A and C 
both demonstrated irritancy and escaped from chambers after being exposed by contact 
and non-contact to DDT and pyrethroids (Potikasikorn et al., 2005). Studies conducted on 
An. albimanus (Chareonviriyaphap et al., 1997), An. minimus (Chareonviriyaphap et al., 
2001), An. minimus (Sungvornyothin et al., 2001) and Ae. aegypti (Kongmee et al., 2004) 
all showed forms of behavioural resistance. 
 
1.4.4 Penetration resistance 
Penetration resistance results when the insect’s exoskeleton has been modified such that 
foreign compounds are prevented from entering its body. Reducing the infiltration of the 
insecticide through the insects adapted cuticle will result in the body having ample time to 
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detoxify the foreign substances, hence being less effective (Plapp, 1976). This results in 
the slow absorption of the insecticides into their bodies. This type of resistance usually 
occurs together with other forms of resistance (IRAC, 2009). Very few studies have 
investigated this type of resistance, particularly in mosquitoes. Studies conducted on cotton 
bollworm Helicoverpa armigera in Thailand (Ahmad and McCaffery, 1999) and west 
Africa (Martin et al., 2002) found that this species is resistant to pyrethroids due to 
cuticular thickening. Decreased penetration of insecticide has been found in the housefly, 
Musca domestica (L.) (Wen and Scott, 1999). The molecular basis of this mechanism is yet 
to be investigated. Both Djouaka et al. (2008) and Awolola et al. (2009) have found 
overexpression of cuticular genes in pyrethroid resistant An. gambiae. Recently, Wood et 
al. (2010) showed that individual pyrethroid resistant An. funestus mosquitoes had a 
thicker cuticle than their susceptible counterparts. However, the role this plays in 
resistance is still unclear as the main resistance mechanism in this population is metabolic 
of nature (Brooke et al., 2001). 
 
 
1.5 Malaria in South Africa 
The main malaria areas in South Africa include parts of the Limpopo province, 
Mpumalanga and KwaZulu Natal (http://www.doh.gov.za/). The vectors responsible for 
malaria transmission are mainly An. arabiensis and An. funestus when it is allowed to 
encroach into the sprayed areas.  There have been reports of insecticide resistance in 
malaria vectors in southern Africa and these include DDT and pyrethroid resistance in An. 
arabiensis in South Africa (Hargreaves et al., 2003; Mouatcho et al., 2009) and An. 
funestus resistant to pyrethroids and carbamates in South Africa and Mozambique 
(Hargreaves et al., 2000; Brooke et al., 2001).  
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The first account of insecticide resistance in An. funestus in southern Africa and its impact 
on malaria transmission was reported by Hargreaves et al. (2000).  During 1996, South 
Africa discontinued DDT in favour of deltamethrin (pyrethroids) for indoor residual house 
spraying, unaware that the neighbouring population of An. funestus in southern 
Mozambique had developed resistance to pyrethroids (Hargreaves et al., 2000). As a 
result, South Africa experienced its worst malaria epidemic in over 50 years (Figure 1.4).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Malaria cases and deaths in South Africa from 1971-2009 (Department of Health, 2010, 
unpublished reports) 
 
Malaria cases in South Africa peaked at 64 000 during the 1999/2000 malaria season 
(Coetzee, 2005). Effective control was re-established by using DDT in traditional houses, 
whilst retaining pyrethroids for use in western style houses. It was subsequently 
established that pyrethroid and carbamate resistance in An. funestus from South Africa and 
southern Mozambique was based on monooxygenase detoxification (Brooke et al., 2001). 
The malaria situation in South Africa has since returned to pre 1996 levels. Presently, the 
continuous report of malaria infections in South Africa is due to travelling between South 
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Africa and neighbouring malarial countries such as Mozambique and Zimbabwe 
(Department of Health, 2010, unpublished reports). 
 
 
1.6 Insecticide Resistance in South Africa 
An understanding of resistance mechanisms in vector populations enables the development 
of resistance management strategies and ultimately the control of malaria. Hence, it is 
imperative to study the vector’s phenotype in response to exposure to insecticides, as well 
as the resistance mechanisms involved at the molecular level. Very few molecular studies 
have been reported on An. funestus. Studies by Brooke et al. (2001) found that An. funestus 
from South Africa and southern Mozambique showed evidence of resistance to pyrethroid 
and carbamate insecticides. Results showed that high levels of monooxygenases were 
responsible for the detoxification of pyrethroids in the resistant mosquitoes and this was 
carried out using insecticide exposure, synergist and biochemical assays. Additional 
pyrethroid resistance studies were carried out by Hunt et al. (2005) showing that An. 
funestus resistant mosquitoes exhibited increased monooxygenase and glutathione S-
transferase activity.  
 
Up until this point no information was available on the genes involved in the elevated 
activity of monooxygenase and glutathione S-transferase. However, in 2005, Amenya et al. 
isolated 31 partial P450 CYP genes. These gene sequences had a 75% identity to An. 
gambiae amino acid sequence level. This information gave insight into the genes that may 
possibly be involved in insecticide resistance. In 2008, Amenya et al. conducted one of the 
first studies to use molecular techniques to identify a gene, CYP6P9, which was thought to 
play a role in insecticide resistance in a pyrethroid resistant strain of An. funestus from 
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Mozambique. Genetic mapping studies by Wondji et al. (2007) identified the P450 gene, 
CYP6P9 as being highly overexpressed in the resistant FUMOZ-R strain. Two years later, 
Wondji et al. (2009) identified a duplicate gene of CYP6P9, called CYP6P9b. 
Furthermore, Matambo et al., (2010) identified several single nucleotide polymorphisms 
(SNPs) between the full-length CYP6P9 gene from the resistant and susceptible An. 
funestus strains. Another CYP gene, named CYP6P13, was found to be closely related to 
the CYP6P9 gene. Amino acid comparisons between CYP6P13 and CYP6P9b implied that 
these are the same gene (Wondji et al., 2009; Matambo et al., 2010).  
 
1.7 Objectives 
Very few studies have been carried out to characterize the complex resistance mechanisms 
in An. funestus. The research done thus far has confirmed pyrethroid resistance in An. 
funestus and suggested resistance to carbamates. Molecular research on An. funestus has 
not progressed at the same rate as An. gambiae due to the difficulty of rearing An. funestus 
in the laboratory.  
 
This study aimed to examine the effects of pyrethroid resistance on transcription of 
metabolic enzymes in An. funestus. The objectives of this study are listed below and the 
workflow for each objective is presented in Figure 1.5. 
 
1.7.1 Objective one 
a) To investigate the levels of pyrethroid resistance at different ages in males and 
females of a resistant An. funestus strain.  
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b) The expression profiles of genes, CYP6P9 and CYP6P13, that have been previously 
reported to play a role in pyrethroid resistance in An. funestus, were determined at 
these different ages.  
 
1.7.2 Objective two 
a) To determine the transcription profile of detoxification genes in both the 
susceptible and pyrethroid resistant strain of An. funestus using the An. gambiae 
detoxification chip (detox chip).  
 
1.7.3 Objective three 
a) To determine the transcription profile of the detoxification genes in the first instar, 
fourth instar and 3-day old adult mosquitoes using the An. gambiae detox chip.  
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Figure 1.5 Workflow of the aims, materials and techniques used in this study 
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CHAPTER TWO 
 
The effect of age on pyrethroid resistance and the expression level of two 
duplicate P450 genes in Anopheles funestus* 
 
2.1 Background 
Various insecticide resistance mechanisms have been described and molecular techniques 
have been used successfully to provide a better understanding of these mechanisms (Nikou 
et al., 2003; Vontas et al., 2007; Wondji et al., 2007; Amenya et al., 2008; Ben Cheikh et 
al., 2009). Insecticide resistance in An. gambiae and An. funestus has previously been 
described (Hargreaves et al., 2000; Hemingway and Ranson, 2000; Coetzee and Fontenille, 
2004; Munhenga et al., 2008; Okoye et al., 2008; Awolola et al., 2009). However, the 
molecular understanding of these mechanisms in An. gambiae far out-weighs that of An. 
funestus. The availability of the An. gambiae genome has enlarged the gap in information 
between these two species. It is only recently that the molecular mechanism of 
monooxygenase-based pyrethroid resistance in An. funestus was initiated despite the lack 
of available genomic sequence data (Amenya et al.,  2005; Wondji et al., 2007; Amenya et 
al., 2008; Matambo et al., 2010). Recently, Serazin et al. (2009) reported the functional 
annotation and comparative genomics of 2 005 expressed sequenced tags from An. funestus 
– information which will prove useful in future molecular characterisation studies. The 
information from this study also adds to the body of molecular information available for 
An. funestus.  
                                                
* Footnote: Accepted for publication in Journal of Genetics and Molecular Research. See Appendix C, page 148.  
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Initial molecular characterisation of pyrethroid resistance in An. funestus included the 
isolation of 31 partial P450 sequences (Amenya et al., 2005). One of these, CYP6P9, was 
shown to be overexpressed in the egg and adult stages of a pyrethroid resistant strain from 
Mozambique (Amenya et al., 2008). Wondji et al. (2007) identified a quantitative trait 
locus (QTL) associated with pyrethroid resistance in the same An. funestus strain. These 
QTL markers contained a cluster of P450 genes including the CYP6P9 gene. Recently, 
Wondji et al. (2009) have also identified a duplicate gene of CYP6P9, and called this gene, 
CYP6P9b. 
 
Full-length CYP6P9 sequence comparisons between the resistant and susceptible An. 
funestus strains identified several single nucleotide polymorphisms (SNPs) (Matambo et 
al. 2010). Furthermore, an additional CYP6, closely related to CYP6P9, was identified and 
named by the Dr Nelson (http://drnelson.utmem.edu/CytochromeP450.html) P450 
Nomenclature committee as CYP6P13 (Matambo, 2008). Based on amino acid similarities 
it seems likely that CYP6P13 and CYP6P9b are the same gene (Wondji et al., 2009; 
Matambo et al., 2010).  
 
This newly obtained information from the latter two publications resulted in confusion as 
to the role of CYP6P9 expression in pyrethroid resistance. Expression studies conducted by 
Amenya et al. (2008) as well as by Wondji et al. (2009) were aimed at “CYP6P9” without 
differentiation between CYP6P9 and CYP6P9b/CYP6P13. The study in this chapter aimed 
to characterize the role of these genes separately in pyrethroid resistance. Due to the 
confusion in naming and differentiating between these two genes the following 
nomenclature was used:  
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i. Combined effect of CYP6P9 and CYP6P13: this naming was used to imply that 
amplicons produced are similar to amplicons from previous literature by Amenya et 
al. (2008) and Wondji et al. (2009). Amplicons were obtained using the same 
primers as described by Amenya et al. (2008). 
ii. CYP6P9: this implies that the amplicon produced is specific for CYP6P9 (Matambo 
et al., 2010) or CYP6P9a named by Wondji et al. (2009). As Wondji et al. (2009) 
did not name either CYP6P9a or b it was decided to use the formal naming system 
as obtained by the Dr Nelson (http://drnelson.utmem.edu/CytochromeP450.html) 
P450 Nomenclature committee. New primer pairs were designed specific for this 
gene. 
iii. CYP6P13: this implies that the amplicon produced is specific for CYP6P13 or 
CYP6P9b (Wondji et al., 2009). The same reason for naming was used as described 
above. New primer pairs were designed specifically for this gene. 
 
In order to study the expression of these genes, the mRNA of each had to be determined. 
Determining the mRNA levels of a gene can be done using quantitative Real-Time PCR or 
qPCR. qPCR is one of the most sensitive methods for the detection of the amount of 
DNA/cDNA in a sample (Stahlberg et al., 2005). In conventional PCR, the amplified 
product is only detected at the end of the PCR reaction on an agarose gel (end point 
analysis). In qPCR however, the amount of amplified PCR product and detection of the 
product is determined at every step as the reaction progresses in “real time” (Bio-Rad, 
2006). Sufficient product accumulates to yield a fluorescent signal at a certain point. The 
cycle number at which this occurs is called the quantification cycle, CQ value. Higher copy 
number of target DNA or RNA in the starting material will result in a significant increase 
in fluorescent signal, which in return will result in a lower CQ value. The detection of the 
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PCR product is achieved by fluorescent molecules (SYBR Green) that bind to the double 
stranded (ds) DNA. The fluorescent signal in a reaction is therefore relative to the amount 
of (ds) DNA present and will increase as the target is amplified (Bio-Rad, 2006). The 
general steps followed in a qPCR reaction are outlined in Figure 2.1. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 2.1 Flow diagram of steps involved in a qPCR reaction  
 
There are two ways in which qPCR data can be analysed, i.e. absolute quantification or 
relative quantification. In absolute quantification, the CQ value of a test sample is 
compared to a standard curve. The quantity of an unknown gene is interpolated using a 
range of standards of known quantity (Bio-Rad, 2006). The results are analysed by 
determining the copy number of a gene in a given amount of sample. In the relative 
 30 
quantification method, the sample gene expression is determined by calculating the ratio or 
relative amount of the test (sample of interest) sample DNA to the calibrator (also known 
as the control) sample DNA. 
 
 
2.2 Aim and Objectives 
It is well known that the age of female mosquitoes contributes to the vectorial capacity of 
malaria-transmitting Anopheles. Once a female is infected with the Plasmodium parasite, 
there is generally an incubation period during which the parasite matures and is ready to be 
transmitted to a host. This usually occurs between 10-14 days of age (Cook and Sinkins, 
2010). During this time mortality of females is high and only a small number of females go 
on to transmit malaria. The examination of mosquitoes’ susceptibility to insecticide at 
different life stages greatly contributes to the understanding of vectorial capacity. Also, 
understanding if gene expression is affected by age and blood feeding greatly contributes 
in the control of these vectors.  
 
The aim of these experiments was to quantify the effect of adult mosquito age on the 
expression of pyrethroid resistance in An. funestus as well as to evaluate the mRNA 
expression of two P450 genes (CYP6P9 and CYP6P13) in association with age.  
 
2.2.1 Objective one 
This objective was designed to quantify the levels of pyrethroid resistance at a range of 
ages of adult pyrethroid resistant An. funestus (3, 5, 10, 14, 20 and 30-days post 
emergence) using standard WHO insecticide susceptibility bioassays. 
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As blood feeding female mosquitoes are potentially infectious and able to transmit malaria 
from 10-days and older it is important to understand the impact of mosquito age on 
insecticide resistance. The results from this should indicate if the effectiveness of 
pyrethroids is age-related. In turn, this should also indicate the age at which adult An. 
funestus mosquitoes are most vulnerable when exposed to insecticides. 
 
2.2.2 Objective two 
This objective was designed to quantify the differential mRNA levels of CYP6P9, 
CYP6P13 and the combined effect of both genes in pyrethroid resistant An. funestus in 
association with age.  
 
 
2.3 Biological Material  
The following An. funestus laboratory colonies were used in this study: FUMOZ-R, 
originating from southern Mozambique and selected for resistance to permethrin 
(pyrethroid), since 2001 and selected for approximately 45 generations. Selection for 
permethrin resistance has been halted in the last 5 years, however recent WHO bioassay 
tests have shown that FUMOZ –R has a 15 % mortality to 0.75% permethrin. Details on 
the colony, rearing, selection and insectary conditions can be found in Hunt et al. (2005). 
FANG, originating from southern Angola is fully susceptible to all insecticides. Female 
and male adult mosquitoes were separated on emergence and were maintained on a 10% 
sugar solution until they reached the ages of 3, 5, 10, 14, 20 or 30-days. Another group of 
14-day old FUMOZ-R adult females were allowed to mate and take three blood meals.  
These females were given a blood meal when they were 6, 8 and 10-days of age. On day 
14 they were used either for insecticide tolerance testing or for RNA extractions. 
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2.4 Methods 
 
2.4.1 WHO insecticide bioassays 
The insecticide susceptibility assays described in this study were carried out according to 
WHO specifications using WHO insecticide treated papers (WHO, 1998) (Figure 2.2). The 
efficacy of all test papers was first confirmed using samples of the susceptible strain, 
FANG. A 100% mortality was obtained when FANG was used. 
 
 
 
 
 
 
 
 
 
Figure 2.2 WHO standard insecticide testing tubes  
       Mosquitoes are placed into the holding tube (green dot) which is lined with 
untreated paper. The adults are then transferred to the exposure tube (red dot) 
lined with 0.75% permethrin for one hour. The adults are transferred back to the 
holding tube, the knockdowns recorded, and the mosquitoes fed 10% sucrose. The 
total number of dead and alive mosquitoes are recorded 24-hours post exposure 
(WHO, 1998) 
 
A total of ± 30 FUMOZ-R adults per replicate were assayed against 0.75% permethrin 
treated papers. Ten replicates (in some age groups, more) for each age and sex cohort were 
used (total of 300 mosquitoes per age group). For each replicate an untreated control was 
included. Mortality in this control was never observed during this study. Knockdown was 
recorded after one-hour exposure and final mortality was recorded 24-hour post exposure. 
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Data analysis was conducted on final mortality rates as this is used to determine resistance 
(WHO, 1998). Statistix 7 package (USA) was used to perform the analysis. The two 
sample t-test was used to compare the results of two different ages and linear regression 
was carried out to determine any relationship between all samples. Standard errors (SE) 
were calculated for each replicate. 
 
Bioassay data were compared with expression levels of mRNA of the two genes, CYP6P9, 
CYP6P13 and the combined effect of both these genes at different ages in order to 
ascertain any relationship between gene expression and pyrethroid resistance phenotype 
over age.  
 
2.4.2 Quantitative Real-Time PCR (qPCR) 
qPCR was conducted to: 
i) Quantify FUMOZ-R mRNA expression of CYP6P9, CYP6P13 and their combined 
effect for each age cohort. 
ii) Determine the relative fold expression of CYP6P9 and CYP6P13 as a baseline 
quantification in 3-day old FANG samples. 
 
An analysis of the combined effect was included for two reasons. Firstly, to allow for 
comparison with previously published work prior to the differentiation of these two genes 
(Amenya et al., 2008; Wondji et al., 2009). Gene expression studies by Amenya et al. 
(2008) and Wondji et al. (2009) showed that CYP6P9 (defined in this thesis as the 
combined effect of CYP6P9 and CYP6P13) is highly overexpressed in 3-day old 
pyrethroid resistant An. funestus. Analyses conducted on 14-day old adults showed an even 
greater level of expression than that of 3-day old adults (Amenya et al., 2008). Therefore, 
qPCR, using three different primer pairs i.e. CYP6P9, CYP6P13 and the combined effect 
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of both these genes at each of the different ages, was conducted to determine the mRNA 
levels of these genes in the resistant An. funestus colony.  
 
Secondly, we hypothesise that the combined mRNA levels of CYP6P9 and CYP6P13 will 
be equal to the sum of the mRNA levels of CYP6P9 and CYP6P13 when analysed 
separately. If this hypothesis is not supported, it becomes conceivable that other P450 
genes might also be involved in pyrethroid resistance in FUMOZ-R.  
 
2.4.2.1 RNA isolation 
RNA was extracted to prepare cDNA for the amplification of the CYP6P9, CYP6P13 and 
the combined effect of both genes in qPCR. Total RNA was extracted from 15 adult An. 
funestus FUMOZ-R mosquitoes to form one biological repeat. Extractions were done 
separately for each sex and age cohort for FUMOZ-R as well as from 3-day old females 
and males from FANG.  Three biological extractions were performed for each age and sex. 
The extractions were carried out using 600!l Tri reagent (Sigma, U.S.A, T9424). The 
homogenate was left to stand for five minutes at room temperature and 120!l of 
chloroform was added. The mixture was mixed and left to stand for a further five minutes. 
The homogenate was centrifuged at 12 000 rpm for 15 minutes at 4ºC. Three layers 
formed, and the top clear aqueous phase was collected and transferred into a clean 1.5ml 
microcentrifuge tube. Isopropanol (300!l) was added to the aqueous phase and left at room 
temperature for five minutes after which the sample was centrifuged at 12 000 rpm for ten 
minutes at 4ºC. The supernatant was removed and the RNA pellet was washed in 600!l of 
70% ethanol. The pellet and ethanol mixture was centrifuged at 7 500 rpm for five minutes 
at 4ºC. The RNA pellet was air dried for five minutes and re-suspended in 30!l ddH2O or 
DEPC water. 
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The RNA samples were DNase treated using the RNase-Free DNase set (Qiagen, 
Germany, 79254) by adding 35!l Buffer RDD and 5!l DNase I Stock Solution. The 
samples were incubated at room temperature for 15 minutes and quantified using a 
Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). The 
RNA was considered good quality if the samples had an A260/A280 ratio value between 
1.8-2.0 and the concentration of the RNA was higher than 200ng/!l. The RNA was stored 
at -70ºC until further use. 
 
2.4.2.2 cDNA synthesis 
The cDNA was prepared for use in the qPCR component of this study. This was achieved 
by converting total RNA to cDNA. A solution of 1!l Oligo (dT)20 (50!M) (Invitrogen, 
18418020, USA), 1!l dNTP mix (10mM) and 1!l distilled water was added to 10!l of 
RNA (10pg-5!g). This mixture was incubated at 65ºC for five minutes and cooled on ice 
for one minute. To this RNA mixture, 4!l of 5X first strand buffer (Invitrogen, 18080044 
USA), 1!l of dTT (0.1M) (Invitrogen, 18080044, USA), 1!l of RnaseOUT Recombinant 
Ribonuclease Inhibitor (40U/!l) (Invitrogen, 10777019, USA) and 2!l of Superscript III 
(200U/!l) (Invitrogen, 18080044, USA) was added. This was incubated at 50ºC for one 
hour and at 70ºC for 15 minutes. The quality and quantity of cDNA was measured using 
the Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) and 
the cDNA samples were stored at -70ºC until further use. 
 
2.4.2.3 Primer design 
Three sets of primers were used in this study: CYP6P9, CYP6P13 and the combined effect 
of both these genes. Reasons for using these different primer sets are detailed below. 
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Matambo et al. (2010) have previously sequenced the CYP6P9 and CYP6P13 genes from 
the susceptible An. funestus strain, FANG, and carried out a sequence alignment between 
the two genes (Figure 2.3). The CYP6P9 and the CYP6P13 gene sequences showed 32 
amino acid differences between them. When the forward primer sequence of the CYP6P9 
gene from the Amenya et al. (2008) study was located on the alignment between CYP6P9 
and CYP6P13 (Figure 2.3), it was not located in the sequence-specific regions. This primer 
pair was designed in a region that contained no nucleotide differences between the two 
genes and it was able to amplify both CYP6P9 and CYP6P13 as indicated in the yellow 
region in Figure 2.3 (Matambo et al., 2010). As there are no sequence differences between 
these genes in this location, one product is observed in the melt curve analysis as well as 
after sequencing. For this reason, we have called the amplicons obtained from the primer 
set designed by Amenya et al. (2008), “combined CYP6P9 and CYP6P13”. The forward 
and reverse primers of CYP6P9, CYP6P13 and the combined genes are represented in 
Figure 2.3. 
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Figure 2.3 Nucleotide sequence alignment of CYP6P9 and CYP6P13 using FANG genomic DNA 
Nucleotide base differences are noted in grey shade and identical nucleotides are indicated 
with asterisks while similar residues are indicated with a dot (Matambo et al., 2010). The 
green and yellow highlighted areas indicates the CYP6P9 and “combined CYP6P9 and  
CYP6P13” forward and reverse primers respectively, whilst CYP6P13 forward and reverse 
primers are represented in the boxed areas. 
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Two additional primer sets were used in this study, CYP6P9 (gene-specific primers) and 
CYP6P13 (gene-specific primers). These two primer pairs, CYP6P9 (GeneBank accession 
number: EU450763) and CYP6P13 (GeneBank accession number: EF152577) were 
designed in the regions containing nucleotide differences, as illustrated in Figure 2.3. The 
CYP6P9 primer was designed in this study as indicated in the green highlighted area, using 
the FUMOZ-R DNA sequence (in the same region as that illustrated in the FANG 
sequence) (Figure 2.3) whilst the CYP6P13 primer was designed in the study conducted by 
Matambo (2008). Matambo (2008) designed two sets of primers for the CYP6P13 gene and 
these include primer set (1) and primer set (2) (Table 2.1). A third primer set was generated 
and this included the CYP6P13 forward primer from set (2) and the reverse primer from set 
(1). The rsp 7 (EF450776) primers were used as a reference gene against which to 
normalise data.  
 
These three CYP6P13 primer sets and conditions outlined in Matambo et al. (2008) were 
used in a PCR amplification reaction. These primers were used to amplify both FANG and 
FUMOZ-R cDNA and genomic DNA in females. The amplicons of all three primer pairs 
were electrophoresed on a 1% agarose gel. The CYP6P13 primer set which produced the 
best result was carried forward to the qPCR experiments. The cycling conditions outlined 
in the Amenya et al. (2008) study were carried out for the “combined CYP6P9 and 
CYP6P13”, whilst cycling conditions established in this study were used for the CYP6P9 
gene. 
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Table 2.1 Primers used in qPCR 
 
 
Gene Primer Sequence Fragment 
Length (bp) 
qPCR 
Annealing/Detection 
Temp (°C) 
References 
Combined effect 
(CYP6P9 and CYP6P13) 
Fwd  5' GAG GAA GTG AAG AAG CGA CAT C 3' 
Rev   5' TGA CGG TGA GAA GCG GAA C 3' 
140 52/ 84.00 Amenya et al., 2008 
CYP6P9 
Fwd  5' AGA TGT GAT TGG CAC CTG T 3' 
Rev   5' TCG ATA TTC CAC CGT TTC CT 3' 
232 55/ 82.00 Primer set designed in 
this study 
CYP6P13 
Primer set (1) 
 
 
Primer set (2) 
 
 
Primer set (3) 
 
Fwd  5' CTG GAT CTC CTA ATT ATG ATG AAG TTT TTC 3' 
Rev   5' GTT CAC CGT CTC GCG GAC T 3' 
 
Fwd  5' ACT ATC AGG ACA CTT G 3' 
Rev   5' GAA AAA CTT CAT CAT AAT TAG GAG ATCC AG 3' 
 
Fwd  5' ACT ATC AGG ACA CTT G 3' 
Rev   5' GTT CAC CGT CTC GCG GAC T 3’ 
 
 
132 
 
59.1/ 81.00 
 
Matambo, 2008 
rsp 7 Fwd  5' TTA CTG CTG TGT ACG ATG CC 3' Rev   5' GAT GGT GGT CTG CTG GTT C 3' 
135 */ 85.50 Amenya et al., 2008 
 
 
* Annealing temperature for the rsp 7 gene was 52ºC for the combined effect gene, 55ºC for CYP6P9 and 59.1ºC for CYP6P13. 
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2.4.2.4 Quantification of CYP6P9, CYP6P13 and the “combined effect of CYP6P9 
and CYP6P13” 
The qPCR reactions were carried out using the Bio-Rad CFX96™ Real-Time PCR 
Detection System (Bio-Rad, Hercules, CA, USA). A total volume of 25!l containing 
12.5!l IQ™ SYBR supermix (Bio-Rad, USA, 1708882), 4!l primer (0.4!M), 1!l cDNA 
(50ng) was used per reaction (Table 2.2). A standard curve was generated using a 2-fold 
serial dilution of cDNA for each of the target genes of interest and the reference gene. 
Serial dilutions of cDNA for the standard curve were prepared (Paton et al., 2000; Bio-
Rad, 2006). This was correlated to the initial cDNA template used in the reaction and then 
converted to transcript copy number (Bio-Rad, 2006). 
 
Table 2.2 qPCR reagents and volumes used for combined genes primer set, CYP6P9 and CYP6P13 
 
 
Reagents Volume (!l) Final Concentration 
 
SYBR Green mix 
 
12.5  
Forward primer (2.5!M) 
 
4 0.4!M 
Reverse primer (2.5!M) 
 
4 0.4!M 
cDNA (50-150ng) 
 
Variable Variable  
Distilled water 
 
Variable Variable 
Total volume 25  
 
 
 
The cycling conditions for each primer set differed from each other. These conditions are 
presented in Table 2.3. Triplicates of each biological sample were carried out in each plate 
and the qPCR for the three different biological extractions was performed on different 
days. The reference gene, rsp 7, did not vary between the different ages when amplified. 
The identity of all amplified products was confirmed by sequence analysis by sequencing 
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in both directions. The sequenced genes were blasted against the CYP6P9 and CYP6P13 
genes sequences to ensure that the correct product was amplified during qPCR. 
 
Table 2.3 qPCR cycling conditions used for the CYP6P9, CYP6P13 and the combined gene primer 
set, CYP6P9 and CYP6P13 
 
Genes Stage Cycles Temperature  Time 
 
Combined genes 
CYP6P9 + 
CYP6P13 
1 1 95ºC 3 mins 
 2  
35 95ºC 30 secs 
   
 55ºC 30 secs 
   
 72ºC 30 secs 
 3  
1 7 ºC 4 mins 
   
   
CYP6P9 1  
1 95ºC 3 mins 
 2  
39 95ºC 10 secs 
   
 55ºC 15 secs 
   
 72ºC 15 secs 
 3  
1 72ºC 30 secs 
   
   
CYP6P13 1  
1 94ºC 2 mins 
 2 
 
35 94ºC 30 secs 
  
 
 59.1ºC 30 secs 
  
 
 72ºC 40 secs 
 3 
 
1 72ºC 5 mins 
 
 
2.4.2.5   qPCR data analysis 
In order to proceed with qPCR data analysis a number of criteria needed to be met in the 
initial stages of the experiment. A valid qPCR experiment must have a PCR efficiency 
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percentage value between 90–105% for each gene. The R2 (square of the coefficient of 
regression indicates how well the line fits the data) value must be as close to one as 
possible and the slope of the line must be greater than -3.00. 
 
Two methods of data analysis were used in this study, the absolute quantification and the 
relative quantification method. 
 
a) Absolute quantification 
The qPCR data for the comparison of ages between 3, 5, 10, 14 unfed, 14 blood-fed, 20 
and 30-day old adults were analysed using the absolute quantification method, as shown in 
the formula in Figure 2.4 (Bio-Rad, 2006). The values were converted into transcript copy 
numbers and the ratio of each gene to the reference gene, rsp 7, expression was determined 
(Bio-Rad, 2006).  
 
Nn = 10 (n-b)/ m, 
where Nn = copy number, n = CQ, b = y intercept,  
m = slope of line 
 
Figure 2.4 Formula used to calculate the copy number of each gene 
 
 
 
 
b) Relative quantification 
Comparisons between 3-day old resistant versus susceptible mosquitoes were done using 
the relative quantification method (Figure 2.5) (Pfaffl, 2001). 
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[(Etarget)"CQ, target(calibrator – test] ÷ [(Eref)"CQ, ref(calibrator- test)] 
 
Where target is the gene of interest, reference is the house-keeping gene,  
test is the resistant sample and calibrator is the susceptible sample. 
 
 
Figure 2.5 Formula used to calculate the relative expression of each gene 
 
2.4.2.6 Verification of qPCR product 
The amplified PCR products from the qPCR experiments were sent to Macrogen (Korea) 
for sequence verification of the synthesized product. Sequence analysis was conducted as 
described in section 2.4.2.7. It was expected that some PCR products that were < 140bp 
would be too small in size for sequencing to be carried out. The fragments that failed the 
first attempt of sequencing were then cloned into a vector to increase the size of the 
product, enabling subsequent successful sequencing. 
 
a) Cloning 
The PCR products from the qPCR reactions (25µl) were cleaned using the QIAquick Spin 
Kit (Qiagen, Germany, 28106). Five volumes of the PB buffer were added to one volume 
of the PCR sample. This sample mixture was applied to the QIAquick column and 
centrifuged for 30–60 seconds. The flow-through was discarded and 0.75ml of the PE 
buffer was added to the QIAquick column and centrifuged for 30–60 seconds. The flow-
through was discarded and re-centrifuged for an additional minute. The QIAquick column 
was placed in a clean 1.5ml microcentrifuge tube and 50µl Buffer EB (10mM Tris#Cl, pH 
8.5) or water was added to the column to elute the DNA. The column was centrifuged for 
one minute.  The cleaned samples were nanodropped to determine the concentration of the 
purified samples. 
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b) Ligation 
The ligation was performed using the pGEM-T Easy Vector kit (Promega, USA, A1360). 
The cDNAs from each of the genes were ligated into the pGEM-T Easy Vector and 
incubated at 4ºC overnight (Table 2.4). A positive and a negative ligation were also 
included. A positive ligation control is a reaction that contains a closed plasmid that is 
known to produce positive white clones. A negative control is one that contains all the 
reagents required in a ligation reaction without the PCR product (no closed plasmid will be 
present). This control should not produce any colonies in the transformation reaction due to 
no PCR product being present. If blue or white colonies are found in the negative, this 
could indicate that contamination had occurred during the ligation process and the results 
obtained in the sample reaction could be a false positive. The ligation process then has to 
be repeated. 
 
Table 2.4 Ligation reaction for the cloning of the CYP and rsp 7 genes into pGEM-T Easy Vector 
Reagents Volume (!l) 
2x Rapid Ligation Buffer, T4 DNA Ligase 5 
pGEM-T Easy Vector (50ng) 1 
PCR Product (50ng/!l) 3 
T4 DNA Ligase (3 weiss unit/unit) 1 
Total volume 10 
 
c) Transformation 
The ligation reactions were removed from the fridge (4ºC ) and incubated at 72ºC for 15 
minutes. Approximately 5!l of the ligation reaction was added to 50!l E. coli JM109 
competent cells, which were thawed on ice. A positive transformation was also carried out 
and this control is included in the transformation kit. The reaction was mixed gently by 
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flicking the tube and stored on ice for 20 minutes. The transformation reactions were heat-
shocked at 42ºC in a water bath for 45 seconds and immediately stored on ice for two 
minutes. Luria Bertani (LB) broth (“LB”- see Appendix A for recipe) (960!l) or recovery 
medium from the E. coli JM109 kit was added to the cells and incubated at 37ºC for two 
hours with shaking at 200 rpm. LB plates containing ampicillin (AMP) (100!g/ml) were 
made (see Appendix A for recipe) and 16!l IPTG (50mg/ml) and 40!l of XGAL 
(20mg/ml) were added to plates once they were cooled. The transformation mixture 
(100!l) was added to the agar plates and spread using a sterile spreader. The plates were 
incubated at 37ºC overnight.  
 
d) Colony screening  
On day three, the plates were kept in the fridge (4ºC ) for ± two hours to bring out the 
white colouration. Positive white clones were those that had the insert and sample of 
interest. The blue colonies contained no insert. The positive white clones of interest were 
selected and screened in a PCR reaction to identify the correct clone fragments (Table 2.5). 
The PCR cycling conditions are presented in Table 2.6. Ten clones per gene were selected 
from a plate for PCR screening. Five positive ligation samples were also selected and 
added for PCR. The selected remaining colonies of interest were added to 1-2ml of 
LB/AMP (50!g/ml) and were left to grow overnight at 37°C. The samples were added to 
30% glycerol and stored at -70°C. 
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Table 2.5 PCR reaction of the cloned CYP and rsp7 genes 
Reagents Volume (!l) 
10 x PCR buffer  2.5 
MgCl2 (25mM) 1.5 
dNTPs 2.0 
*SP6 primer 6 pmol  0.6 
*T7 primer 6 pmol 0.6 
Sample  Variable 
dH2O 17.55 
Taq (5U) 0.25 
Total volume 25  
 
 
Table 2.6 Cycling conditions used in the PCR reaction of the cloned products, CYP and  
rsp 7 genes 
 
 
Stage Cycles Temperature  Time 
 
1 
 
1 94ºC 3 mins 
2 
 
25 94ºC 30 secs 
 
 
 
 56.5ºC 30 secs 
 
 
 
 72ºC 30 secs 
3 
 
1 72ºC 10 mins 
 
 
The PCR products were electrophoresed on a 1-2% gel and 3-5!l of the sample was loaded 
on an agarose gel. The samples were electrophoresed at 100 volts for 90 minutes. Positive 
PCR products that were correctly identified from their fragment size on the gel were 
selected and sent to Macrogen (Korea) for sequencing.  
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2.4.2.7 Sequence analysis 
The sequences for all the products were obtained on the Macrogen website 
(http://dna.macrogen.com). The sequence data were aligned against the available 
sequences on BLAST (http://blast.ncbi.nlm.nih.gov). The percentage similarity was 
determined and if the gene of interest had a percentage value greater than 98% to the 
deposited sequences on the NCBI website then it was taken that the correct gene was used 
in qPCR and sequenced. Alternatively, the sequence obtained from Macrogen and the 
full/partial length sequences of the genes of interest were copied into the program 
DNASTAR Lasergene EditSeq (2007) and checked manually. These gene sequences were 
saved and then loaded to the DNASTAR Lasergene Megalign (2007) package. The 
sequences were aligned to each other using the Jotun Hein Method. The percentage 
similarities were then determined. 
 
 
2.5 Results  
 
2.5.1 WHO insecticide bioassays 
Percentage survival of pyrethroid resistant adults (FUMOZ-R) 24-hours post exposure to 
0.75% permethrin (WHO, 1998) was calculated by gender for each age cohort. There was 
a significant trend in survival with age in females (linear regression: P=0.04; R2=0.59) and 
males (linear regression: P=0.02; R2=0.60) in the FUMOZ-R strain.  Although the R2 value 
was close to 1 indicating a loose fit of the data, the P value was still significant. In both 
cases survival tended to decrease with age. Figure 2.6 shows the trend of survival across all 
the ages. Three-day old females showed a mean survival of 78.1%, which decreased 
steadily through ages 5 (71.71%), 10 (68%) and 14-days (37.70%), showing that female 
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susceptibility to permethrin increased with age. The lowest survival was recorded in the 
blood-fed female cohort at 14-days (32.70%), although a two sample t-test revealed that 
there was no significant difference between blood-fed and unfed females at this age (two 
sample t-test: P=0.64). Survival increased in the female cohorts at 20-days old (53.39%) 
and decreased again at 30-days (39.20%). A two sample t-test done between 3-day and 14-
day old unfed females revealed that there was a significant difference in survival between 
the two ages (P=0.0006) (Table 2.7). A second two sample t-test between 3-day and 14-
day old blood-fed females revealed that there was a significant difference in survival 
between the two ages (P=0.0011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Percentage survival of 3 to 30-day old pyrethroid resistant An. funestus, FUMOZ-R,  
in (A) females and (B) males after exposure to 0.75% permethrin 
14-day UF = unfed female mosquitoes 
14-day BF = blood-fed female mosquitoes 
 
A 
B 
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A similar trend was observed in the males (Figure 2.6 B). The male’s resistance to 
permethrin was high at ages three (71.81% survival) and five (77.86% survival). At 10-day 
old the percentage survival decreased to 48.83% and then steadily decreased to a low of 
26.84% at age 14. However, the lowest survival in the males was recorded at age 20 
(17.40%). The percentage survival increased to 26.40% at 30-days. There was a significant 
difference in percentage survival between 3-day and 14-day old males based on a two 
sample t-test (P=0.0000). 
 
Table 2.7 Two sample t-test 
Comparison Mean Replicate size Standard 
deviation 
Standard 
Error 
P-value 
 
3-day unfed vs.  
14-day unfed 
females 
21.886 
62.309 
10 
25 
26.828 
28.832 
8.4836 
5.7664 
0.0006 
3-day vs.  
14-day males 
28.186 
73.160 
10 
25 
12.563 
25.651 
3.9726 
5.1303 
0.0000 
3-day unfed vs.  
14-day blood-fed 
females 
21.886 
67.286 
10 
9 
26.828 
22.943 
8.4836 
7.6476 
0.0011 
14-day unfed vs.  
14-day blood-fed 
females 
62.309 
67.286 
25 
9 
28.832 
22.943 
5.7664 
7.6476 
0.6445 
 
 
2.5.2 qPCR mRNA levels analysis of CYP6P9, CYP6P13 and the combined effect of 
both genes within the resistant colony, FUMOZ-R 
 
qPCR was successful for all three gene sequences and the results were evaluated by a 
number of criteria before data analysis was complete. qPCR optimisation included 
determining the correct primer concentrations and the annealing temperatures for each of 
the genes. All reactions resulted in good exponential curves and CQ values (Figure 2.7). 
The PCR efficiencies for all genes were between 90–105% (Figure 2.8). The R2 value was 
greater than 0.995 and the slope of the regression line was always ± -3.350.  
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Figure 2.7  Amplification plot for the combined gene effect (CYP6P9 and CYP6P13) 
 The amplification curves in blue represent the standard curves and the amplification  
 curves in red are that of the samples of the combined gene effect (RFU- relative   
        fluorescence unit) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8  The standard curve of the combined genes, CYP6P9 and CYP6P13 
    The PCR efficiency, R2 value and the slope of the line are all represented in this graph 
 
A melt peak analysis was also carried out to determine if any primer dimers had formed 
and if any contamination of the reaction had occurred. Any gene of interest would have a 
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single melt temperature and a different melt temperature detects any foreign samples 
present in the reaction.  
 
2.5.3 mRNA levels analysis using the “combined CYP6P9 and CYP6P13 genes” 
Amenya et al. (2008) reported that this gene (combined CYP6P9 and CYP6P13 genes) was 
3.5-fold and 15-fold overexpressed in 3-day old males and females, respectively when the 
susceptible and resistant strains were compared. Wondji et al. (2009) on the other hand 
concluded that the gene (combined CYP6P9 and CYP6P13 genes) was 18-fold and 25-fold 
overexpressed in males and females respectively. The differences in expression values 
between these two studies can be attributed to dissimilar RNA extraction techniques used 
and the different generations of FANG and FUMOZ-R mosquito strains used. However, it 
is clear from both these studies that the combined gene was overexpressed. None of these 
authors looked at the change in gene transcription over age. In this section, the change in 
mRNA expression over age within the pyrethroid resistant strain was investigated.  
 
The transcript copy number ratio (tCNR) of the “combined genes CYP6P9 and CYP6P13” 
using the non-specific primers in FUMOZ-R females was calculated. tCNR varied between 
1.3, 0.94, and 1.93 at age 3, 5 and 10-days, respectively. However, the tCNR decreased at 
day 14 to 1.18 (Figure 2.9A), and increased slightly to 1.35 in this age group in association 
with a blood meal although there was no significant difference in tCNR between blood-fed 
and unfed samples (two sample t-test: P=0.8). There was no significant difference between 
3-day and 14-day old (P=0.52) nor between 10-day old and 14-day old unfed females 
(P=0.12). The tCNR was highest at day 20 (1.98) in females. The tCNR in males was 
lowest at day 3 (3.89) and highest at day 10 (15.27) (Figure 2.9 B).  
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Figure 2.9 mRNA levels expressed as copy number ratio of the combined effect of CYP6P9  
and CYP6P13 in (A) females and (B) males by age from the pyrethroid  
resistant An. funestus FUMOZ-R strain 
14-day UF = unfed female mosquitoes 
14-day BF = blood-fed female mosquitoes 
 
2.5.4 mRNA expression of CYP6P9 
We first established if CYP6P9 was differentially expressed between the resistant and 
susceptible strains using gene-specific primers. Relative gene expression levels of CYP6P9 
were compared between 3-day old FUMOZ-R and 3-day old FANG strains. The relative 
expression of CYP6P9 was 67-fold and 51-fold higher in 3-day old resistant FUMOZ-R 
A 
B 
 53 
females and males respectively compared with the susceptible strain of the same age 
(Figure 2.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 2.10 Fold overexpression of CYP6P9 and CYP6P13 in female and male 3-day old pyrethroid  
resistant An. funestus FUMOZ-R expressed as a ratio relative to the insecticide susceptible 
FANG strain 
 
In order to correlate CYP6P9 mRNA levels with insecticide survival over the range of ages 
within the resistant strain, absolute quantification analysis was used. Absolute 
quantification of this gene in the resistant FUMOZ-R strain showed a similar pattern to that 
of the combined gene effect. In the pyrethroid resistant females, as well as in the males, the 
tCNR was high at day 10 (9.3 for females and 20.1 for males) but decreased by day 14 
(3.63 for females and 12.1 for males) (Figure 2.11 A).  
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Figure 2.11 CYP6P9 mRNA levels by age, expressed as copy number ratio, in pyrethroid resistant An.  
funestus FUMOZ-R (A) females and (B) males  
 
In 3-day old females, the tCNR was 1.88, which increased to 9.3 by day 10. However, the 
tCNR decreased to 3.63 for unfed females and 1.74 for blood-fed females at day 14, 
although there was no significant difference in tCNR between blood-fed and unfed cohorts 
(two sample t-test: P=0.18). The tCNR increased again at day 20 (3.54) and then decreased 
to 0.52 at day 30.  
A 
B 
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Analysis of adult males showed that the tCNR was 9.15 at 3-days, which increased to 23.9 
at 5-days followed by a steady decrease (20.1 at 10-days, 12.1 at 14-days, 5.77 at 20-days 
and 6.56 at 30-days) (Figure 2.11 B).  
 
2.5.5 mRNA expression of CYP6P13 
Primers for the CYP6P13 gene were designed and tested briefly by Matambo (2008) on 
FANG cDNA and genomic DNA (gDNA) and FUMOZ-R cDNA and gDNA. The results 
from that study showed that the CYP6P13 gene fragment could only be amplified in FANG 
gDNA. These primer sets were, therefore, re-tested on FANG and FUMOZ-R cDNA and 
gDNA. Primer set (1) had worked on both FANG and FUMOZ-R cDNA and gDNA, 
whilst primer set (2) and (3) only worked on FANG cDNA and gDNA but did not wok on 
FUMOZ-R cDNA and gDNA (Figure 2.12). Primer set (1) was, therefore, used in the 
qPCR studies. Due to only one primer set being required for this study, further 
optimization was not carried out on the other two primer sets.  
 
 
 
 
 
 
 
 
  
           
 
Figure 2.12  Amplification of a partial fragment of CYP6P13 gene using FUMOZ-R and    
   FANG cDNA and genomic DNA. The negative control was included in the PCR 
amplification reaction and loaded on another gel, however not present on this gel.  
   M: Molecular weight marker 
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As mentioned above, we first established if CYP6P13 was differentially expressed between 
the pyrethroid resistant and susceptible strains when using gene-specific primers as this 
had not been published by Amenya et al. (2008) or Wondji et al. (2009). Relative gene 
expression levels of CYP6P13 were compared between 3-day old FUMOZ-R and 3-day 
old FANG strains. The relative expression of CYP6P13 was 8-fold and 15-fold higher in 
the 3-day old resistant FUMOZ-R females and males respectively compared to samples of 
similar age from FANG (Figure 2.10).  
 
mRNA levels of CYP6P13, using the absolute quantification method, within the resistant 
strain over age revealed that the tCNR changed only slightly from 4.69 in 3-day old 
females to 4.82 in 10-day old females, while males of the same age had a tCNR of 28.84 
(Figure 2.13). However, there was a considerable change in tCNR between 3 and 14-day 
old unfed females although the difference is not significant (two sample t-test: P=0.15). 
The tCNR of the gene had decreased from 2.0 at 14-days when the females were not given 
a blood meal to a significant 0.38 when the females had access to a blood meal (P=0.01). 
The tCNR increased to 0.79 by day 30 in females and had increased to 13.67 in males from 
8.92 at day 20.  
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Figure 2.13 CYP6P13 mRNA levels by age, expressed as copy number ratio, in pyrethroid resistant An.  
funestus FUMOZ-R (A) females and (B) males 
 
 
2.5.6 Correlation between survival and mRNA levels 
There was no correlation between percentage survival and tCNR of the combined effect 
gene in females (linear regression: P=0.60; R2=0.15) or males (linear regression: P=0.90; 
R2=0.24).  Similar results were obtained for CYP6P9 (linear regression: females, P=0.46; 
R2=0.07; males, P=0.16; R2=0.27) and CYP6P13 (linear regression: females, P=0.06; 
R2=0.52; males, P=0.52; R2=0.11).  
A 
B 
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It was interesting to find that the percentage survival increased at day 20 and the tCNR for 
each gene also increased at this age. This suggests that these genes, together with other 
genes, could play a role in insecticide resistance. This could also imply that there is an 
association between phenotype expression and mRNA levels at this age.  
 
2.5.7 Confirmation of qPCR products 
All qPCR products were confirmed by sequencing. The CYP6P9 gene was 250bp in size 
thus allowing for successful sequencing without cloning. The remaining genes, CYP6P13, 
the combined gene primer set and rsp 7 genes were all < 140bp in length and were too 
small and as a result failed sequencing on two attempts. These genes were successfully 
cloned into the pGEM-T Easy Vector. The PCR conducted on clones for all genes worked 
on the first attempt (Figure 2.14). The size of the CYP6P13 gene PCR product was 
approximately 132bp. The size of the T7 fragment length is 78bp and the SP6 fragment 
length is 100bp. Therefore, the size of the CYP6P13 cloned PCR product together with the 
T7and SP6 fragments is ~ 310bp. The size of the rsp 7 and the combined genes cloned 
PCR products were 313bp and 318bp, respectively. The size of the positive ligation cloned 
PCR products was 650-700bp in length. 
 
 
 
 
 
 
Figure 2.14 Amplification of selected clones of the CYP6P13 and rsp 7 genes 
         Lane M: Molecular weight marker; lanes 1-5: CYP6P13 clones; lanes 6-18: rsp 7 
                       clones; lane 19: positive ligation clone. The negative control was included in the PCR  
   amplification reaction and loaded on another gel, however not present on this gel. 
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The cloned products were sent to Macrogen (Korea) and sequencing was successful on the 
first attempt. An example of a portion of the sequence obtained is presented in Figure 2.15. 
A BLAST search (NCBI) was performed on all the sequences and all the genes had a 
percentage similarity > 98% to the genes of interest. 
 
 
 
 
 
 
 Figure 2.15 A portion of the chromatogram of the forward sequence of the CYP6P13 
   gene 
 
 
2.6 Discussion 
Variation in the expression of insecticide resistance with age is shown here for An. funestus 
and has also been described in other anophelines. Hunt et al. (2005) describe fluctuations 
in the expression of pyrethroid resistance with age in unselected and selected generations 
of FUMOZ-R. Lines and Nassor (1991) reported that resistance to DDT declines in 
association with age in An. gambiae. The same phenomena has been found with pyrethroid 
tolerance in An. stephensi and An. gambiae (Hodjati and Curtis, 1999), resistance to 
malathion in An. stephensi (Rowland, 1985; Rowland and Hemingway, 1987) and An. 
arabiensis (Lines, 1983; Rawlings, 1985). The effect of age may lead to a weakening of 
resistance mechanisms as a consequence of a general progressive decrease in physiological 
capacity (Hodjati and Curtis, 1999).  This could in turn result in the mosquitoes having 
reduced ability to respond or adapt to environmental changes. 
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The bioassay data revealed that there was a significant difference in percentage mortality 
(as per conversion from percentage survival) between the ages in the resistant An. funestus 
strain when exposed to permethrin. The data showed that mortality increased as the adults 
aged. Successive blood-feeding of females prior to 14-days of age did not affect female 
susceptibility to pyrethroids as assessed four days after the last blood meal when compared 
to unfed females of the same age. When using standard WHO susceptibility assays, 
however, pyrethroid resistance is enhanced in the FUMOZ-R strain four hours post blood-
feeding in 3-day old females using dose response analysis (Spillings et al., 2008). Hunt et 
al. (2005) showed that pyrethroid induced mortality was significantly reduced in 14-day 
old and 20-day old blood-fed FUMOZ-R females when compared to unfed females.  
 
These results collectively suggest that the level of the resistance phenotype varies in 
response to fluctuations in the physiological state of the mosquito, which is a function of 
various parameters including age, blood-feeding history and mating status. This 
information could impact on vector control as pyrethroid resistant females are likely to 
survive pyrethroid intoxication beyond 14-days of age, enabling infective individuals to 
transmit malaria even though the rate of mortality in this age cohort is higher. A different 
situation would have been possible if females were fully susceptible to pyrethroids from 
14-days of age. 
 
The overexpression of at least one P450 gene, CYP6P9, has been reported by two 
independent groups (Amenya et al., 2008; Wondji et al., 2009). However, there is no data 
to date showing whether or not this gene combination (CYP6P9 plus CYP6P13) is able to 
metabolise pyrethroids, and the data given here show no correlation between resistance 
phenotype expression (as measured by bioassay) and mRNA levels. If the phenotype is 
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showing reduced susceptibility to pyrethroids with age it will most likely be correlated 
with a change in those genes associated with resistance, as demonstrated at day 20 in 
females.  
 
Amenya et al. (2008) showed that CYP6P9 is differentially expressed in 3-day old females 
and males (~15- and 3-fold, respectively) of the pyrethroid resistant FUMOZ-R strain. 
Wondji et al. (2009) confirmed that this gene is also differentially expressed in the same 
strain. However, both of these studies amplified CYP6P13 or in combination with CYP6P9 
owing to sequence similarities between them. The present study attempted to elucidate the 
role of these genes in pyrethroid resistance individually and establish the molecular basis 
for age variation in the expression of resistance. CYP6P9 and CYP6P13 were both 
overexpressed in the resistant FUMOZ-R strain relative to the insecticide susceptible 
FANG strain, implying that these genes are associated with pyrethroid resistance in An. 
funestus. 
 
Relative quantification revealed that CYP6P9 had a 67-fold up-regulation in 3-day old 
FUMOZ-R females when compared to the susceptible strain. CYP6P13 showed only a 8-
fold overexpression in females. Both these genes showed either a much higher or lower 
fold expression than the 15-fold overexpression reported by Amenya et al. (2008) using 
samples of the same age.  The discrepancy in the results is due to the fact that these genes 
were now examined individually and not as a combined gene. These results also suggests 
that CYP6P9 and CYP6P13 do not contribute cumulatively to the total fold effect reported 
by Amenya et al. (2008), and that they may not be the only genes that were amplified by 
Amenya et al. (2008) and Wondji et al. (2009). Due to sequence similarity of the P450 
genes it is highly possible that other closely related P450 genes are co-amplified when 
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primers from Amenya et al. (2008) are used. Without a full genome sequence available it 
is difficult to explain the differences observed in the qPCR data. Genes within the same 
P450 sub-family, for example CYP6P, will share a  >55% identity at the amino acid 
sequence level (Feyereisen, 1999). Fourteen CYP6 genes have been identified in An. 
gambiae (Ranson et al., 2002b). Four CYP6P (1-4) genes were aligned and these showed a 
high level of similarity (Ranson et al., 2002b). It is, therefore, possible that the fold-over 
expression reported by Amenya et al. (2008) and Wondji et al. (2009) is the combined 
effect of four genes (assuming the same number of genes in the CYP6 class is present 
between these two species). A study conducted by Cuamba et al. (2010) on An. funestus 
field samples from Mozambique (Tihuquine) showed that CYP6P9a and CYP6P9b were 
overexpressed in both females and males. These genes were also differentially expressed 
when the Tihuquine samples were compared to FANG and a susceptible field samples 
from Mali. Morgan et al. (2010) also found the overexpression of CYP6P9b in females and 
males in the Tororo population when compared to FANG. 
 
 The bioassay data clearly showed that mortality to permethrin increased with age in the 
resistant strain. We analysed the tCNR of both CYP6P9 and CYP6P13 to investigate if 
there is an association between mRNA levels and permethrin mortality over age within the 
resistant strain. The highest tCNR was observed in CYP6P9 (9.30) and CYP6P13 (4.82) at 
10-days old. Permethrin survival of females was also the highest between 3-10 days of age. 
Overall CYP6P9 and CYP6P13 showed decreased absolute mRNA levels over time and 
this was mimicked by bioassay data although the difference was not significant. As 
indicated above it is most likely that these are not the only genes involved and that they 
may function in a cascade manner to detoxify pyrethroids at various stages in the adult 
 63 
female life cycle, a function that is most likely assisted by a number of other gene 
products. 
 
Absolute mRNA levels (given as copy number ratio) in the combined gene effect (CYP6P9 
and CYP6P13) did not alter significantly in association if females had access to blood 
meals, but when these genes were assessed separately the absolute mRNA levels were 
reduced following blood-feeding.  
 
Overall, the male tCNR’s were higher than those of females, in contrast to the bioassay 
data in which males showed a slightly lower survival than females. This discrepancy may 
be attributable to other biological functions (such as pheromone production) that P450s are 
associated with in males (Kasai and Tomita, 2003). This will need to be investigated 
further. 
 
This study has shown the effect of permethrin exposure at different ages in An. funestus 
mosquitoes. Permethrin tolerance generally decreases with age. This part of the study 
also highlighted two important genes that are associated with permethrin resistance in 
adults. Both of these genes show variation in mRNA levels with age. As so little is 
known about their role in pyrethroid metabolism, it is possible that they are only a link 
in a chain of reactions that result in the pyrethroid resistance in this species. Other 
possible metabolic genes and physiological events in addition to these two genes may 
contribute to the production of the resistance phenotype. 
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CHAPTER THREE 
 
Microarray analysis of pyrethroid resistant Anopheles funestus, from 
southern Africa* 
 
3.1 Background 
Expression profiling between different sample types was challenging until the advent of 
the microarray technology. Microarrays enables one to study thousands of genes 
simultaneously. For example, they can be used to compare gene expression levels between 
normal and diseased tissues, help detect single nucleotide polymorphisms (SNPs), and 
enable comparisons between different life stages or treated versus untreated time courses 
(Korkola et al., 2003; Naidoo et al., 2005).  
 
3.1.1 What are microarrays? 
Microarray technology evolved from Southern blotting where fragmented DNA is applied 
to a substrate, which is then probed to a known gene. In 1995, Patrick Brown and 
colleagues from Stanford University developed the first microarray slide to conduct gene 
expression studies (Naidoo et al., 2005). A microarray is an orderly arrangement of 
thousands of sequenced and identified genes printed on silicon chips, nylon membranes or 
a glass surface onto which complementary DNA (cDNA) or gene specific oligonucleotides 
can be spotted (Yang et al., 2005). The DNA microarray slide may contain the entire 
genome of an organism or a group of genes of particular interest. There are two types of 
microarrays. One consists of probes of a known sequence of up to 70 mers of cDNA or 
oligonucleotides. The probes are spotted robotically onto a glass surface. The second type 
                                                
* Footnote: Accepted for publication in Journal of Pesticide Biochemistry and Physiology. See Appendix D, page 149. 
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is the in situ synthesized oligonucleotide array, the Affymetrix GeneChip system. In this 
system, the DNA oligonucleotides are synthesized in situ onto the DNA chip and this is 
done by photolabile protecting groups and photolithographic masks (Lipshutz et al., 1999). 
These Affymetrix arrays consist of oligonucleotides that are 25 base pairs in length.  
  
3.1.2 Microarray experimental design 
Microarray experiments consist of three different categories, which assist the researcher to 
determine their objective/s and these are class comparison, class discovery and class 
prediction (Simon and Dobbin, 2003; Naidoo et al., 2005).  
 
i. Class comparison 
A class comparison design involves comparison between two different samples, for 
example differential gene expression between a susceptible and a resistant mosquito.  
 
ii. Class prediction  
Class prediction involves using the gene expression data obtained by class comparison 
and then using a multi-gene formula to determine to which class a new sample belongs.  
 
iii. Class discovery  
Class discovery involves studies in which the samples are not predetermined to 
different classes prior to the microarray experiment. This involves discovering clusters 
of the samples based on gene expression data and then identifying the genes that 
distinguish these clusters.  
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Before any microarray experiment is carried out, the study design needs to be established. 
There are four types of designs (Figure 3.1). These include the direct comparison design, 
reference design, balanced block design and loop design (Simon and Dobbin, 2003; 
Naidoo et al., 2005).  
 
i. The direct comparison  
This design  (Figure 3.1A) is used to compare two samples e.g. the susceptible RNA 
sample is co-hybridised to the resistant sample on the same slide or untreated to the 
treated sample (Naidoo et al., 2005).  
 
ii. The reference design  
The reference design (Figure 3.1B) is an indirect method in microarray experiments 
(Churchill, 2002). This design uses a common aliquot of reference RNA on every 
array, i.e. each experimental sample is hybridised against a common reference sample. 
The intensity of the spot of the sample of interest is measured or standardized against 
the same spot on the same array for the reference sample (Simon and Dobbin, 2003). 
The reference RNA sample usually has to be available in large quantities (Naidoo et 
al., 2005). This design can be used when one wants to determine differentially 
expressed genes in two different transgenic sample types. The untransformed sample, 
transgenic sample type 1 and transgenic sample type 2 can be individually compared to 
a reference sample. The reference sample consists of a pool of equal amounts of RNA 
from each sample. The reference sample has to be labelled with the same dye in each 
experiment (Naidoo et al., 2005). 
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iii. The balanced block design  
This design (Figure 3.1C) usually compares two groups of samples to each other. For 
example, if one wishes to compare four insecticide susceptible mosquito samples to 
four resistant samples, then the array is set up as follows: on one half of each array a 
resistant sample will be compared to the susceptible sample where the resistant sample 
is labelled with red dye and the susceptible sample labelled with green dye. The 
labelling of the samples will be reversed on the other half of the slide (Simon and 
Dobbin, 2003; Naidoo et al., 2005). A disadvantage of this method is that cluster 
analysis of the expression profiles cannot be performed effectively. One advantage of 
this method is that half the number of slides can be used as compared to the reference 
or direct comparison (Naidoo et al., 2005). 
 
iv. The loop design  
The loop design (Figure 3.1D) links samples together in a loop in an array 
hybridisation. The sample comparisons control for variation in spot size and sample 
distribution patterns using a statistical model (Simon and Dobbin, 2003). In this design, 
two aliquots of each sample and n arrays are used to study n samples. For example, a 
comparison of three, five and 10-day old mosquitoes would enable determination of 
gene expression differentiation by age. It is usually recommended that dye swaps are 
performed using the same sample (technical replicates) or a balanced block design is 
performed by carrying out a loop design with the biological replicates labelled with the 
reverse dyes to account for dye biases (Naidoo et al., 2005). This design results in half 
the variance per estimate, because each sample occurs twice, rather than once, at the 
cost and use of only one chip. 
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Figure 3.1 Diagrammatic representations of the four microarray designs 
An arrow represents each microarray slide. The head of the arrow indicates the sample  
labelled with the red (Cy-5) dye and the tail labelled with the green (Cy-3) dye. (A) The  
direct comparison between a resistant and susceptible sample. (B) The reference design  
using a common reference sample. (C) A balanced block design showing the comparison of  
four resistant samples to four susceptible samples. (D) A loop design compares all samples  
to each other (Naidoo et al., 2005)   
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3.1.3 The microarray technique 
The microarray technique consists of four steps, the first involves manufacturing of the 
microarray slide (Butte, 2002). This entails a chip or glass slide with a special surface 
chemistry. The slide is then spotted with the genes/probes of interest. Probe spotting is 
carried out by robotic arms with fine needles. These are inserted into wells containing the 
probes, and the probes are then spotted onto the slide to create a positional grid. The 
position of each probe is usually determined prior to printing. Control spots are also 
spotted onto a slide. These control spots consist of blank spots containing no probes, 
calibration controls, which contain equal amounts of Cy-3 and Cy-5 dye and ratios spots, 
which contain varying amounts of Cy-3 and Cy-5 dye. Post hybridisation, the control blank 
spots should contain no colour, the calibration controls should be yellow and the ratio spots 
should be varying shades of green or red depending on the amounts of Cy-dye added. The 
control spots indicates how well the labelling or microarray experiment was carried out.  
 
The second step is sample preparation (Figure 3.2). This requires RNA extractions, and 
cDNA/mRNA synthesis of the samples. The samples that are to be compared to each other 
are labelled with either a Cy-5 (red) or a Cy-3 (green) dye. These samples are then mixed 
together and cleaned using purification kits. The cDNA concentration and the Cy-dye 
incorporation are detected to check the quality of the material that is to be hybridised to the 
slide.  The third stage involves washing of the slides. The slides need to be subjected to a 
series of washing steps in specially prepared wash solutions for pre- and post-
hybridisation. This allows for the preparation of the slides for pre-hybridisation and the 
removal of unhybridised probes in the post-hybridisation step. After the pre-hybridisation 
treatment of the slides, the samples are deposited onto the arrays and incubated overnight 
for ± 16 hours. Usually two technical and three biological replicates are carried out. Dye 
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swaps are also considered a form of technical replication. Here, the hybridisations are 
carried out with the reciprocal dye labelling of sample targets in the second hybridisation. 
Dye swaps reduce the dye bias in the red and green intensities. This form of technical 
repeat can only be included if enough sample material is available.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Workflow of a microarray experiment 
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The final stage involves scanning of the slides and data analysis. The slides are scanned 
under standard conditions using a specialised scanner. The features are edited in software 
specific for microarray data analysis. Spot finding is carried out and this involves 
‘flagging’ the poor-quality features or spots (Bajcsy, 2005). The image is quantified into 
numerical values, these values are then run through software packages which allow the 
data to be analysed and interpreted. The microarray software packages TM4 (Saeed et al., 
2003) and Limma (Smyth, 2005) are generally used to carry out the analysis. 
Normalization (van Heerden et al., 2007), background correction and statistical analyses 
are carried out on the microarray data.  
 
3.1.4 Standardizing of microarray data 
Data can be stored in different formats. This is sometimes problematic when data are 
presented and exchanged. The presentation of microarray data is now standardised by 
listing prerequisites. The Minimum Information About a Microarray Experiment 
(MIAME) is one such checklist that describes what information is essential if the 
experiment is repeated and interpreted (Brazma et al., 2001). The MIAME checklist lists 
the following details as essential when sharing data: the raw data file for each hybridisation 
experiment (e.g. GPR files); the final normalised gene expression data; sample annotation 
including experimental factors and their values; experimental design; probe information on 
the microarray slide (e.g. oligo or cDNA probes, control spots); and the laboratory and data 
analysis protocols used (Brazma et al., 2001). 
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3.2 Use of Microarrays to Determine Differentially Expressed 
Detoxification Genes in An. funestus 
Very few studies have been carried out to determine the genes involved in detoxification in 
insecticide resistant An. funestus mosquitoes. Metabolic resistance (detoxification enzyme-
based resistance) in insects is characterized by increased activity of detoxifying enzymes 
such as esterases, cytochrome P450 monooxygenases (cytochrome P450s), and glutathione 
S-transferases (GSTs) (Brogdon and McAllister, 1998; Liu et al., 2006). All three enzyme 
groups are encoded by large gene families and identifying the individual genes associated 
with resistance can be laborious. This task was expedited for An. gambiae by the 
development of a custom microarray specifically designed to detect transcription variation 
in genes associated with insecticide resistance (David et al., 2005). This array was named 
the detoxification chip. The array contains over 255 putative genes. A total of 103 of these 
genes belong to the cytochrome P450 monooxygenase (P450s), 41 are Red/Ox genes, 35 
glutathione S-transferases (GSTs), 31 esterases, 5 ATP-binding-cassette transporters, and 
the remaining are control genes, tissue-specific genes and house-keeping genes (David et 
al., 2005). David et al. (2005) used the chip successfully and identified a number of genes 
up-regulated in DDT and pyrethroid resistant strains of An. gambiae from East Africa. 
Some of these genes were previously implicated in insecticide resistance while others were 
novel, not previously associated with insecticide resistance (David et al., 2005). The detox 
chip has been utilized for screening An. gambiae populations from Kenya and Zanzibar 
(David et al., 2005), Benin (Djouaka et al., 2008), Nigeria (Awolola et al., 2009) and 
Ghana (Müller et al., 2007; Müller et al., 2008b) and has also been successfully used for 
An. arabiensis from Cameroon (Müller et al., 2008a) and An. stephensi from Dubai 
(Vontas et al., 2007). 
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In this study, we aimed to use the An. gambiae detox chip on An. funestus samples, which 
represents a cross-species hybridisation. Cross-species hybridisations are common and 
many studies have successfully identified differentially expressed genes using this method 
(see section Section 3.7). Many factors were considered prior to the implementation of this 
method (Bar-Or et al., 2007). The percentage sequence identity between the reference 
species i.e., An. gambiae (the sample represented on the microarray) and the target sample 
i.e., An. funestus (the sample under study) was determined. The question of whether the 
use of cross-species hybridisation would yield the same results as same-species 
hybridisation was taken into consideration. Grigoryev et al. (2005) and Bar-Or et al. 
(2007) both conducted such studies and found that data sets from both the cross-species 
hybridisation and same-species hybridisation produced similar results. The reproducibility 
of the slides was also considered. Biological and technical replicates were carried out to 
ensure that the results obtained were consistent. The validation of the microarray results 
were confirmed by the use of other techniques such as quantitative PCR (qPCR) (Bar-Or et 
al., 2007).  
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3.3 Aim and Objectives 
To date very few studies have been conducted to determine genes potentially involved in 
insecticide resistance in. An. funestus. The study conducted by Amenya et al, (2005) 
isolated 31 P450 genes and showed that An. funestus P450s have an average of 75% amino 
acid identity to that of An. gambiae. The An. gambiae detox chip was, therefore, used in 
this study as a tool to screen for differentially expressed detoxifying genes in both 
susceptible and pyrethroid resistant An. funestus strains. Selected significantly 
overexpressed genes from the microarray results were validated using quantitative PCR 
(qPCR). 
 
 
3.4 Biological Material  
 
3.4.1 Mosquito strains 
Two An. funestus strains were used in this study. The pyrethroid resistant FUMOZ-R strain 
and the insecticide susceptible FANG strain. Information on the two strains is detailed in 
Chapter Two (Section 2.3). 
 
3.5 Methods 
 
3.5.1 Sample preparation and microarray hybridisations 
Female and male An. funestus adults were separated on the day of emergence and fed on a 
10% sugar solution until they were 3-days old. The detox gene transcription levels in the 3-
day old resistant, FUMOZ-R, adult females were compared to insecticide susceptible 
females of the same age. The same was done for the males. The resistant strain was not 
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exposed to insecticides prior to RNA extractions. This strain has been under selection for 
generations to maintain high resistance levels. Each microarray comparison in all 
experiments consisted of three independent biological and two technical repeats which 
consisted of dye swaps to control for dye bias. A biological replicate involved isolating 
RNA independently from three sets of mosquito samples. The biological replicates served 
to control for biological diversity. The technical replicate involved carrying out the same 
experiment using the same sample on a number of occasions. The technical replicates 
controlled for technical variability in an experiment.  
 
3.5.2 RNA isolation 
Isolation of RNA was conducted using the PicoPure® RNA Isolation kit (Arcturus,  
KIT0204, USA). Extraction buffer (100!l) was added to 15 mosquitoes. These samples 
were homogenised and incubated at 42°C for 30 minutes in a heating block. The samples 
were then centrifuged at 12 000 rpm for two minutes, the supernatant removed and placed 
into a new tube.  A volume of 100!l of 70% ethanol was added to the cell extract and 
mixed thoroughly. A RNA purification column was pre-conditioned by adding 250!l 
conditioning buffer onto the column filters membrane. This was left to incubate for five 
minutes and the column was then centrifuged at 14 000 rpm for one minute. The sample 
and ethanol mix was added onto the pre-conditioned purification column and centrifuged 
for two minutes at 270 rpm, immediately followed by a centrifugation at 14 000 rpm for 30 
seconds. A volume of 100!l wash buffer 1 was added into the purification column and 
centrifuged for one minute at 9 900 rpm. The samples were DNase treated by adding 5!l 
DNase I Stock Solution and 35!l buffer RDD and left to incubate at room temperature for 
15 minutes. The columns were centrifuged at 9 900 rpm for 15 seconds. Wash buffer 2 
(100!l) was added into the purification column and centrifuged for one minute at 9 900 
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rpm. Another 100!l of wash buffer 2 was added into the purification column and 
centrifuged for two minutes at 14 000 rpm. The flow through waste was discarded and the 
column re-centrifuged for one minute at 14 000 rpm. The purification column was added to 
a new 0.5 ml microcentrifuge tube and 30!l of elution buffer was added directly onto the 
membrane of the purification column. The column was incubated at room temperature for 
one minute and centrifuged for one minute at 3 500 rpm to distribute elution buffer in the 
column, and then for an additional one minute at 14 000 rpm to elute the RNA. The 
quantity of RNA was determined using the Nanodrop spectrophotometer (Nanodrop 
Technologies, Wilmington, USA). The RNA was stored at -70°C until further use. 
 
3.5.3 Synthesis of amplified mRNA   
Complementary DNA (cDNA) and amplified mRNA (amRNA) were obtained using the 
RiboAmpTM RNA Amplification Kit (Arcturus, KIT0201, USA). All primers and reagents 
were available from the kit. For the first strand (cDNA) synthesis total RNA (10!l) was 
added to 1!l of primer A. This was incubated at 65°C for five minutes and then cooled at 
4°C for at least one minute. The complete 1st strand master mix (7!l) and 1st strand enzyme 
mix (2!l) was added to the RNA mixture and incubated at 42°C for 45 minutes followed 
by 4°C for at least one minute. To this, 2!l of 1st strand nuclease mix was added and the 
samples were incubated at 37°C for 20 minutes, 95°C for five minutes and then held at 
4°C. 
 
For the 2nd strand synthesis primer B (1!l) was added to the samples and incubated at 95°C 
for two minutes, then chilled and maintained at 4°C for at least two minutes. The complete 
2nd strand synthesis mix (29!l) and 2nd strand enzyme mix (1!l) were added to the samples 
and incubated at 25°C for five minutes, 37°C for ten minutes, 70°C for five minutes and 
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4°C for two minutes. These samples were cleaned using the cDNA purification kit. The 
DNA binding buffer (DB) (250!l) was added to the DNA/RNA purification column for 
five minutes at room temperature and centrifuged for one minute. The second strand 
synthesis mixture was added to 200!l of DB, which was transferred into the purification 
column. The column was centrifuged at 270 rpm for two minutes, immediately followed 
by a centrifugation at 11 000 rpm for 30 seconds to remove flow through. DNA wash 
buffer (DW) (250!l) was added to the column and centrifuged at 14 000 rpm for two 
minutes. The flow through was discarded and the column placed into a clean centrifuge 
tube. DNA elution buffer (DE) (16!l) was placed onto the centre of the purification 
column membrane and centrifuged at 3 500 rpm for one minute, followed immediately by 
14 000 rpm for one minute. The elution was retained for further processing. 
 
In vitro transcription (IVT) was then carried out. To the cleaned samples, the following 
reagents were added for the IVT reaction: 8!l of IVT buffer, 12!l of IVT master mix and 
4!l of IVT enzyme mix. These samples were incubated at 42°C for four hours. DNase mix 
(2!l) was added to each sample and incubated at 37°C for 15 minutes. These samples were 
cleaned using the amplified RNA (amRNA) purification kit. A volume of 250!l of RNA 
binding buffer (RB) was added to the DNA/RNA purification column, incubated for five 
minutes at room temperature and centrifuged at 14 000 rpm for one minute. RB buffer 
(200!l) was added to the IVT samples and pipetted into the purification column and 
centrifuged at 270 rpm for two minutes, immediately followed by a centrifugation at 11 
000 rpm for 30 seconds. The RNA wash buffer (RW) (200!l) was added to the purification 
column, and centrifuged at 11 000 rpm for one minute. A total of 200!l of fresh RW buffer 
was added to the purification column, and centrifuged at 14 000 rpm for two minutes. The 
purification column was placed into a new 0.5 ml micro centrifuge tube provided in the kit 
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and 30!l of RNA elution buffer (RE) was added directly onto the centre of the purification 
column membrane. The columns were incubated at room temperature for one minute and 
centrifuged at 3 500 rpm for one minute, immediately followed by 14 000 rpm for one 
minute.  
 
The amRNA was measured using the Nanodrop spectrophotometer (Nanodrop 
Technologies, Wilmington, USA) and the quality of the amRNA was assessed on a 0.8% 
agarose with 1x RNase-free TAE buffer. The expected yield of amRNA should be between 
30 and 50!g and the A260/A280 ratio should range between 1.8-2.0. A concentration of 
0.5!g of amRNA was mixed with 3!l DEPC-treated H2O and 2!l loading buffer and 
denatured at 70°C for five minutes prior to loading the gel. The amRNA should appear as a 
smear on the gel from 250 to 1 800 bases in length, with the majority of product around 
600 bases in length. 
 
3.5.4 Microarray experiment 
A RNA and primer mix which consisted of 8!g of amRNA for each of the samples, 2!l 
mRNA spike mix (Universal Lucidea Scorecard, Amersham), 1.3!l random hexamers 
(Invitrogen, 48190011, USA) and distilled water was incubated for five minutes at 70ºC. 
The RNA mix was reverse transcribed into Cy-labelled cDNAs using 2!l Cy-3 (GE 
Healthcare, PA53022, UK) or Cy-5-dUTPs (Amersham, PA55022, UK), 4!l 5x RT buffer, 
2!l DTT, 0.4 !l dT-NTPs, 0.7!l RNAsin and 1.5!l Superscript III (Invitrogen, 18080044, 
USA). The samples were incubated at 50ºC for 2 " hours. A mixture of 1M NaOH/ 20mM 
EDTA (1!l) was added to the labelled cDNAs to stop the reaction. The Cy-labelled 
cDNAs that were to be hybridised together were pooled and purified using the 
Cyscribe™GFX™ Purification kit (GE Healthcare, 27960601, UK). Capture buffer 
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(500!l) was added to each Cyscribe column. The labelled samples were added to the 
buffer, mixed thoroughly and centrifuged at 13 000 rpm for 30 seconds. The flow through 
was discarded and 600 !l of wash buffer was added to each column and spun at 13 000 
rpm for 30 seconds. Three washes were done per sample. The columns were transferred to 
a clean microcentrifuge tube and 60!l of elution buffer was added to each column, allowed 
to stand at room temperature for four minutes and centrifuged at 13 000 rpm for two 
minutes. Another 40!l of elution buffer was added to each column, allowed to stand at 
room temperature for four minutes and centrifuged at 13 000 rpm for two minutes. 
 
The concentration of the cDNAs and the binding efficiencies of the Cy-dyes were 
determined using the Nanodrop spectrophotometer (Nanodrop Technologies, Wilmington, 
USA). Samples that had a low cDNA yield (<15ng/!l) and poor dye incorporation (<0.1 
pmol/!l of each dye) were not used in the hybridisation step. Approximately 2!l (5!g) of 
poly dA oligo (Amersham Biosciences, 277836, USA) was added to the purified targets to 
prevent nonspecific hybridisation. The labelled samples were dried in a speed vacuum 
centrifuge for one hour at 30ºC and re-suspended in 15.5!l of hybridisation buffer 
(Corning, 40026, USA). The targets were denatured by incubation at 95°C for five 
minutes. The An. gambiae detox chip was pre-treated using the Universal Hybridisation kit 
(Corning, 40026, USA), according to manufacturer’s instructions. However, the wash 
solutions were made up using three times the amount of components as stated in the 
original An. gambiae protocol, after optimization (David et al., 2005) (Table 3.1). The 
Pronto! Universal Pre-Soak Solution and Pronto! Universal Pre-Hybridisation Solution 
(50ml) were heated to 42ºC for 30 minutes. Sodium Borohydride (500 !l) was added to the 
Pronto! Universal Pre-Soak Solution and left to dissolve for five minutes. The slides were 
incubated in the solution at 42ºC for 20 minutes. The slides were rinsed in two consecutive 
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wash solutions 2 and incubated at room temperature for 30 seconds. The slides were 
incubated in the Pronto! Universal Pre-Hybridisation Solution at 42ºC for 15 minutes 
followed by a wash in wash solution 2 for one minute. This was followed by washing the 
slides in two consecutive wash solutions 3 at room temperature for 30 seconds. The detox 
chip was rinsed in deionised water for two seconds and dried by centrifugation at 2 500 
rpm for 2 " minutes. The slides were stored in a dust/light/humidity free environment. The 
target mix was added to the microarray chips, which were placed into hybridisation 
chambers. The chambers containing the slides were placed into a water bath set at 38°C for 
16 hours. 
 
Table 3.1 Wash solution adjustments for the optimization of An. funestus 
 Reagents An. gambiae 
protocol 
An. funestus 
protocol 
Universal wash 
reagent A 
25ml 75ml 
Universal wash 
reagent B 
1.25ml 3.75ml 
Wash Solution 
1 
(250ml) 
Deionised water 223.75ml 171.25ml 
Universal wash 
reagent A 
25ml 75ml Wash Solution 
2 
(500ml) Deionised water 475ml 425ml 
Wash solution 2 100ml 300ml Wash Solution 
3 
(500ml) 
Deionised water 400ml 200ml 
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After incubation, the slides were washed using the Universal Hybridisation kit (Corning, 
40026, USA). The slides were pre-soaked in wash solution 1 for one to two minutes at 
38°C, followed by a second wash of solution 1 for 2 " minutes and finally incubated in 
wash solution 2 at ambient temperature for five minutes. The slides were subjected to three 
washes in fresh wash solution 3 at ambient temperature for one minute. Excess wash 
solution was removed from the slides by centrifugation at 2 500 rpm for two minutes. 
 
3.5.5 Microarray scanning and data analysis 
The slides were scanned using the Genepix 4000B scanner (Molecular Devices, USA). The 
PMT (photomultiplier tube) values were adjusted to give a ratio of 1:1. The quality of spots 
and background intensities were examined and corrected using the Genepix Pro 6.0 
software (Axon instruments, USA).  
 
The raw intensity values were analysed using the Limma software package version 2.12.0, 
from the BioConductor project, in the R programming environment (Smyth et al., 2005). 
Image plots were generated to inspect the variation of background values across the arrays. 
Background correction was carried out using the ‘normexp’ method (Ritchie et al., 2007) 
with an offset of 50. Within array normalization was performed, using the ‘control’ method 
in Limma to fit a global loess curve through a set of non-differentially expressed control 
spots. This curve was applied to all the other spots, thereby normalizing the M-values for 
each array separately (Smyth and Speed, 2003). Between array normalization was 
performed using the ‘Aquantile’ method to ensure that the A values have the same 
empirical distribution across arrays. To visualize the effect of normalization, MA-plots 
were used. The Limma package uses empirical Bayes analysis to assess differential 
expression, by calculating a B-statistic, a moderated t-statistic and an adjusted P-value for 
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each gene (Smyth, 2004). A top table was generated which revealed the highly 
differentially expressed genes for both the strains of interest. The B-statistics values were 
ranked from the highest to lowest for all the genes. The B-statistics value is the log odds 
that a gene is differentially expressed. If a gene has a B-statistic value of 0 it indicates that 
the gene has a 50% chance that it is differentially expressed. B values and P-values usually 
rank the genes in the same order. A high B-statistics value and a low P-value indicates that 
a gene is significantly differentially expressed. Genes exhibiting adjusted P-values <0.001 
and fold-changes #1.5 were considered as statistically significant overexpressed genes. 
 
The data were deposited into Vectorbase, a database where mostly molecular data or 
information on invertebrate vectors of disease is deposited. This facility allows one to 
browse genomes, deposit microarray and gene expression data and conduct BLAST 
searches (https://www.vectorbase.org).   
 
3.5.6 Quantitative Real-Time PCR (qPCR) 
Quantitative PCR analysis was carried out on 3-day old FUMOZ-R and FANG females 
and males to verify the results obtained from the microarray experiments. Only the top 
three genes common to both females and males were carried forward to qPCR analysis. 
qPCR on the remaining up-regulated genes will be carried out in future studies. Primers 
were designed for genes CYP6M7 and COI.  The primer pair used for the CYP6P9 and 
CYP6P13 genes was the gene-specific primers designed in Chapter Two subsequent to the 
discovery that CYP6P9 is a combination of CYP6P13 and CYP6P9 (Matambo et al., 2010). 
The cDNA probe sequence of the CYP6P3 gene (CYP6P9 ortholog in An. funestus) on the 
detox chip was aligned to both the CYP6P13 (Genbank accession number: EF152577) and 
CYP6P9 (Genbank accession number: EU450763) gene sequences to determine the 
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relationship between the three sequences. The cDNA probe on the microarray slide had a 
81% sequence identity to both CYP6P9 and CYP6P13. Due to both sequences having high, 
similar percentage identities to the cDNA probe, primers for both CYP6P9 and CYP6P13 
were used. 
 
3.5.6.1 RNA isolation 
The RNA samples for qPCR were obtained from the extractions conducted in the 
microarray experiments. The samples were quantified using a Nanodrop ® 
Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA).  
 
3.5.6.2 cDNA synthesis 
Total RNA was converted to cDNA using the High Capacity RNA-to-cDNA kit (Applied 
Biosystems, 4387406). Total RNA (2!g) was added to 10!l 2x RT buffer, 1!l 20x enzyme 
mix and nuclease-free water to give a reaction volume of 20!l. The reaction was incubated 
at 37ºC for one hour, 95ºC for five minutes and at 4ºC for 30 minutes. The quality and 
quantity of cDNA was measured using the Nanodrop ® Spectrophotometer (Nanodrop 
Technologies, Wilmington, DE, USA) and the cDNA samples were stored at -70ºC until 
further use. 
 
3.5.6.3 Primer design 
Primer sequences for CYP6P9 and CYP6P13 were used from Chapter Two. Primers were 
designed for the CYP6M7 and COI genes using the An. funestus gene sequences 
(www.ncbi.nlm.nih.gov/). These primers were designed using Beacon Designer 3.0 
software (Bio-Rad, Hercules, CA, USA). The rsp 7 (EF450776) primers were used as a 
reference gene to normalize data. Two different sets of primers were designed for the 
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CYP6M7 gene (Table 3.2). However, amplification of the product was unsuccessful after 
numerous attempts to optimize the cycling conditions, primer and cDNA concentrations.  
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Table 3.2 Primers used in qPCR 
 
Gene Primer Sequence Fragment Length 
(bp) 
qPCR Annealing/Detection 
Temp (°C) 
 
Reference 
 COI Fwd     5' ATG GAG CAG GAA CAG GAT GAA CAG 3' 
Rev      5' AAT CAA CTG AAG CAC CAG CAT GAG 3' 
75 59.4/79.00 Primer set 
designed in this 
study 
CYP6M7 Fwd1   5' GAA GTG CTG GAA CGT CAT AAC 3' 
Rev1    5' CGG ATA TTT ACG CAG GCT TTC 3' 
 
Fwd2   5' TCA GAT TCC GAA AGA AAG C 3' 
Rev2    5' ATC ACG ATG AAT CGC ATA C 3' 
 
* 
 
 
* 
* 
 
 
* 
Primer set 
designed in this 
study 
CYP6P9 Fwd     5' AGA TGT GAT TGG CAC CTG T  3' 
Rev      5' TCG ATA TTC CAC CGT TTC CT 3' 
232 55/ 82.00 Primer set 
designed in this 
study 
CYP6P13 
 
Fwd     5' CTG GAT CTC CTA ATT ATG ATG AAG TTT TTC 3' 
Rev      5' GTT CAC CGT CTC GCG GAC T 3' 
 
132 59.1/ 81.00 Matambo, 2008 
 rsp 7 Fwd     5' TTA CTG CTG TGT ACG ATG CC 3' 
Rev      5' GAT GGT GGT CTG CTG GTT C 3' 
135 **/ 85.50 Amenya et al., 
2008 
 
* No amplification 
 
** Annealing temperature for the rsp 7 gene is 59.4ºC for COI, 55ºC for CYP6P9 and 59.1ºC for CYP6P13. 
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3.5.6.4 Quantification of CYP6P9, CYP6P13, CYP6M7 and COI 
The qPCR experiments were performed using the Bio-Rad CFX96™ Real-Time PCR 
Detection System (Bio-Rad, Hercules, CA, USA). A total volume of 25!l containing 
12.5!l IQ™ SYBR supermix (Bio-Rad, 1708882), 4!l primer (2.5!M), 1!l cDNA (50ng) 
was used per reaction. A 2-fold serial dilution of cDNA was used for the standard curve 
reaction. Serial dilutions of cDNA for the standard curve were prepared. 
 
The cycling conditions for each primer set are presented in Table 3.2. Each biological 
sample was repeated three times on a plate. Three biological repeats were done on different 
days. All amplified products were sequenced in both directions to confirm the product. The 
data were analysed using the relative quantification method (Pfaffl, 2001).  
 
All qPCR products were cloned into a vector due to the small fragment length of the 
product (as per methods section in Chapter Two). These cloned PCR products were sent to 
Macrogen for sequencing to verify that the correct gene was amplified in qPCR.  
 
 
3.6 Results 
Results from Chapter Two have shown that both females and males are resistant to 
permethrin, although mortality rates varied between the two sexes. Therefore, gene 
expression was determined separately in 3-day old adult females and males of the An. 
funestus FUMOZ-R (resistant) and FANG (susceptible) strains using the An. gambiae 
detox chip. Minor adjustments to the original protocol were made in order to maximize 
hybridisation of the targets to the chip. The hybridisation temperature was reduced from 
42ºC to 38ºC and lower stringency wash buffers and shorter washing times were used. The 
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slides were left in wash solution 1 for 2 " minutes instead of 5 minutes, wash solution 2 
for 5 minutes instead of 10 minutes and the last wash in solution 3 for 1 minute instead of 
2 minutes. These optimized conditions were similar to those used for cross-species 
hybridisation to An. stephensi (Vontas et al., 2007). After optimization of the hybridisation 
conditions, over 90% of the probes were detected as opposed to 55% obtained when using 
the more stringent, original hybridisation conditions described by David et al. (2005) 
(Figure 3.3). The percentage of probes detected was obtained by manually counting the 
number of fluorescent spots on the slides after hybridisation. All technical and biological 
repeats produced comparable results with a correlation consensus of 0.89 for the females 
and 0.91 for the males. The correlation consensus value indicates how reproducible the 
data are between different arrays using the same sample. The closer the correlation value is 
to 1, the stronger the correlation between the samples. 
 
 
 
 
 
 
 
 
Figure 3 .3 Microarray image generated by hybridising the An. funetsus targets onto an  
       An. gambiae chip 
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3.6.1 Microarray data analysis 
The microarray data were run in the Limma software package version 2.12.0, which was 
run in the program R version 2.8.0 (http://cran.r-project.org/bin/windows/base/old/2.8.0/). 
The data were displayed in various ways as a quality measure to detect any inconsistencies. 
An MA plot of the raw data for each array was generated using the command: 
[plotMA(RG,array=1,legend = T,ylim=c(-2,2))]. An MA plot compares the values of the 
green dye (Cy-3) against the red dye (Cy-5), where M is the intensity ratio and A is the 
average intensity for a dot in a plot. The plot contains information on the spike in controls, 
genes and other controls that are present on the array. Most of the non-differential genes 
and controls are expected to fall within the region of 0 and the differentially expressed 
genes fall either above or below 0. From the results obtained in this study, it was found that 
most of the differentially expressed genes and ratios fell either above or below zero. The 
calibration controls and non-differential genes fell in the region of zero as is expected in a 
MA plot (Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 MA plot of a single array 
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The print layout of each slide was also examined. The print layout is the assembly of the 
spots on the arrays. Each array corresponds to a print tip on the print head used to print the 
arrays and the layout of the blocks on the array corresponds to the layout of the tips on the 
print head (Smyth et al., 2006). The print layout can be examined by using the command: 
[RG$printer][imageplot(log2(RG$Rb [,1]),RG$printer,low="white",high="red")]. This 
allows one to view the image in both the green and red fluorescence, hence determining 
any inconsistencies between dyes and slides. An example of the print layout obtained in 
this study (Figure 3.5) showed that there were no inconsistencies between the dye swap 
slides. This can be seen by the reciprocal image produced.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 The print layout of a slide presented in the red channel (A) and the green channel (B)  
A 
B 
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Background correction was carried out for each slide (Figure 3.6). This entails subtracting 
the background intensity from the foreground intensity for each spot using the command: 
[RGb<-backgroundCorrect(RG,method="normexp",offset=50)]. This adjusts the 
foreground in relation to the background intensities and thus generates only positive 
adjusted intensities, thereby avoiding negative and zero corrected intensities.  The spike in 
controls in this plot usually stands out from the other spots. The data presented here show 
that the spots are comparative to standard results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Graph presenting the background correction of a slide 
 
Within array normalisation (Figure 3.7) was carried out. This method normalize the M 
values for each array separately [MA<normalizeWithinArrays (RGb,method= "control", 
controlspots=nonDE)]. The array normalisation data shown here are comparative to 
standard results. 
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Figure 3.7 Graph presenting the within array normalisation of a slide 
 
The plot densities within and between arrays were also examined using the following 
commands respectively, [plotDensities(MA[,1])] and [MAbet<-
normalizeBetweenArrays(MA,method="Aquantile")]. Plot densities display the empirical 
densities for the individual green and red channels on the arrays. This has to be conducted 
to ensure that there are no significant variations between both channels and between arrays 
(Smyth et al., 2006). The density plots produced in one example in this study showed that 
there was very little variation between the dyes (Figure 3.8) and arrays (Figure 3.9) and 
this can be seen by the consistent overlap of the red and green intensity values. 
 
 
 
 
 
 
 
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Presentation of the plot density within arrays 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Plot density graph between arrays 
 
3.6.2 Gene expression analysis 
Genes were considered to be differentially expressed if they demonstrated a B-statistics 
value >2, ±1.5-fold change in expression between the two strains and a P-value of <0.001 
over the entire experiment. No genes were found to be overexpressed in females and males 
from the susceptible An. funestus, FANG, strain. Out of a total of 255 gene probes on the 
An. gambiae detox chip, 1.18% of genes were significantly differentially expressed in the 
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resistant, FUMOZ-R, females as opposed to 9.45% in males, of the same strain. Three 
genes were highly expressed in the females of the resistant An. funestus, FUMOZ-R, strain 
(Figure 3.10). The gene with the highest fold change in expression (5.4-fold) in the females 
was cytochrome P450 gene CYP6P9 (CYP6P3 orthologous gene in An. gambiae) (Table 
3.3). The cytochrome oxidase I gene, COI, was 2.7-fold overexpressed and the third gene, 
also a member of the cytochrome P450 enzyme family, CYP6M7 (CYP6M3 orthologous 
gene in An. gambiae) was 1.8-fold overexpressed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Volcano plot representing genes differentially expressed in females of the  
     An. funestus strain, FUMOZ-R 
     The horizontal line represents the cut off for the level of significance #=0.001 and vertical  
lines indicate cut off for the 1.5-fold change threshold 
 
A total of 24 genes were significantly differentially expressed in males from the resistant, 
FUMOZ-R, strain. Fifty percent of these genes (n=12) belonged to the cytochrome P450 
enzyme group, 17% (n=4) to glutathione S-transferases, 8% (n=2) to Copper-Zinc (Cu-Zn) 
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superoxide dismutase, 8% (n=2) to the thioredoxin (TRX) group and the remaining 17% 
(n=4) to other groups (Figure 3.11). Three genes that were highly expressed and common 
to both sexes included the cytochrome P450 genes, CYP6P9 (CYP6P3 orthologous gene in 
An. gambiae) (6.0-fold), CYP6M7 (CYP6M3 orthologous gene in An. gambiae) (3.6-fold) 
and cytochrome oxidase I, COI (2.9-fold). Other differentially expressed genes in the 
males are shown in Table 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Volcano plot representing genes differentially expressed in males of the An.  
        funestus strain, FUMOZ-R 
The horizontal line represents the cut off for the level of significance #=0.001 and vertical  
lines indicate cut off for the 1.5-fold change threshold 
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Table 3.3 List of genes differentially expressed in females and males of the resistant An. funestus 
strain, FUMOZ-R 
Gene names provided in table are as per An. gambiae naming, except for those where the 
An. funestus specific name has been identified (Amenya et al., 2005) which appears in 
brackets behind An. gambiae names 
 
Gene Name Group Accession Number Fold 
Change 
Adj. P-value 
 
 
Females 
 
CYP6P3 
(CYP6P9) 
Cytochrome P450 AGAP002865 
 
5.4 2.84 x 10 -07 
COI Cytochrome 
oxidase I 
DQ465331 (GB) 
 
2.7 5.11 x 10 -06 
CYP6M3 
(CYP6M7) 
Cytochrome P450 AGAP008213 
 
1.8 8.82 x 10 -04 
Males  
 
CYP6P3 
(CYP6P9) 
Cytochrome P450 AGAP002865 
 
6.0 3.99 x 10 -14 
CYP6M3 
(CYP6M7) 
Cytochrome P450 AGAP008213 
 
3.6 4.13 x 10 -08 
CYP6M2 
(CYP6M8) 
Cytochrome P450 AGAP008212 
 
3.0 8.46 x 10 -09 
COI Cytochrome 
oxidase I 
DQ465331 (GB) 
 
2.9 5.21 x 10 -12 
SOD2 Superoxide 
dismutase 
AGAP005234 
 
2.5 2.7 x 10 -06 
GSTS1-1 Glutathione S-
transferases 
AGAP010404 
 
2.5 5.21 x 10 -12 
TRX1 Thioredoxin AGAP009584 2.4 6.74 x 10 -04 
Actincytopl Actin TIGR: TC48694 2.3 5.96 x 10 -04 
CYP6R1 Cytochrome P450 AGAP008205 2.2 1.30 x 10 -06 
TRX3 Thioredoxin AGAP003338 2.2 6.74 x 10 -04 
Cytochrome_C Cytochrome C AGAP009537 2.2 1.06 x 10 -07 
CYP12f2 Cytochrome P450 AGAP008021 2.2 2.92 x 10 -04 
CYP6AG1 Cytochrome P450 AY745223 (GB) 2.0 1.36 x 10 -04 
CYP9J5 
(CYP9J11) 
Cytochrome P450 AGAP012296 
 
2.0 6.54 x 10 -06 
MnSOD1 Superoxide 
dismutase 
AGAP010517 
 
2.0 2.30 x 10 -05 
SP8898 Serine protease AGAP003642 1.9 2.73 x 10 -04 
CYP9M1 Cytochrome P450 AGAP009374 1.8 4.73 x 10 -05 
GSTS1-2 Glutathione S-
transferases 
AF513639 (GB) 
 
1.7 6.74 x 10 -04 
CYP6Z1 Cytochrome P450 AGAP008219 1.7 1.30 x 10 -06 
CYP6AG2 Cytochrome P450 AY745224 (GB) 1.6 8.50 x 10 -04 
GSTMS3 Glutathione S-
transferases 
AGAP009946 
 
1.6 1.01 x 10 -03 
CYP6M1 
(CYP6M1) 
Cytochrome P450 AGAP008209 
 
1.6 5.96 x 10 -04 
GSTD2 Glutathione S-
transferases 
AGAP004165 
 
1.6 3.18 x 10 -05 
CYP9J3 
(CYP9J12) 
Cytochrome P450 AGAP012291 
 
1.5 7.71 x 10 -04 
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The remaining differentially expressed genes in males from the cytochrome P450 group 
were CYP6M8 (CYP6M2 orthologous gene in An. gambiae) (3.0-fold), CYP6R1 (2.2-fold), 
CYP12f2 (2.2-fold), CYP6AG1 (2.0-fold), CYP9J11 (CYP9J5 orthologous gene in An. 
gambiae) (2.0-fold), CYP9M1 (1.8-fold), CYP6Z1 (1.7-fold), CYP6AG2 (1.6-fold), 
CYP6M1 (1.6-fold) and CYP9J12 (CYP9J3 orthologous gene in An. gambiae) (1.5-fold). 
Genes that were highly expressed in the males from the glutathione S-transferases (GST) 
group included GSTS1-1 (2.5-fold), GSTS1-2 (1.7-fold), GSTMS3 (1.6-fold) and GSTD2 
(1.6-fold). Two genes from the Cu-Zn superoxide dismutase group were also 
overexpressed in the males, SOD2 (2.5-fold) and SOD1 (2.0-fold). Two genes from the 
thioredoxin group were overexpressed, TRX1 (2.4-fold) and TRX3 (2.2-fold). The 
remaining genes were Actincytopl (2.3-fold), Cytochrome_C (2.2-fold) and serine protease 
gene SP8898 (1.9-fold).  
 
Out of a total of 255 genes on the An. gambiae detox chip, 18 probes failed to produce any 
signal on the array (Figure 3.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 Percentage of genes that did not hybridise to the An. gambiae detox chip  
      in both the females and males from FUMOZ-R resistant and the FANG  
      susceptible strains 
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Five of these genes, CYP306A1, CYP6P4, CYP4C28, CYP305A3, and CYP6Z2 belonged to 
the cytochrome P450 group (Table 3.4). Only two genes belonged to the GST group, 
GSTD4 and GSTD3 and the HPX (Peroxidases) group, HPX7 and HPX5. However, a large 
number of genes that did not bind to the microarray slide belonged to the carboxylesterase 
group. These include COEAE1G, COEJHE1E, COEunkn, COEAE1F, COEAE7G, 
COEBE2O and COEBE4C. The remaining genes were superoxidase dismutase (SOD3B) 
and the serine protease gene (SP21408).  
 
Some sequence data for detoxification genes are available for An. funestus (Amenya et al., 
2005) enabling the degree of identity between the An. gambiae probes and their putative 
An. funestus orthologs to be determined. The probe sequences of the genes on the An. 
gambiae detox chip were aligned against the known An. funestus sequences. The 
percentage identities were calculated for differentially expressed genes and one gene that 
did not produce any signal on the slide and these include: COI, CYP6M1, CYP6M8, 
CYP9J11, CYP9J12, CYP6P9, CYP6P13, CYP6M7 and CYP6P4 (Table 3.5). All genes 
had a percentage similarity >40%. The three genes with the highest percentage similarity 
were genes CYP6P9 (81%), CYP6P13 (81%) and CYP6M1 (79.4%). Surprisingly, no 
signal was detected for CYP6P4 despite the 75% sequence similarity between the two 
species.  
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Table 3.4 List of genes that did not hybridise onto the An. gambiae detox chip in both the females 
and males of the resistant and susceptible An. funestus strain, FUMOZ-R and FANG 
respectively 
 
Gene Name Group Accession number 
 
CYP306A1 Cytochrome P450 AGAP004665 
 
CYP6P4 Cytochrome P450 AGAP002867 
 
CYP4C28 Cytochrome P450 AGAP010414 
 
CYP305A3 Cytochrome P450 AGAP005657 
 
CYP6Z2 Cytochrome P450 AGAP008218 
 
SOD3B Superoxide dismutase AGAP010347 
 
GSTD4 Glutathione S-
transferase 
AGAP004381 
 
GSTD3 Glutathione S-
transferase 
AGAP004382 
 
COEAE1G Carboxylesterases AGAP006700 
 
COEJHE1E Carboxylesterases AGAP005833 
 
COEunkn Carboxylesterases AGAP011509 
 
COEAE1F Carboxylesterases AGAP006227 
 
COEAE7G Carboxylesterases AGAP006728 
 
COEBE2O Carboxylesterases AGAP001101 
 
COEBE4C Carboxylesterases AGAP005370 
 
HPX7 Peroxidase AGAP004036 
 
HPX5 Peroxidase AGAP000051 
 
SP21408 Serine protease AGAP004015 
 
 
The low level of sequence identity between some of the probes and their putative target 
genes in An. funestus suggests that some care should be taken in the interpretation of the 
results, particularly given the high level of sequence identity between some detoxification 
genes in the same species (Amenya et al., 2005).  The possibility that the microarray 
results are confounded by cross hybridisation of probes to multiple genes cannot be 
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excluded. Therefore, quantitative PCR was performed to validate the results from the genes 
found overexpressed in both sexes.  
 
Table 3.5 Percentage similarity between cDNA probes on An. gambiae detox chip and the An.    
                    funestus genes 
 
An. funestus gene name An gambiae gene 
name 
Percentage DNA 
similarity (%) 
An. funestus gene 
accession number 
COI COI 50.3 AY423059.1 
 
CYP6M1 CYP6M1 79.4 AY987356.1 
 
CYP6M8 CYP6M2 49.4 AY729660.1 
 
*CYP6P4 CYP6P4 75.0 EU852651.1 
 
CYP9J11 CYP9J5 52.3 AY729662.1 
 
CYP9J12 CYP9J3 43.5 AY729663.1 
 
CYP6P9 CYP6P3 81.0 EU450763 
 
CYP6P13 
 
CYP6P3 81.0 EF152577 
CYP6M7 CYP6M3 54.1 AY729660.1 
 
 
* Indicates gene that did not produce any signal on the array 
 
3.6.3 Validation 
Quantitative PCR (qPCR) was used to validate the microarray results for the three genes 
overexpressed in both sexes. The up-regulation of CYP6P9, CYP6P13 and COI in the 
resistant FUMOZ-R strain in both females and males is presented in Figure 3.13A and 
Figure 3.13B, respectively. The females had a fold change of 67 for CYP6P9, eight for 
CYP6P13 and four for the COI gene. The males had a fold change of 51 for the CYP6P9 
gene, 15 for CYP6P13 and one for COI in the qPCR analysis.  
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Figure 3.13 Comparison of qPCR and microarray results for CYP6P9, CYP6P13 and COI  
                        genes in (A) females and (B) males  
 
 
The comparison of all three genes for the qPCR and microarray data within each sex shows 
that only two genes, CYP6P13 and COI were statistically significant in the females (Figure 
3.13). However, each gene is overexpressed in the resistant strain in both males and 
females although at different levels. One of the reasons for this could be due to the effects 
of the low stringency hybridisation conditions and this could affect fold overexpression 
values. The sequence of the probes present on the array for each gene is different to the 
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sequence of the primers designed for the CYP6P9 and COI genes for the An. funestus 
samples. This could be another contributing factor to the differences seen.  
 
Two sets of primers were designed for the CYP6M7 gene based on sequence information 
from the partial sequence of this An. funestus gene (Amenya et al., 2005) (Table 3.2). 
However, amplification of the product was unsuccessful for both primer pairs even after 
numerous attempts.  
 
3.6.4 Sequencing 
All amplified genes verified in the qPCR experiments were cloned into a vector (as per 
section 2.4.2.6) for sequencing by Macrogen (Korea). A BLAST search was run on the 
COI sequence and this gene had a 98% match to the An. funestus cytochrome oxidase 
subunit 1 (COI) gene, partial sequence (Accession number: AY423059.1). The sequence 
results for the CYP6P9 and CYP6P13 genes are presented in section 2.5.7. 
 
 
3.7 Discussion 
Gene expression in 3-day old An. funestus females and males was determined using the An. 
gambiae detox chip developed by David et al., (2005). This study used cross-species 
(heterologous) hybridisation of An. funestus samples to a An. gambiae microarray platform 
due to the fact that, unlike An. gambiae, a fully sequenced genome for An. funestus is 
currently unavailable. Many studies have successfully evaluated gene expression using non 
species-specific arrays due to lack of availability of arrays. Moody et al. (2002) used 
human microarrays to study gene expression in pigs. They found that the reproducibility of 
microarray hybridisation of pig cDNA to human microarrays was high. Cross-species 
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hybridisation has also been conducted on rhesus macaque monkeys using a human high-
density Affymetrix oligonucleotide array (Chismar et al., 2002). Their results confirmed 
that a large number of genes were differentially expressed, thereby validating the use of 
cross-species hybridisations for nonhuman primate studies. Adjaye et al. (2004) used 
human and bovine fetal brain target samples on a human cDNA microarray. Highly 
expressed genes were obtained and the study proved that using tissues from across species 
to identify co-expressed orthologous genes on a human microarray platform is possible. 
The An. gambiae detox chip has been successfully used to determine the transcriptional 
analysis of pyrethroid resistance in An. stephensi (Vontas et al., 2007) and An. arabiensis 
(Müller et al. 2008a). This is the first study to use microarrays to determine the genetic 
basis of pyrethroid resistance in An. funestus.  
 
The heterologous hybridisation approach was used successfully in this study and 
approximately 90% of the probes were detected. Three genes common to both sexes, were 
differentially expressed, CYP6M7, CYP6P9 and COI whilst CYP6P9, CYP6P13 and COI 
(although at higher levels when compared to microarray results) were confirmed to be 
overexpressed in association with pyrethroid resistance using qPCR analysis. The fact that 
CYP6M7 could not be amplified from An. funestus mRNA could possibly imply that it is a 
pseudogene, but further studies are needed before such a conclusion is made. The lower 
hybridisation stringencies can result in hybridisation of another closely related P450 gene 
to the CYP6M7 probe. This hypothesis can only be validated when a full genome sequence 
of An. funestus is available. Wondji et al. (2009) also attempted to amplify the CYP6M7 
gene using a different primer set from the ones used in this study and also failed to obtain 
amplicons.  
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The CYP6P9 gene has been implicated in insecticide resistance in An. funestus in various 
studies (Amenya et al., 2008; Wondji et al., 2009) prior to differentiation of this gene. 
Therefore, in this study, the CYP6P9 and CYP6P13 primers were designed in the regions 
that contained nucleotide base pair differences to differentiate between these two duplicate 
genes. This would ensure that the product obtained was the correct product. The fact that 
this gene (CYP6P9) was identified through a cross-species microarray holds promise for 
other similar studies.  
 
Interestingly, the CYP6P3 (An. gambiae ortholog) was also found to be differentially 
expressed (2.82-fold) in field caught An. gambiae adults from Ghana (Müller et al., 
2008b). The CYP6P3 gene was also found at significantly high levels (2.6-fold) in An. 
arabiensis adults from Cameroon (Müller et al., 2008a). This gene was also found to be 
overexpressed in pyrethroid resistant populations from Benin and Nigeria (Djouaka et al., 
2008). 
 
In this study, the COI gene has been found to be differentially expressed in the pyrethroid 
resistant FUMOZ-R females. The COI gene was also found to be differentially expressed 
in an An. arabiensis resistant strain (Nardini, per comms). The mitochondrial cytochrome 
oxidase I (COI) gene has been used as a genetic marker in evolutionary studies and serves 
to transfer electrons and protons across the membrane (Lunt et al., 1996). The abundance 
of the mitochondrial COI transcripts in the females from the resistant strain may play a role 
in the control of insecticide resistance and, therefore, resistance should also be studied at 
the mitochondrial level as well as at the nuclear stage. This might explain why the females 
were more resistant than the males (Chapter Two). However, functional genomic studies 
would be needed to confirm this. It should be noted that the COI gene was overexpressed 
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in both the females and males at almost the same level (females: 2.7 fold; males: 2.9 fold). 
However, in the qPCR analysis, the fold change differed between the two sexes (females: 
4.0 fold; males: 1.0 fold). The results from the qPCR analysis however are more accurate 
due to the use of gene specific An. funestus primers as opposed to the probes on the detox 
chip, which are An. gambiae specific. Hence, the interpretation of the results is based on 
the qPCR results. 
 
The observation that additional genes were up-regulated in males in the FUMOZ-R strain 
was surprising given that the resistance phenotype finds a stronger expression in females 
(Chapter Two). It is possible that these 21 additional differentially expressed genes are 
unrelated to the resistance phenotype. It is interesting to note that several of them are 
putatively involved in the oxidative stress response (superoxide dismutases (SOD) (Chary 
et al., 1994; Jamieson et al., 1994; Park et al., 2005), thioredoxins (TRX) (Bauer et al., 
2002) and glutathione S-transferases (GSTs) (Zou et al., 2000; Singh et al., 2001; Ding et 
al., 2003). This suggests that male mosquitoes experience oxidative stress in a different 
manner to that of females.  
 
A total of 12 cytochrome P450s were significantly differentially up-regulated in the males 
as opposed to only two in the females. This difference may be ascribed to other biological 
functions (such as pheromone production) that P450s are associated with in males. 
Cytochrome P450 enzymes are also involved in the metabolism of other xenobiotics 
(Bergé et al., 1998; Scott and Wen, 2001). The role of these P450’s in resistance needs to 
be clarified and it is unclear why there are additional up-regulated genes in the males, 
warranting further investigation. 
 
 105 
Insect P450s also function in oxidative metabolism of insecticides. Monooxyegenases 
serve many functions but their most prominent role in Anopheles mosquitoes has been 
mediation of resistance to insecticides (Scott and Wen, 2001). Insect P450s consist of 6 
CYP families, CYP4, 6, 9, 12, 18 and 28 (Bergé et al., 1998; Hemingway and Ranson, 
2000). The CYP4, CYP6 and CYP12 classes are found at elevated levels in insecticide 
resistant honeybees (Claudianos et al., 2006), An. funestus (Amenya et al., 2008) and 
houseflies (Tomita and Scott, 1995). The CYP6 class has been reported to play a role in 
insecticide resistance in An. gambiae (Nikou et al., 2003; Müller et al., 2007; Müller et al., 
2008b). The CYP6M2 gene, which was found to be overexpressed in males in this study, 
was also found at high levels in studies by Djouaka et al. (2008) and Müller et al. (2008b). 
The CYP6 and CYP9 class featured among the genes up-regulated in males. The study 
conducted by David et al., (2005) also found the CYP6Z1, GSTS1-2, CYP612F2 and 
CYP9J5 genes overexpressed in the An. gambiae strains. In a study conducted by Nikou et 
al. (2003), the CYP6Z1 gene was found to be overexpressed in the An. gambiae strain. 
 
The genes SOD1 and SOD2 have been found to be up-regulated in FUMOZ-R males. 
Superoxide dismutase (SOD) is active during defence against reactive oxygen species, 
which plays a role in cellular and DNA damage (Park et al., 2005). For example, fungus 
lacking SOD1 are more susceptible to oxygen and superoxide generating agents (Chary et 
al., 1994; Jamieson et al., 1994). It is thus suggested that FUMOZ-R males are more 
susceptible to oxidative stress than females explaining the differential expression of SOD 
genes in males. Duttaroy et al., (2003) showed that a decreased level of the SOD2 gene 
resulted in a reduction in the life span in Drosophila. SOD2, which is found in 
mitochondria, contains the bulk of detoxifying superoxide radicals. Therefore, the lack of 
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SOD2 activity will affect the life span of insects (Duttaroy et al., 2003). The biological 
effect of the SOD genes on male longevity in FUMOZ-R will have to be investigated.  
 
TRX1 and TRX3 genes were differentially expressed in males. Thioredoxins play an 
important role in cellular function in insects such as cellular response to oxidative stress 
(Bauer et al., 2002). The high levels of expression of the TRX genes in males in FUMOZ-
R also suggests that males are more susceptible to oxidative stress when exposed to 
insecticides. 
 
Four different glutathione S-transferases (GSTs) GSTS1-1, GSTS1-2, GSTD2 and GSTMS3 
were up-regulated in the males. GST genes, like the SODs and TRX genes, have been 
implicated in protection against oxidative stress and the detoxification of endogenous and 
xenobiotic compounds (Zou et al., 2000; Singh et al., 2001; Ding et al., 2003).  
 
 Only eighteen probes did not hybridise to the RNA target. A large portion of those probes 
(38%) belongs to the COE group with 28% from the P450 family. Surprisingly, two P450 
genes, CYP6P4 and CYP6P1, which were significantly differentially expressed in a study 
by Wondji et al., (2009) did not hybridise to the array. The study conducted by Cuamba et 
al., (2010) also failed to attain elevated levels of the CYP6P4 gene in An. funestus. The 
CYP6P1 and CYP6P4 genes have been shown to have amino acid identity to that of An. 
gambiae, of 82% and 89% respectively on small partial sequences analysis (Amenya et al., 
2005). It is unknown why these genes did not hybridise to the slide. This will have to be 
investigated. 
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In addition to the 38% of carboxylesterases not hybridising to the slide, no 
carboxylesterases were found to be differentially expressed in females and males. High 
levels of esterases are known to mediate insecticide resistance in mosquitoes (Hemingway 
et al., 2004). However, to date, no reports have implicated carboxylesterase genes in 
resistance in An. funestus.  
 
The An. gambiae detox chip provided valuable information in terms of identifying 
potential genes involved in pyrethroid resistance in An. funestus. It is acknowledged that 
heterologous hybridisation is most likely to produce an under representation of differential 
expression of detoxifying genes, but it is currently the only tool available to screen 
multiple probes at once. This is a useful and an informative alternative given that the 
development of a species-specific An. funestus array will require full genome sequencing. 
This information will ultimately be used to understand the underlying mechanisms 
involved in pyrethroid resistance in this important malaria vector.  
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CHAPTER FOUR 
 
Expression profile analysis of detoxification genes in different life stages 
of Anopheles funestus 
 
4.1 Background 
A mosquito’s life cycle consists of four different phases. These include the egg stage, four 
larval stages, a pupa and an adult stage. The first three phases are aquatic and the adult 
phase is terrestrial. Such variation in habitat coincides with the development of a genome 
that accommodates a wide array of adaptive characteristics.  Larvae and pupae in water are 
potentially exposed to chemical waste, algae and the toxic by-products of decomposed 
animal and plant matter all of which may affect their survival. Adults may be exposed to 
insecticides, blood contaminants from mammal hosts and other substances that could prove 
to be potentially harmful to them.  Detoxification enzymes can provide protection against 
xenobiotic compounds in their natural environment. Previous studies have shown that an 
array of detoxification enzymes including cytochrome P450 monooxygenases (P450s), 
glutathione S-transferase (GSTs) and esterases are present at varying levels in different life 
stages in An. gambiae (Strode et al., 2006). This suggests that these genes play different 
roles in the mosquito’s life cycle. Variation in the expression of these enzymes through the 
developmental stages in An. funestus is currently undocumented. 
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4.2 Aims and Objectives 
The aim of this study was to determine the transcription profile of the detoxification genes 
in the first instar (early aquatic stage), fourth instar (late aquatic stage) and 3-day old adult 
mosquitoes. The larval and adult stages of a mosquito are exposed to different 
environmental conditions e.g. diet and toxins. Quantifying differential expression of these 
genes at the different life stages will provide some insight into their role and function. As 
this study examined only the profile of detoxification genes in An. funestus, qPCR was not 
carried out. This will be investigated further in future studies.  
 
 
4.3 Biological Material  
 
4.3.1 Mosquito strains 
The An. funestus pyrethroid resistant strain, FUMOZ-R, was used for this experiment. 
Cohorts of FUMOZ-R eggs were reared either to first or fourth instar larvae. All larvae 
were maintained on a diet of brewers yeast and ground dog biscuits. A mixture of 3-day 
old adult females and males (±8 adults each) were also collected.  
 
 
4.4 Methods 
RNA extractions were carried out for the adults (8 females and 8 males), first (±60) and 
fourth instar (±11) larvae. Microarray experiments were set up to allow for gene expression 
comparisons between first and fourth instar larvae, fourth instar larvae and adults and first 
instar larvae and adults. The indirect microarray design (Simon and Dobbin, 2003) was 
used to compare the expression profile of first instar larvae to that of fourth instar larvae. A 
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similar design was also used to compare expression profiles between fourth instar larvae 
and 3-day old adults (Figure 4.1). These data were then used to analyse differentially 
expressed genes between first instar larvae and adults without conducting additional 
experiments (Novoradovskaya et al., 2004; Naidoo et al., 2005). The procedures for the 
RNA extractions and microarray experiments can be found in Chapter Three. Details on 
data analysis are presented in section 3.5.5. 
 
 
 
Figure 4.1. Design of microarray experiments using the indirect microarray design 
 
 
4.5 Results 
Hybridisation of the An. funestus targets resulted in over 90% of the probes being detected. 
Genes that displayed a B-statistics value >2, ±1.5-fold change in expression and a P-value 
of <0.001 in the statistical analysis were considered to be differentially expressed.  
 
Six probes failed to produce any signal on the array when a comparison was carried out 
between the first and fourth instar larvae and these include CYP305A4, SP21408, PX2, 
PX3, TRX2 and Flightin. Genes that failed to produce any signal on the array between the 
fourth instar and 3-day old adult comparison include SP21408, PX2, PX3 and TRX2.The 
genes PX2, PX3 and TRX2, however had hybridised on the slides used in the FUMOZ-R 
and FANG comparison. One reason for this occurrence could be due to printing errors. 
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4.5.1 First instar and fourth instar larvae comparison 
Microarray comparisons were conducted between first and fourth instar larvae to 
determine which genes were being differentially expressed at these aquatic life stages. Out 
of 255 gene probes present on the An. gambiae detox chip, 76 genes (30%) were 
significantly differentially expressed, of which 67 showed increased gene transcription in 
the first instar larvae. Only nine genes were differentially expressed in the fourth instar 
larvae (Appendix B). Twenty two (33%) of the genes differentially expressed in the first 
instar larvae belonged to the P450 enzyme group.  
 
Ten genes (15%) belonging to the esterase group, seven (10%) to GSTs, three (5%) to the 
serine protease (SP) genes, four (6%) to peroxidase (HPX) genes, three (4%) to the ABC 
transporter (ABCC) group, two (3%) to the NIT, thioredoxin peroxidise (TPX) and 
thioredoxin reductases (TRX) group and 12 (18%) to other groups, showed increase 
transcription (Figure 4.2). Information regarding the total number of gene groups present 
on the slide and the number of these genes within each gene family/class, differentially 
expressed on the slide is presented in Appendix B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Proportions of genes differentially expressed by class in first instar larvae when compared  
to the fourth instar larvae 
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The top five genes differentially expressed in the first instar larvae include COEAE1A (5.5-
fold), CYP6M2 (4.6-fold), ABCC11 (4.4-fold), TubulinA (4-fold) and XD18014 (3.9-fold) 
(Figure 4.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Volcano plot representing the top ten genes differentially expressed in the first and     
     fourth instar larvae of the An. funestus strain, FUMOZ-R 
 The horizontal line represents the cut off for the level of significance !=0.001 and vertical  
 lines indicate cut off for the two-fold change threshold  
 
Genes differentially expressed in the fourth instar larvae include nine genes of which the 
most differentially expressed are CYP4G17 (2.4-fold), SOD2 (2.2-fold), GRX1 (2.1-fold), 
GSTU1 (1.8-fold), NIT8537 (1.8-fold), COI (1.8-fold), JV1 (1.8-fold), RPL19 (1.5-fold) 
and MnSOD1 (1.5-fold) (Appendix B). 
 
4.5.2 First instar larvae and 3-day old adult comparison 
A comparison between first instar larvae and 3-day old adult mosquitoes revealed that 96 
(38%) genes were differentially expressed out of a total of 255 genes on the slide. Ninety 
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one of these were differentially expressed in the first instar larvae (Appendix B) and the 
other five were differentially expressed in the adults.  
 
A breakdown of those genes showing increased transcription levels in the first instar larvae 
revealed that the bulk (39%; n=35) were P450s. Analysis revealed that only 16 (18%) and 
14 genes (15%) of the esterase and GST genes respectively were differentially expressed. 
The remaining differentially expressed genes in the first instar larvae include 4 (5%) 
belonging to the HPX group, 3 (3%) to the SP group, 2 (2%) belonged to the NIT, 
glutathione peroxidase (GP) and Tubulin groups and 13 (14%) belonged to other groups 
(Figure 4.4).  
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Proportions of genes differentially expressed by class in first instar larvae when compared  
to the 3-day old adults 
 
The top five genes that were the most highly expressed in the first instar larvae were again 
COEAE1A (21.0-fold) and four other genes: CYP4H24 (11.2-fold), COEAE3G (7.9-fold), 
HPX15 (7.0-fold) and TubulinA (6.9-fold) (Appendix B). 
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Figure 4.5 Volcano plot representing the top ten genes differentially expressed in first instar larvae  
and 3-day old adults of the An. funestus strain, FUMOZ-R 
The horizontal line represents the cut off for the level of significance !=0.001 and vertical  
lines indicate cut off for the two-fold change threshold 
 
Only five genes were differentially expressed in the adult mosquitoes (Figure 4.5): JV2 
(4.3-fold), AGM1 (2.5-fold), CYP4G17 (2.3-fold), COI (2.1-fold) and MnSOD1 (1.6-fold) 
(Appendix B).  
 
4.5.3 Comparison between fourth instar larvae and 3-day old adults  
Fourth instar larvae and 3-day old adult mosquitoes were compared to each other to 
represent the change in detoxification genes of late aquatic stage vs. adults. Results showed 
that a total of 42 (17%) genes were differentially expressed on the slide, between these 
samples. Thirty five were differentially expressed in the fourth instar larvae (Appendix B) 
while seven genes were differentially expressed in the adult stage.  
 
The differentially expressed genes in the fourth instar larvae include nine (25%) P450s, 
seven (20%) GSTs and six (17%) esterases. The remaining genes include two (6%) genes 
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belonging to the tubulin and the glutathione peroxidase (GP) group and nine (26%), 
belonging to other groups (Figure 4.6). 
 
 
 
 
 
 
 
 
Figure 4.6 Proportions of genes differentially expressed in fourth instar larvae when compared to  
3-day old adults 
 
The top five genes which were most highly expressed in the fourth instar larvae 
include CYP4H24 (4-fold), CYP325D1 (3.9-fold), TubulinB (3.7-fold) and GSTD10 
(2.8-fold) (Figure 4.7). COEAE1A (3.9-fold) was also highly expressed as in the previous 
two analyses (section 4.5.1 and 4.5.2). 
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Figure 4.7 Volcano plot representing the top ten genes differentially expressed in fourth instar larvae  
and 3-day old adults of the An. funestus strain, FUMOZ-R 
The horizontal line represents the cut off for the level of significance !=0.001 and vertical  
lines indicate cut off for the two-fold change threshold 
 
In the adults seven genes were differentially expressed including two P450s and five other 
genes (Appendix B). Those showing highest differential expression were: JV2 (5.2-fold), 
AGM1 (2.8-fold), CPLC8 (2.2-fold), TPX2 (2.0-fold) and Cytochrome_C (2.0-fold) (Figure 
4.7). 
 
4.5.4 Genes expressed at specific life stages 
The differential expression of certain genes was unique to a life stage, particularly in first 
instar larvae. These genes are listed in Table 4.1. 
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Table 4.1 Life stage specific genes* 
 
First instar Fourth instar Adults 
CYP301A1 COEAE2G GPRNPY3 SOD2 AGM1 
CYP307B1 COEAE3D AMYL JV1 JV2 
CYP314A1 COEAE3G CAT1 GSTU1  
CYP49A1 COEAE5G Actincytopl GRX1  
CYP4AA1 GSTD1-3 ABCC11 RPL19  
CYP4C26 GSTD1-6 XD18014 NIT8537  
CYP4C27 GSTD11 AD20590   
CYP4D16 GSTD6 NADPH_P450_red   
CYP4D22 GSTE1 TRXR   
CYP4H14 GSTU2 GSG8   
CYP4H18 GSTZ1 AP7862   
CYP4H19 SP8898 Xanthdehydro   
CYP4H24 SP8907    
CYP4J5 HPX15    
CYP6M2 HPX5B    
CYP6P2 HPX8    
CYP6P5 HPX9    
CYP9K1 NIT8503    
COE13O NIT8730    
COEAE1A ACE1    
COEAE2A ACE2    
COEAE2D TubulinA    
 
*Details on these genes are listed in supplementary tables provided in Appendix B 
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4.6 Discussion 
This study used the indirect (reference) design approach to carry out the microarray 
experiment. The reference design method uses a common reference RNA sample (Naidoo 
et al., 2005), in this case fourth instar larvae, which is compared to samples of interest i.e. 
first instar larvae and 3-day old adults. To account for dye effects, reverse-dye comparison 
was incorporated into the biological replicates. One of the reasons why this method was 
undertaken was due to the reduced number of microarray slides utilised and the reduced 
cost of reagents. In this study, 12 slides were used for hybridisations as opposed to 18 if a 
direct comparison between each sample was undertaken. Like most microarray designs, 
this method has its advantages and disadvantages. One of the disadvantages is that gene-
specific dye bias can occur when using this method (Naidoo et al., 2005). However, this 
can be overcome by performing reverse dye comparison, as was done in this study. One of 
the advantages of this method is that if a large quantity of reference sample is available, 
this design can be extended to accommodate a large number of sample comparisons 
(Naidoo et al., 2005). An added advantage is the reduced cost of microarray reagents and 
number of slides used.  
 
Gene expression profiles between the three different life stages of An. funestus (i.e. first 
and fourth instar larvae, first instar and 3-day old adults, and fourth instar larvae and 3-day 
old adults) were determined using the An. gambiae detox chip. A large number of genes in 
each comparison were differentially expressed. In addition, a large number of differentially 
expressed genes were common in all life stage. It is likely that the enhanced expression of 
these genes at particular life stages is important to each respective stage in terms of 
physiological regulation and development.   
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These results will provide some insight into the role and function of these genes. 
Interestingly, a larger number of genes were differentially expressed when comparing first 
instar (early aquatic stages) with either fourth instar larvae (late aquatic stage) or adults. 
Contrary to this the comparison between the late aquatic stage and adult stage revealed a 
relatively low number of genes being differentially expressed.  
 
Most metabolic enzyme classes were found to be expressed at high levels during the larval 
stages, particularly in the first instar larvae. These gene groups include cytochrome P450 
monooxygenase, esterase, glutathione S-transferase, ABC transporter, serine protease, NIT, 
thioredoxin peroxidase, peroxidase, tubulin and thioredoxin.  
 
These data show that the P450s, esterases and GSTs are the most differentially expressed 
and it is interesting because these gene families are also involved in metabolising 
insecticides. The P450s differentially expressed in the larval stages belong to the CYP4, 
CYP6, CYP9 and other families, however, no genes from the remaining CYP12 gene 
family were differentially expressed. Cytochrome P450 monooxygenase is an important 
metabolic system that is involved in regulating compounds such as hormones, steroids, 
fatty acids and xenobiotics (Werck-Reichhart and Feyereisen, 2000; Scott and Wen, 2001; 
Liu et al., 2006) and the metabolism of pheromones (Bergé et al., 1998). However, other 
classes of P450 such as the CYP314A1 (shade) gene, which belongs to the Halloween gene 
set, was differentially expressed in the first instar larvae. They have been found to play a 
role in embryonic development in D. melanogaster (Chavez et al., 2000) and ecdysis and 
adult ovary development (Rewitz et al., 2006; Strode et al., 2006). This gene was also 
found to be expressed at high levels in larvae, pupae and adults in An. gambiae (Strode et 
al., 2006). The biological function of this large enzyme family is extremely diverse, 
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complex and poorly understood. This study emphasizes the need to enhance and accelerate 
future studies in this field.  
 
Many esterase transcripts were also differentially expressed in the larval stages. In contrast 
to this no esterase transcripts were found to be differentially expressed in adults. 
COEAE1A was the only esterase gene showing a high level of transcription in any of the 
larval comparisons (first vs. fourth and first vs. adult) and in the comparison between 
fourth instar larvae and adults. This implies that transcription of esterase genes is most 
important during the larval stages although their exact function is still unknown. Esterases 
are generally involved in the metabolism of lipids and fats in Drosophila larvae (Campbell 
et al., 2003), the detoxification of xenobiotics (Russell et al., 1996), detoxification of 
insecticides (Wheelock et al., 2008) as well as hydrolysis of the juvenile hormone and 
neurotransmitter acetylcholine (Taylor and Radic, 1994; Riddiford et al., 2003).  
 
Only a few esterases were differentially expressed that metabolise ß esterase substrates. 
However, a large number of esterases that metabolises !-naphthyl acetate type substrates 
were differentially expressed in most of the comparisons. This study however, did not aim 
to identify the function of the individual genes that were differentially expressed. 
 
Various members of the GST enzyme family are associated with insecticide resistance 
(Grant, 1991; Grant et al., 1991), metabolism and detoxification of endogenous and 
exogenous compounds (Ortelli et al., 2003; Hemingway et al., 2004), stress physiology, 
intracellular transport and numerous biosynthetic pathways (Wilce and Parker, 1994; Ding 
et al., 2003). The group of GSTs that was the most differentially expressed in all life stage 
comparisons belonged to the delta group. Insect delta GSTs are known to play a key role in 
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detoxifying xenobiotics including insecticides and plant allelochemicals (Mittapalli, et al., 
2007). 
 
All three of the above-mentioned enzyme groups have various biological functions and it is 
almost impossible to speculate on their individual roles in pyrethroid resistance in An. 
funestus. However, it is highly likely that these enzyme families are involved in 
biosynthesis pathways and detoxifying foreign compounds ingested by the aquatic stage 
larvae. These functions are shared with other gene families such as the ABC transporter 
genes and ACE genes. ABC transporter genes are thought to play a role in protecting 
mosquitoes from the toxic chemicals in their environment by metabolizing them (Roth et 
al., 2003). ABC transporters act as a cells first line of defence, but do not function in the 
same way as detoxification mechanisms. Their functions are associated with transport 
processes and act by binding the ATP-binding domain and hydrolysing ATP to provide 
energy to transfer a range of molecules (e.g. toxic) across concentration gradients (Roth et 
al., 2003). 
 
Structural genes such as tubulin and cuticular genes were also differentially expressed. 
Tubulin, which was differentially expressed in the larvae, form part of the structural genes 
that contribute to the components of the cytoskeleton that mediate shape, motility, cell 
division and control of substances in the cell (Nielsen et al., 2010). The TubulinA and 
TubulinB genes could be providing these functions in the larvae.  
 
Immune genes such as serine protease were also differentially expressed. These genes are 
involved in immune protection against microbial agents. Other genes protecting against 
oxidative stress were also found to be differentially expressed in the larval stages and 
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included superoxide dismutases (SOD), peroxidases (PX), thioredoxin reductases (TRX), 
and thioredoxin peroxidases (TPX) (Zou et al., 2000). 
 
A number of genes were also exclusively highly differentiated in the adults. Two genes, 
JV2 and AGM1, proved to be highly transcribed in the adults regardless of which larval 
stage they were compared to. The AGM1 transcript is a midgut maltase, which is 
associated with sugar meal digestion (Ribeiro, 2003). As the adult mosquitoes were 
provided with a sugar solution it is not surprising that this gene was expressed in adult 
mosquitoes and not in the larvae.  Based on this analysis, it is suggested that the cuticle 
gene, JV2, is adult specific. It is not unexpected to find a cuticle gene highly expressed as 
cuticle genes are essential for cuticle deposition in adults (Wood et al., 2010). Studies 
conducted by Djouaka et al. (2008) and Awolola et al. (2009) also have found 
overexpression of cuticular genes in pyrethroid resistant An. gambiae. 
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CHAPTER FIVE 
 
General Discussion and Conclusion 
 
5.1 Discussion 
The emergence of insecticide resistance in An. funestus has hampered both the control of 
this vector as well as transmission of the disease. Understanding the underlying 
mechanisms involved in insecticide resistance greatly facilitates our capabilities to develop 
novel or better insecticides.  
 
Pyrethroid resistance in southern African An. funestus populations have been shown to be 
metabolic in nature and mostly due to increased monooxygenase activity (Hargreaves et 
al., 2000; Brooke et al., 2001; Casimiro et al., 2006; Cuamba et al., 2010). This study 
aimed to contribute additional information to this complex mechanism of pyrethroid 
resistance in An. funestus. This was firstly attained by determining the effect of age on 
pyrethroid resistance and examining the gene expression of two P450 genes; namely 
CYP6P9 and CYP6P13, at different ages. The second was to identify changes in gene 
transcript levels associated with resistance by using the An. gambiae detox chip. The third 
and final aim in this study was to investigate how these detoxification gene transcripts 
change between three different life stages in An. funestus.  
 
5.1.1 Effect of age on pyrethroid resistance and the gene expression of CYP6P9 and 
CYP6P13 at different ages 
In the first part of this study, adults of different ages and of both sexes were exposed to 
0.75% permethrin. It was found that in both sexes tolerance to permethrin decreased with 
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increasing age and reached its lowest point at day 14. The intake of a blood meal in 
females also did not have a significant effect on the percentage mortality when compared 
with unfed females of the same age. Female An. funestus can only become malaria 
infective when they reach an age of 10 to 14-days. The data from this study has shown that 
females older than 14-days old were more susceptible to insecticide than younger females. 
Reducing the vector population at this age and when the mosquito is older is imperative in 
any vector control intervention. The spraying of insecticides indoors will target and kill 
mosquitoes as soon as they enter houses for blood feeding and insecticide resistance 
interferes with the effectiveness of such an intervention. Pyrethroid resistance in An. 
funestus, from Mozambique, peaks when the risk to infection is also high which will in 
turn, enhance its ability to transmit the disease. 
 
The gene expression of CYP6P9, CYP6P13 and the combined effect of both genes were 
also determined by age and sex in a resistant strain of An. funestus mosquitoes. This was 
done to determine if these genes by themselves can explain the change in resistance 
observed over age. CYP6P9 has previously been shown to be expressed at high levels in 
insecticide resistant An. funestus mosquitoes (Amenya et al., 2008; Wondji et al., 2009). 
However, these studies were done without separation of the individual duplicate genes, 
CYP6P9 and CYP6P13. Therefore, the up-regulation of CYP6P9, CYP6P13 and the 
combined effect of both genes was determined in 3, 5, 10, 14, 20 and 30-day old female 
and male pyrethroid resistant An. funestus. The variation in gene expression of the 
combined genes (CYP6P9 and CYP6P13), and CYP6P9 and CYP6P13 individually, in 
FUMOZ-R females and males, was shown to vary with age. Also, the combined effect 
results were not comparative to the addition of the gene expression of the CYP6P9 and 
CYP6P13 genes, indicating that there may be other genes contributing to the effects seen.  
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This study is comparable to other studies conducted on age and gene expression. Work 
done by Lemos et al. (1996) showed that the expression of trypsin and aminopeptidase 
genes varied at different ages of An. gambiae mosquitoes. Marinotti et al. (2006) showed 
that variation of age and the intake of a blood meal in the same species resulted in the 
down-regulation in approximately 5% of all genes.  
 
5.1.2 Changes in gene transcript levels in adult An. funestus 
For the second part of the study, the transcript profile of detoxification genes in pyrethroid  
resistant An. funestus was determined using the An. gambiae detox chip. The comparison 
between the resistant FUMOZ-R and the susceptible FANG strain showed that no genes 
were differentially expressed in the susceptible mosquitoes for both sexes. In the resistant 
strain, only three genes were differentially expressed in the females, CYP6P9 (5.4-fold), 
COI (2.7-fold) and CYP6M7 (1.8-fold). In the males the same three genes were up-
regulated, in addition to another 21 genes. Half of these belonged to the P450 group, which 
is implicated in insecticide resistance. This corresponds well with previous publications 
indicating that monooxygenases (P450s) are one of the main mechanisms (Hargreaves et 
al., 2000; Brooke et al., 2001; Casimiro et al., 2006; Cuamba et al., 2010). The top three 
differentially expressed genes for the females and males were validated using qPCR and 
these genes had a higher fold expression in the resistant strain than the susceptible. In this 
study, the use of the An. gambiae detox chip has provided valuable information regarding 
detoxification genes in An. funestus. It has also proven that the use of heterologous 
hybridisations can be useful in the initial screening of gene expression profiling in an 
organism. Although care should be taken in the interpretation of the results, verification of 
results is also essential to prevent false results.  
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5.1.3 Gene transcript changes in three life stages 
Due to the hybridisation success of the An. funestus adult’s cDNA to the An. gambiae 
detox chip, it was decided to further investigate the transcription profile at three different 
life stages of this species, within the resistant, FUMOZ-R, strain. The life stages studied 
were first and fourth instar larvae and 3-day old adults (females and males). In the 
microarray comparison between the life stages, the following results were obtained: 67 and 
nine genes were differentially expressed respectively in the first instar and fourth instar 
larvae comparison. A total of 91 genes were differentially expressed when the first instar 
larvae were compared to 3-day old adults. Very few (only five) genes were differentially 
expressed in the 3-day old adults in the same comparison. Comparison between the fourth 
instar larvae and 3-day old adults showed a total of 35 and eight genes differentially 
expressed, respectively. The results showed that between any two life stage comparisons, 
the common trend was that the early developmental phase of a mosquito always had 
significantly more genes differentially expressed as opposed to the late phase. The role and 
function of these individual proteins in larval life stages would provide insight into this 
phenomenon. As this microarray contains a large number of P450s, esterases and GSTs, it 
was not surprising to find numerous up-regulated genes within these enzyme families. 
Interestingly, no esterases where up-regulated in the adults, although elevated levels of 
esterases in the male accessory glands of An. funestus have previously been described 
(Green, 1977). The discrepancy in the two studies may be attributed to the following. In 
this study, the adult RNA used on the detox chip was obtained from both females and 
males, and not males only. Further, the up-regulation of esterases was not detected 
possibly because of the sequence differences between those on the chip, which belonged to 
An. gambiae and those hybridised to the slide, which belonged to An. funestus. 
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5.2 Further Investigations 
A number of additional research questions were raised during this study, however, as the 
objectives in this study were well defined and time was a limiting factor, it was not 
possible to add these to the current project. Additional research on insecticide resistance in 
An. funestus would greatly benefit the understanding of these genes and their role in 
resistance. One way in which this could be done would be to test field populations from 
different localities in Africa and determine if there is a difference in the resistance 
mechanisms between field and laboratory reared populations of An. funestus. The 
transcription profile of the field population could also be established. These types of 
studies have recently been initiated. 
 
Further research would also involve verifying, using qPCR, the remaining genes that were 
differentially expressed in 3-day old resistant males in the microarray experiment. As only 
three genes were up-regulated in the females and these were already verified using qPCR, 
only the genes up-regulated in the males need to be investigated. Only three genes were 
verified using qPCR in the present study due to time constraints. Further investigations 
will involve researching the roles these genes play in insecticide resistance in both females 
and males.  
 
The use of cross-species microarrays provides a useful method for initial screening of up-
regulated genes. However, the construction of a species-specific microarray platform for 
An. funestus would provide more accurate results. The sequencing of the An. funestus 
genome and the development of a An. funestus microarray will greatly aid in answering a 
large number of questions still unknown in this malaria vector.   
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It is important to note that microarray technology only observes changes due to gene 
expression; therefore, if a gene is associated with resistance due to point mutations, they 
will not be detected. Combining microarray and SNP analysis or QTL mapping would 
yield more thorough results in a larger scale project. 
 
Another approach to studying insecticide resistance in this species would involve using 
gene knockdown RNAi technology. This could be used to target genes of interest (e.g. 
CYP6P9) by inhibiting gene expression at the translation stage or blocking the 
transcription of this gene. In the case of CYP6P9, this could result in the pyrethroid 
resistant strain, FUMOZ-R, becoming susceptible which will clarify the role of CYP6P9 in 
pyrethroid resistance. 
 
 
5.3 Concluding Remarks 
To date various studies have been conducted on genes and gene expression in An. funestus 
(Amenya et al., 2005; Amenya et al., 2008; Wondji et al., 2007; Wondji et al., 2009; 
Serazin et al., 2009; Cuamba et al., 2010; Matambo et al., 2010). Most of these have 
focused on only a few genes, and no research has been done on their expression profile in 
An. funestus. The present study has shown that various genes are up-regulated in 
association with resistance, but may not necessarily be involved in insecticide resistance. A 
large number of P450s and other genes could also be involved. Overall, this study has 
contributed to the understanding of An. funestus genes associated with insecticide 
resistance. 
 129 
APPENDIX A 
 
Recipes agar plates and broth 
  
1. Luria Bertani Broth (1 litre) 
10g Bacto-tryptone 
5g Bacto-Yeast extract 
10g NaCl 
Adjust to 1L with distilled water and autoclave. 
 
2. Luria Bertani Agar (1 litre) 
10g Bacto-tryptone 
5g Bacto-Yeast extract 
10g NaCl 
15g Bacto-Agar 
Adjust to 1L with distilled water and autoclave. 
Add Ampicillin (100 mg/ml), when LB agar is cool. 
Pour to plates when cooled. 
 
3. Ampicillin (100mg/ml) 
1g ampicillin 
10ml deionised water 
Add ampicillin to water.  
Aliquot into 1ml tubes and store at -20°C until further use. 
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4. IPTG 
0.12g IPTG 
5 ml distilled water 
Mix and store at 4°C for many months. 
 
5. Positive transformation Control  
The concentration of the plasmid is (1ng/!l). 
Dilute the positive plasmid 1:100 in dH2O and use 1 !l for transformation. 
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APPENDIX B 
 
 
Table 1   List of genes differentially expressed in first instar larvae in comparison to fourth instar larvae 
 
 
Gene Name Vectorbase Accession 
Number 
Fold 
Change 
Adj. P-
value 
Gene families/class 
numbers present on 
slide  
Number of genes 
within families/class 
differentially 
expressed * 
Cytochrome P450 
monooxygenase 
      
    
CYP301A1 AGAP006082 2.83 5.42E-12 CYP3 (30) 4 (13%) 
CYP307B1 AGAP008682 2.49 3.15E-08     
CYP314A1 AGAP002429 2.40 1.13E-09     
CYP325C2 AGAP002205 1.62 5.05E-06     
CYP49A1 AGAP005774 2.59 3.18E-11 CYP4 (30) 12 (40%) 
CYP4AA1 AGAP003608 2.67 1.39E-11     
CYP4C26 AGAP000192 1.81 1.13E-05     
CYP4C27 AGAP009246 1.58 4.21E-05     
CYP4D15 AY062193 (GB) 1.71 5.19E-05     
CYP4D16 AGAP002418 1.64 7.85E-05     
CYP4D22 AGAP002419 1.75 3.30E-07     
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CYP4H14 AGAP001861 1.92 3.01E-06     
CYP4H18 AY062195 (GB) 2.74 4.75E-09     
CYP4H19 AGAP000088 2.01 1.11E-09     
CYP4H24 AGAP000088 2.80 1.39E-09     
CYP4J5 AGAP006048 1.76 1.04E-07     
CYP6M2 AGAP008212 4.60 6.40E-16 CYP6 (29) 4 (13%) 
CYP6P2 AGAP002869 1.97 9.04E-10     
CYP6P5 AGAP002866 2.63 1.35E-07     
CYP6Z1 AGAP008219 1.96 2.52E-11     
CYP9J4 AGAP012292 3.22 9.96E-07 CYP9 (9) 2 (22%) 
CYP9K1 AGAP000818 1.93 0.000143     
            
Esterase           
COE13O AGAP011507 1.65 2.66E-05 COE1 (2) 1 (50%) 
COEAE1A AGAP001722 5.55 2.28E-10 COEAE (16) 7 (43%) 
COEAE2A AGAP001723 3.38 3.65E-08     
COEAE2D AGAP005757 2.34 1.11E-09     
COEAE2G AGAP006723 1.59 1.31E-06     
COEAE3D AGAP005758 2.70 1.88E-08     
COEAE3G AGAP006724 3.85 1.10E-10     
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COEAE5G AGAP006726 1.63 6.44E-10     
ACE1 AGAP001356 1.82 9.46E-05 ACE (2) 2 (100%) 
ACE2 AGAP000466 1.59 2.64E-09     
      
Glutathione S-
transferase 
      
    
GSTD1-3 AGAP004164 1.98 1.08E-10 GSTD (15) 4 (26%) 
GSTD1-6 AGAP004164 2.12 3.18E-13     
GSTD11 AGAP004378 1.89 1.70E-08     
GSTD6 AGAP004379 1.51 7.12E-09     
GSTE1 AGAP009195 1.85 9.42E-06 GSTE (8) 1 (12%) 
GSTU2 AGAP003257 1.89 1.08E-07 GSTU (3) 1 (33%) 
GSTZ1 AGAP002898 1.50 4.39E-05 GSTZ (1) 1 (100%) 
            
ABC Transporter           
ABCC10  ENSANGG00000004998 1.68 6.71E-05 ABCCC (5) 3 (60%) 
ABCC11 AGAP008436 4.49 4.72E-12     
ABCC12 AGAP007917 2.36 1.55E-07     
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Serine Protease      
SP8898 AGAP003642 3.55 2.58E-08 SP (9) 3 (33%) 
SP8905 AGAP003640 1.62 3.29E-06     
SP8907 AGAP003641 3.81 1.65E-11     
            
NIT           
NIT8503 AGAP012801 1.78 2.24E-05 NIT (4) 2 (50%) 
NIT8730 AGAP012379 1.66 1.33E-06     
            
Thioredoxin 
peroxidase 
      
    
TPX2 AGAP011054 2.51 5.06E-10 TPX (5) 2 (40%) 
TPX3 AGAP007543 1.80 5.12E-06     
            
Peroxidase           
HPX15 AGAP010810 3.42 7.89E-07 HPX (19) 4 (21%) 
HPX5B AGAP000051 2.23 2.28E-10     
HPX8 AGAP004038 1.84 3.15E-08     
HPX9 AGAP010899 2.54 1.13E-09     
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Thioredoxin           
TRX1 AGAP009584 1.76 7.89E-07 TRX (4) 2 (50%) 
TRXR AGAP000565 2.48 4.12E-06     
            
Other            
TubulinA AGAP001219 4.02 8.42E-09 Tubulin (2) 1 (50%) 
XD18014  AGAP006220 3.96 4.01E-10 XD (3) 1 (33%) 
Actincytopl TC48694 (TIGR)  3.79 1.42E-12 Actin (2) 1 (50%) 
CAT1 AGAP004904 3.66 6.40E-16 CAT (1) 1 (100%) 
AD20590 AGAP010499 3.63 5.74E-07 AD (2) 1 (50%) 
AMYL AGAP002317 3.36 2.05E-10 AMYL (1) 1 (100%) 
NADPH_P450_red AGAP000500 3.23 2.45E-06 NADPH_P450_red (1) 1 (100%) 
GPRNPY3 AGAP012378 2.49 8.44E-10 GPRN (7) 1 (14%) 
Cytochrome_C AGAP009537 2.14 4.01E-10 Cytochrome (2) 1 (50%) 
GSG8 AGAP010647 1.98 1.22E-05 GSG8 (1) 1 (100%) 
Xanthdehydro 4A3A-AAK-G-02-R (EMBL) 1.68 1.11E-09 Xanthdehydro (1) 1 (100%) 
AP7862 AGAP007809 1.64 5.29E-07 AP (1) 1 (100%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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Table 2   List of genes differentially expressed in the fourth instar in comparison to first instar larvae 
 
 
 
Gene Name Vectorbase Accession 
Number 
Fold 
Change 
Adj. P-
value 
Gene families/class 
numbers present on 
slide  
Number of genes within 
families/class 
differentially expressed * 
            
Superoxide 
dismutase           
MnSOD1 AGAP010517 1.53 1.08E-04 SOD (4) 2 (50%) 
SOD2 AGAP005234 2.23 6.99E-07     
            
COI DQ465331 (GB) 1.84 3.30E-07 COI (1) 1 (100%) 
CYP4G17 AGAP000877 2.45 3.13E-10 CYP4 (30) 1 (3%) 
GRX1 AGAP011107 2.13 3.30E-07 GRX (3) 1 (33%) 
GSTU1 AGAP000947 1.85 2.24E-05 GSTU (3) 1 (33%) 
JV1   1.80 6.39E-12 JV (2) 1 (50%) 
NIT8537 AGAP003515 1.84 1.75E-04 NIT (4) 1 (25%) 
RPL19 AGAP004422 1.58 3.20E-06 RPL (1) 1 (100%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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Table 3   List of genes differentially expressed in first instar larvae in comparison to 3-day old adults 
 
 
Gene Name Vectorbase Accession 
Number 
Fold 
Change 
Adj. P-
value 
Gene families/class 
numbers present on 
slide  
Number of genes 
within families/class 
differentially 
expressed * 
Cytochrome P450 
monooxygenase           
CYP301A1 AGAP006082 3.85 1.25E-17 CYP3 (30) 6 (20%) 
CYP307B1 AGAP008682 2.90 3.09E-07     
CYP314A1 AGAP002429 2.65 6.03E-15     
CYP325A2 
ENSANGESTG00000005673 
(ETI ID) 1.85 4.33E-05     
CYP325D1 AGAP002206 3.24 7.47E-12     
CYP325G1 AGAP002196 1.66 4.96E-10     
CYP49A1 AGAP005774 3.00 3.88E-09 CYP4 (30) 15 (50%) 
CYP4AA1 AGAP003608 3.05 4.52E-17     
CYP4C26 AGAP000192 1.89 2.58E-05     
CYP4C27 AGAP009246 1.85 1.92E-07     
CYP4C28 AGAP010414 2.88 1.41E-12     
CYP4C36 AGAP009241 3.04 8.63E-10     
CYP4D16 AGAP002418 1.77 7.32E-05     
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CYP4D22 AGAP002419 2.01 9.19E-06     
CYP4H14 AGAP001861 2.40 2.89E-08     
CYP4H18 AY062195 (GB) 3.62 6.87E-05     
CYP4H19 AGAP000088 2.49 2.19E-13     
CYP4H24 AGAP000088 11.21 8.13E-24     
CYP4H25 AGAP001864 1.66 8.01E-05     
CYP4J5 AGAP006048 1.79 1.62E-05     
CYP4J9 AGAP006047 1.78 2.42E-08     
CYP6AA2 AY745221 (GB) 1.85 3.25E-05 CYP6 (29) 10 (34%) 
CYP6AH1 AGAP007480 1.68 1.14E-05     
CYP6M2 AGAP008212 4.63 9.82E-27     
CYP6M3 AGAP008213 1.61 1.02E-07     
CYP6N1 AY028786 (GB) 1.62 1.46E-06     
CYP6P2 AGAP002869 1.90 5.72E-10     
CYP6P4 AGAP002867 2.61 6.87E-06     
CYP6P5 AGAP002866 2.82 1.01E-06     
CYP6Y1 AGAP008208 2.49 2.59E-07     
CYP6Y2 AGAP008207 1.63 3.80E-08     
CYP9J3 AGAP012291 2.05 0.000122 CYP9 (9) 4 (44%) 
CYP9J5 AGAP012296 2.53 6.66E-21     
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CYP9K1 AGAP000818 2.39 4.14E-09     
CYP9L1 AGAP012295 1.80 8.08E-06     
            
Esterase           
COE13O AGAP011507 1.72 8.94E-06 COE1 (2) 1 (50%) 
COEAE1A AGAP001722 21.96 1.83E-20 COEAE (16) 10 (62%) 
COEAE1F AGAP006227 2.36 4.76E-09     
COEAE2A AGAP001723 5.87 1.59E-13     
COEAE2D AGAP005757 2.75 4.15E-13     
COEAE2G AGAP006723 1.74 5.01E-07     
COEAE3D AGAP005758 3.70 8.63E-10     
COEAE3G AGAP006724 7.92 5.10E-21     
COEAE5G AGAP006726 1.86 1.34E-10     
COEAE5O AGAP002391 1.70 0.000116     
COEAE6O AGAP002863 1.79 4.32E-06     
COEBE2C AGAP005371 4.07 2.69E-08 COEB (4) 2 (50%) 
COEBE3C AGAP005372 1.59 1.77E-05     
COEJHE2E AGAP005834 1.63 1.25E-06 COEJ (5) 1 (20%) 
ACE1 AGAP001356 6.60 1.90E-23 ACE (2) 2 (100%) 
ACE2 AGAP000466 2.13 1.25E-14     
 140 
Glutathione S-
transferase           
GSTD1-3 AGAP004164 3.59 4.52E-17 GSTD (15) 8 (53%) 
GSTD1-6 AGAP004164 2.63 1.55E-18     
GSTD10 AGAP004383 2.95 1.12E-08     
GSTD11 AGAP004378 2.91 3.40E-19     
GSTD3 AGAP004382 2.02 5.46E-10     
GSTD6 AGAP004379 1.69 1.36E-13     
GSTD7 AGAP004163 1.51 1.41E-05     
GSTD8 AGAP004171 1.56 4.32E-06     
GSTE1 AGAP009195 2.38 6.56E-12 GSTE (8) 2 (25%) 
GSTE5 AGAP009192 1.73 6.42E-11     
GSTMS3 AGAP009946 1.62 1.44E-05 GSTM (3) 1 (33%) 
GSTS1-2 AF513639 (GB) 2.67 4.20E-15 GSTS (2) 1 (50%) 
GSTU2 AGAP003257 2.44 2.60E-12 GSTU (3) 1 (33%) 
GSTZ1 AGAP002898 1.92 7.41E-09 GSTZ (1) 1 (100%) 
            
Serine Protease           
SP11706 AGAP004014 3.28 4.94E-07 SP (9) 3 (33%) 
SP8898 AGAP003642 4.98 1.72E-14     
SP8907 AGAP003641 4.19 4.45E-09     
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Peroxidase           
HPX15 AGAP010810 7.00 7.15E-14 HPX (19) 4 (21%) 
HPX5B AGAP000051 3.25 9.67E-06     
HPX8 AGAP004038 2.14 2.00E-09     
HPX9 AGAP010899 3.06 1.39E-06     
            
NIT           
NIT8503 AGAP012801 1.58 5.88E-05 NIT (4) 2 (50%) 
NIT8730 AGAP012379 1.65 6.85E-07     
      
Tubulin           
TubulinA AGAP001219 6.98 3.00E-15 Tubulin (2) 2 (100%) 
TubulinB AGAP010510 2.99 6.03E-15     
           
GP          
GPRNPY3 AGAP012378 3.77 9.23E-16 GP (7) 2 (28%) 
GPXH1 AGAP004247 2.10 3.08E-09     
           
Other           
AMYL AGAP002317 5.35 1.49E-19 AMYL (1) 1 (100%) 
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CAT1 AGAP004904 5.31 5.91E-26 CAT (1) 1 (100%) 
Actincytopl TC48694 (TIGR)  5.27 1.25E-14 Actin (2) 1 (50%) 
ABCC11 AGAP008436 5.07 3.92E-20 ABCC (5) 1 (20%) 
XD18014 AGAP006220 4.04 4.15E-13 XD (3) 1 (33%) 
AD20590 AGAP010499 3.64 5.72E-10 AD (2) 1 (50%) 
NADPH_P450_red AGAP000500 3.62 7.32E-11 NADPH_P450_red (1) 1 (100%) 
TRXR AGAP000565 2.80 3.78E-09 TRX (4) 1 (25%) 
GSG8 AGAP010647 2.20 2.47E-09 GSG (1) 1 (100%) 
AP7862 AGAP007809 2.04 6.67E-05 AP (1) 1 (100%) 
RPS26 AGAP012100 1.81 3.45E-11 RPS (1) 1 (100%) 
Xanthdehydro 4A3A-AAK-G-02-R (EMBL) 1.55 7.57E-07 Xanthdehydro (1) 1 (100%) 
SOD3A AGAP010347 1.50 8.22E-05 SOD (4) 1 (25%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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Table 4 List of genes differentially expressed in 3-day old adults in comparison to first instar larvae 
 
   
Gene 
Name 
Vectorbase 
Accession 
Number 
Fold 
Change 
Adj. P-
value 
Gene families/class 
numbers present on 
slide  
Number of genes within 
families/class 
differentially expressed * 
            
AGM1 AGAP012401 2.52 1.04E-08 AGM (1) 1 (100%) 
COI DQ465331 (GB) 2.15 2.97E-07 COI (1) 1 (100%) 
CYP4G17 AGAP000877 2.39 4.51E-12 CYP4 (30) 1 (3%) 
JV2   4.31 1.14E-09 JV (2) 1 (50%) 
MnSOD1 AGAP010517 1.6 6.17E-05 SOD (4) 1 (25%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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Table 5   List of genes differentially expressed in fourth instar larvae in comparison to 3-day old adults 
 
 
Gene Name Vectorbase 
Accession Number 
Fold 
Change 
Adj. P-
value 
Gene families 
numbers/class present 
on slide  
Number of genes within 
families/class differentially 
expressed * 
Cytochrome P450 
monooxygenase           
CYP325D1 AGAP002206 3.94 1.34E-17 CYP3 (30) 1 (3%) 
CYP4C28 AGAP010414 2.19 6.98E-11 CYP4 (30) 3 (10%) 
CYP4C36 AGAP009241 1.79 8.82E-18     
CYP4H24 AGAP000088 4.00 2.62E-17     
CYP6Y1 AGAP008208 1.75 2.51E-06 CYP6 (29) 2 (6%) 
CYP6Y2 AGAP008207 1.54 2.32E-11     
CYP9J3 AGAP012291 2.54 1.02E-08 CYP9 (9) 3 (33%) 
CYP9J5 AGAP012296 1.88 1.00E-18     
CYP9M1 AGAP009374 1.50 4.79E-05     
            
Esterase           
COEAE1A AGAP001722 3.94 4.01E-11 COEAE (16) 5 (31%) 
COEAE1F AGAP006227 1.70 1.08E-07     
COEAE2A AGAP001723 1.73 3.42E-05     
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COEAE3G AGAP006724 2.05 1.39E-10     
COEAE5O AGAP002391 1.69 5.34E-07     
COEBE2C AGAP005371 2.21 4.08E-06 COEBE (4) 1 (25%) 
            
Glutathione S-
transferase           
GSTD1-3 AGAP004164 1.81 6.56E-09 GSTD (15) 4 (26%) 
GSTD10 AGAP004383 2.84 8.28E-11     
GSTD11 AGAP004378 1.54 4.38E-11     
GSTD3 AGAP004382 2.08 4.17E-15     
GSTMS3 AGAP009946 1.76 2.30E-09 GSTM (3) 1 (33%) 
GSTS1-2 AF513639 (GB) 2.78 5.56E-24 GSTS (2) 1 (50%) 
GSTU1 AGAP000947 1.97 3.04E-12 GSTU (3) 1 (33%) 
            
Tubulin           
TubulinA AGAP001219 1.73 2.75E-05 Tubulin (2) 2 (100%) 
TubulinB AGAP010510 3.78 2.05E-25     
      
GP          
GPXH1 AGAP004247 1.62 5.34E-07 GPX (7) 2 (28.6%) 
 146 
GPRNPY3 AGAP012378 1.51 1.01E-05     
            
Other           
JV1   2.72 1.82E-15 JV (2) 1 (50%) 
HPX15 AGAP010810 2.05 1.29E-06 HPX (19) 1 (5%) 
GRX1 AGAP011107 1.89 2.51E-09 GRX (3) 1 (33%) 
NIT8537 AGAP003515 1.81 6.91E-13 NIT (4) 1 (25%) 
AMYL AGAP002317 1.59 1.29E-07 AMYL (1) 1 (100%) 
RPL19 AGAP004422 1.51 9.05E-06 RPL (1) 1 (100%) 
ACE1 AGAP001356 1.77 1.52E-10 ACE (2) 1 (50%) 
SOD2 AGAP005234 2.39 6.36E-11 SOD (4) 1 (25%) 
SP11706 AGAP004014 2.40 5.61E-06 SP (9) 1 (11%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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Table 6   List of genes differentially expressed in 3-day old adults in comparison to fourth instar larvae 
 
 
Gene Name Vectorbase 
Accession 
Number 
Fold 
Change 
Adj. P-
value 
Gene families/class 
numbers present on slide  
Number of genes within 
families/class 
differentially expressed * 
            
Cytochrome P450 
monooxygenase 
      
    
CYP6AK1 AGAP010961 1.69 1.08E-07 CYP6 (29) 1 (3%) 
CYP6Z1 AGAP008219 1.87 1.94E-10     
            
Other           
AGM1 AGAP012401 2.85 9.09E-14 AGM (1) 1 (100%) 
CPLC8 AGAP008446 2.25 4.56E-08 CPLC (1) 1 (100%) 
Cytochrome_C AGAP009537 2.04 1.74E-12 Cytochrome (2) 1 (50%) 
JV2   5.24 1.36E-22 JV (2) 1 (50%) 
TPX2 AGAP011054 2.06 1.03E-14 TPX (5) 1 (20%) 
* These values represent the number of gene families/class within each group differentially expressed. These values are also represented as a percentage of the total 
number of that class present on the slide. 
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 2 
Abstract 34 
 35 
Anopheles funestus is a major vector of malaria in most of the African region. Resistance to 36 
pyrethroid and carbamate insecticides has been recorded in populations of this species in 37 
South Africa and Mozambique. The P450 gene, CYP6P9, has been shown to be highly 38 
transcribed in a permethrin (pyrethroid) resistant laboratory strain FUMOZ-R, originating 39 
from southern Mozambique. The aim of this study was to determine the relationship between 40 
pyrethroid resistance and gene transcription levels of two closely related genes, CYP6P9 and 41 
CYP6P13, by adult mosquito age in FUMOZ-R. Levels of resistance to 0.75% permethrin 42 
were determined based on standard WHO insecticide susceptibility assays using females and 43 
males of different ages ranging from 3 to 30 days old. The transcription levels of the two 44 
genes were quantified using qPCR for each age cohort. The WHO insecticide susceptibility 45 
assays showed that percentage survival in males and females significantly decreased as age 46 
increased. Quantitative analysis of the two genes CYP6P9 and CYP6P13 showed the highest 47 
levels of expression at 10 days of age. There was no correlation between expression of these 48 
two genes and pyrethroid survival by age. 49 
 50 
Key words: Anopheles funestus, age, pyrethroid resistance, P450 expression 51 
52 
 3 
Introduction 52 
 53 
Malaria affects an estimated 247 million people worldwide resulting in approximately one 54 
million deaths each year (WHO 2008). Ninety percent of deaths due to malaria occur in 55 
Africa. Malaria is transmitted by Anopheles mosquitoes including the major African vector 56 
Anopheles funestus, which transmits malaria perennially and has also been associated with 57 
malaria epidemics (Gillies and De Meillon 1968, Fontenille et al. 1990, Hargreaves et al. 58 
2000).  59 
 60 
Effective malaria vector control is potentially hampered by the development of resistance to 61 
insecticides. Therefore, an understanding of resistance mechanisms in vector populations 62 
enables the development of resistance management strategies. The most common modes of 63 
insecticide resistance are reduced target-site sensitivity and enzyme mediated detoxification. 64 
Target-site insensitivity mutations result in reduced affinity of the target receptor to insecticide 65 
(Brogdon and McAllister 1998). Alterations of the sodium ion channel gene (kdr), the ! 66 
amino-butyric acid (GABA) receptor and acetylcholinesterase (AChE) reduce the binding 67 
affinities of pyrethroids and DDT, dieldrin and fipronil, and carbamates and organophosphates 68 
respectively  (see review by Hemingway and Ranson, 2000).  69 
 70 
The first account of insecticide resistance in An. funestus in southern Africa and its impact on 71 
malaria transmission was reported in 2000 (Hargreaves et al. 2000). Pyrethroid resistance in 72 
An. funestus from South Africa and southern Mozambique was subsequently showed to be 73 
mediated by a monooxygenase (P450) detoxification mechanism and no target site 74 
insensitivity was identified (Brooke et al. 2001, Wondji et al. 2007, Okoye, 2008). Recently, 75 
the molecular characterisation of monooxygenase based pyrethroid resistance in An. funestus 76 
was initiated (Amenya et al. 2005, Wondji et al. 2007, Amenya et al. 2008, Wondji et al. 2009, 77 
Matambo et al. 2010).  78 
 79 
Amenya et al. (2005) isolated the first 31 partial monooxygenase P450 sequences and 80 
subsequently reported that one of these, CYP6P9, was over-expressed in the egg and adult 81 
stages of a pyrethroid resistant laboratory strain (FUMOZ-R) originating from southern 82 
Mozambique (Amenya et al. 2008). Wondji et al. (2007) identified a quantitative trait locus 83 
(QTL) associated with pyrethroid resistance in the same An. funestus strain and confirmed the 84 
increase in CYP6P9 transcription. These QTL markers contained a cluster of P450 genes 85 
including CYP6P9. Subsequent work by Matambo et al. (2010) and Wondji et al. (2009) 86 
reported on a duplicate gene and called these genes CYP6P13 and CYP6P9b respectively.  87 
Amino acid similarities between CYP6P13 and CYP6P9b confirm that these are the same 88 
genes (Wondji et al. 2009, Matambo et al. 2010). As CYP6P13 was officially named by the 89 
P450 Nomenclature committee (Dr Nelson, http://drnelson.utmem.edu/CytochromeP450. 90 
html) during 2009 (Matambo, 2008) this paper will retain the name CYP6P13 for this gene.  91 
 92 
 93 
Gene transcription studies by Amenya et al. (2008) and Wondji et al. (2009) did not 94 
differentiate between these two closely related genes as the primers used for both these studies 95 
were designed in a region sharing 100% sequence identity between them.  Recent studies by 96 
Morgan et al. (2010) confirmed the increased mRNA expression of both these genes in An. 97 
funestus from Uganda while Cuamba et al. (2010) reported on the overexpression of one of the 98 
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duplicate genes (CYP6P9a, called CYP6P13 in this article). Furthermore, a recent microarray 99 
study by Christian et al. (2010) showed an increase in gene transcription for these genes. Only 100 
one other P450 gene was found to be upregulated (CYP6M7) but this gene was not validated 101 
using quantitative real-time PCR (qPCR) (Christian et al. 2010).  102 
 103 
 As mosquitoes are infective and able to transmit malaria only after age 10-14 days, it is 104 
important to characterise insecticide resistance in older mosquitoes. The aim of this project 105 
was to quantify the levels of pyrethroid resistance in a highly resistant strain of An. funestus 106 
males and females at different ages (3, 5, 10, 14, 20 and 30 days) as well as to quantify the 107 
transcription levels of the two duplicated genes, CYP6P9 and CYP6P13, in the same age 108 
cohorts in order to ascertain whether there is a direct relationship between gene transcription 109 
and pyrethroid resistance phenotype by age.  110 
 111 
 112 
Materials and Methods 113 
 114 
Mosquitoes: 115 
 116 
The FUMOZ-R An. funestus laboratory colony originates from southern Mozambique and was 117 
selected for high levels of resistance to permethrin (pyrethroid). Details of colony rearing, 118 
permethrin resistance selection and insectary conditions can be found in Hunt et al. (2005). 119 
Female and male adults were separated on emergence and were maintained on a 10% sugar 120 
solution until they reached the ages of 3, 5, 10, 14, 20 or 30 days. A separate cohort of female 121 
adults were allowed to mate after emergence and were offered blood meals when they were 122 
six, eight and 10 days of age. On day 14 they were used either for insecticide susceptibility 123 
testing or for RNA extractions. 124 
 125 
 126 
Evaluation of the influence of An. funestus age on their pyrethroid resistance: 127 
 128 
The insecticide susceptibility assays described in this study were carried out according to 129 
WHO specifications using WHO insecticide treated papers (WHO 1998). The insecticidal 130 
action of all test papers was first confirmed using samples of an An. funestus susceptible strain 131 
(FANG), which showed 100% mortality following exposure to all papers.  132 
  133 
Approximately 30 FUMOZ-R adults per replicate were assayed against 0.75 % permethrin 134 
treated papers through 10 replicates for each age and sex cohort (total of 300 mosquitoes per 135 
age group). For each replicate an untreated control was included. Final mortalities were 136 
recorded 24 h post exposure and subsequent analysis was conducted on these data (WHO, 137 
1998). As sample sizes were large throughout (n=<290), data were not transformed prior to 138 
analysis.  139 
 140 
 141 
 142 
 143 
Quantification of CYP6P9 and CYP6P13 transcripts for each age cohort: 144 
 145 
 5 
Total RNA extraction and cDNA synthesis: Total RNA was extracted from 15 adult An. 146 
funestus FUMOZ-R mosquitoes to form one biological sample. Three biological extractions 147 
(n= 15 mosquitoes per biological sample) were performed per age and sex. The extractions 148 
were carried out using Tri reagent (Sigma, T9424, Munich, Germany). The RNA samples 149 
were DNase treated (Qiagen, 79254, West Sussex, UK), and were quantified using a 150 
Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA).  151 
 152 
Total RNA (up to 2"g) was converted to cDNA using the High Capacity RNA-to-cDNA kit 153 
(Applied Biosystems, 4387406, Johannesburg, SA). The quality and quantity of cDNA was 154 
measured using the Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, 155 
DE, USA) and the cDNA samples were stored at -70ºC until further use. 156 
 157 
 158 
Primer Design: 159 
 160 
Two sets of primers were used in this study, one for CYP6P9 (gene-specific primers) and the 161 
other for CYP6P13 (gene-specific primers). The ribosomal protein 7 or rps 7 (GenBank 162 
accession number: EF450776) primers were used as a reference gene against which to 163 
normalise data. This gene was tested prior analysis to confirm that transcription of this gene 164 
does not change with age. 165 
 166 
The CYP6P9 (GenBank accession number: EU450763) and CYP6P13 (GenBank accession 167 
number: EF152577) primers were designed in the regions containing nucleotide base pair 168 
differences between the two genes and these primers are therefore specific for these genes. 169 
These primers were designed using the full-length CYP6P9 and CYP6P13 gene sequences 170 
(Matambo et al. 2010) (Table 1). 171 
 172 
 173 
 174 
Real Time quantitative PCR (qPCR): 175 
 176 
The qPCR reactions were carried out using the Bio-Rad CFX96™ Real-Time PCR Detection 177 
System (Bio-Rad, Hercules, CA, USA). A total volume of 25"l containing 12.5"l IQ™ SYBR 178 
supermix (Bio-Rad, 1708882), 4"l primer (2.5"M), 1"l cDNA (50ng) was used per reaction. 179 
A standard curve reaction containing a 2-fold serial dilution of cDNA for each of the genes of 180 
interest and the house keeping gene was generated in each reaction. Serial dilutions of cDNA 181 
for the standard curve were prepared (Paton et al. 2000; Bio-Rad 2006). This was correlated to 182 
the initial cDNA template used in the reaction and then converted to transcript copy number 183 
(tCNR) (Bio-Rad 2006).  184 
 185 
The cycling conditions for each primer set differed from each other. These conditions are 186 
presented in Table 1. Triplicates of each biological sample were carried out in each plate and 187 
the qPCR for the three different biological extractions was performed on different days. The 188 
reference gene, rps 7, did not vary between the different ages when amplified. The identity of 189 
all amplified products was confirmed by sequence analysis by sequencing in both directions. 190 
The sequenced genes were blasted against the CYP6P9 and CYP6P13 gene sequences to 191 
ensure that the correct product was amplified during qPCR. 192 
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 193 
The data were analysed using the absolute quantification method, using the formula, Nn = 10 194 
(n-b)/ m, where n = Ct, b = y intercept, m = slope of line (Bio-Rad 2006). The values were 195 
converted into transcript copy numbers (tCNR) and the ratio of each gene to the rps 7 196 
transcription was determined (Bio-Rad 2006). Standard errors (SE) were calculated for each 197 
replicate. 198 
 199 
The Pearsons correlation statistical method was implemented to deduce if there was any 200 
association between the bioassay and the qPCR data. 201 
 202 
 203 
Results  204 
 205 
WHO Insecticide Bioassays: 206 
 207 
Percentage survival of FUMOZ-R resistant adults 24 hours post exposure to 0.75% permethrin 208 
was calculated by gender for each age cohort (10 repeats of ±30 mosquitoes per tube) (Fig. 1). 209 
There was a significant trend in mortality with age in females (linear regression: P= 0.04; R2= 210 
0.59) and males (linear regression: P= 0.02; R2= 0.60).  In both cases survival tended to 211 
decrease with age. Three day old females showed a mean survival of 78.1% (SE: 8.48) which 212 
decreased steadily through ages 5 (71.71%; SE: 8.64), 10 (68%; SE: 7.96) and 14 days 213 
(37.70%; SE: 5.77), showing that female susceptibility to permethrin increased with age (Fig. 214 
1A). The lowest survival was recorded in the blood-fed female cohort at 14 days (32.70%; SE: 215 
7.26), although a two sample t-test revealed that there was no significant difference between 216 
blood-fed and unfed females at this age (P=0.64). Survival increased in the female cohorts at 217 
20 and 30 days old. There was no significant difference between unfed 14 day and 20 day old 218 
females (P=0.08). 219 
 220 
A similar trend was observed in the males (Fig. 1B). The males’ resistance to permethrin was 221 
high at ages three (71.81%; SE: 3.97) and five days (77.86%; SE: 7.68). At 10 days the 222 
percentage survival decreased to 48.83% (SE: 8.85) and then steadily decreased to a low of 223 
26.84% (SE: 5.13) at age 14. The lowest survival in the males was recorded at age 20 224 
(17.40%; SE: 1.89). There was no significant difference between 14 day and 20 day old males 225 
(P=0.09).The percentage survival increased to 26.40% (SE: 4.28) at 30 days. There was a 226 
significant difference in percentage survival between three day and 14 day old males based on 227 
a two sample t-test (P=0.00).  228 
 229 
 230 
 231 
 232 
 233 
Gene transcription analysis of CYP6P9: 234 
 235 
In three day old females, the tCNR was 1.88 (SE: 0.40). In both pyrethroid resistant females 236 
and males, the tCNR was a high 9.3 (SE: 3.08) at day 10 for females and 20.1 (SE: 1.08) for 237 
males at the same age but decreased by day 14 to 3.63 (SE: 1.08) for females and 12.1 (SE: 238 
3.46) for males (Fig. 2). However, the tCNR then decreased to 3.63 (SE: 1.08) for unfed 239 
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females and 1.74 (SE: 0.45) for blood-fed females at day 14, although there was no significant 240 
difference in tCNR between blood-fed and unfed cohorts (two sample t-test: P= 0.18). The 241 
tCNR increased again at day 20 to 3.54 (SE: 1.8) and then decreased to 0.52 (SE: 0.20) at day 242 
30.  243 
 244 
Male tCNR was 9.15 (SE: 3.87) at three days which increased to 23.9 (SE: 7.63) at five days 245 
followed by a steady decrease of 20.1 (SE: 1.08) at 10 days, 12.1 (SE: 3.46) at 14 days, 5.77 246 
(SE: 1.83) at 20 days and 6.56 (SE: 2.02) at 30 days (Fig. 3). Overall, there was no significant 247 
difference in the absolute transcription level of CYP6P9 in association with age (ANOVA: 248 
females, P= 0.17; males, P= 0.07). There was no significant correlation between survival (as 249 
quantified by insecticide bioassay) and gene transcription levels for CYP6P9 (linear 250 
regression: females, P= 0.46, R2= 0.18; males, P= 0.16, R2= 0.37). 251 
 252 
 253 
Gene transcription analysis of CYP6P13: 254 
 255 
Gene transcription levels of CYP6P13, using the absolute quantification method, revealed that 256 
the tCNR changed only slightly from 4.69 (SE: 0.60) in three day old females to 4.82 (SE: 257 
0.56) (Fig. 2) in 10 day old females, while males of the same age had a tCNR of 28.84 (SE: 258 
4.88) (Fig. 3). However, the tCNR almost halved between three and 14 day old unfed females 259 
although the difference is not statistically significant (two sample t-test: P= 0.15). The tCNR 260 
of the gene had decreased from 2 (SE: 0.27) at 14 days when the females were not given a 261 
blood meal to a significant 0.38 (SE: 0.24) when the female had access to a blood meal (P= 262 
0.01). The tCNR increased to 0.79 (SE: 0.32) by day 30 in females and had increased to 13.67 263 
(SE: 0.53) in males from 8.92 (SE: 0.91) by age 20. Overall, there was no significant 264 
difference in the absolute transcription levels of CYP6P13 in association with age (ANOVA: 265 
females, P= 0.39; males, P= 0.6). There was no significant correlation between survival and 266 
gene transcription levels for CYP6P13 (linear regression: females, P= 0.06, R2= 0.62; males, 267 
P= 0.52, R2= 0.11).  268 
 269 
 270 
Discussion 271 
 272 
 273 
Variation in the expression of insecticide resistance with age is shown here for An. funestus 274 
and has also been described in other anophelines. Hunt et al. (2005) describe fluctuations in 275 
the expression of pyrethroid resistance with age in unselected and selected generations of 276 
FUMOZ-R. The effect of age may lead to a weakening of resistance mechanisms as a 277 
consequence of a general progressive decrease in physiological capacity (Hodjati and Curtis 278 
1999). This could in turn result in the mosquitoes having reduced ability to respond or adapt to 279 
environmental changes. 280 
 281 
Successive blood feeding prior to reaching 14 days old did not affect female susceptibility to 282 
pyrethroid intoxication as assessed four days after the last blood meal. However, Spillings et 283 
al. (2008) showed that blood-feeding significantly enhanced resistance to pyrethroid 284 
intoxication in the FUMOZ-R strain four hours post blood-feeding in three day old females 285 
using dose response curves. Hunt et al. (2005) showed that pyrethroid induced mortality was 286 
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significantly reduced in 14 day old and 20 day old blood-fed FUMOZ-R. These results 287 
collectively suggest that the expression of the resistance phenotype varies in response to 288 
fluctuations in physiological state, which is a function of various parameters including age, 289 
blood feeding history and mating status. The increase in survival in females at 20 days of age 290 
warrants further investigation. 291 
 292 
Specific primers were designed for the individual genes CYP6P9 and CYP6P13. The effect of 293 
age on gene transcription in the resistant strain FUMOZ-R was investigated in order to test for 294 
a correlation between insecticide survival and gene transcription levels. Bioassay data showed 295 
that permethrin induced mortality generally increased with age. In terms of gene transcription, 296 
the highest tCNR was observed in CYP6P9 (9.30) and CYP6P13 (4.82) at 10 days old. 297 
Permethrin survival of females was also highest between three and 10 days of age. However, 298 
statistical analysis revealed no significant overall correlation between gene transcription for 299 
either gene and susceptibility to permethrin. Further, the male tCNR’s were higher than those 300 
of the females, in contrast to the bioassay data in which males showed a slightly lower 301 
survival than females. This discrepancy may be attributable to other biological functions (such 302 
as pheromone production) that P450s are associated with in males (Kasai and Tomita 2003). 303 
 304 
Both CYP6P9 and CYP6P13 have shown increased mRNA expression in association with 305 
pyrethroid resistance (Amenya et al. 2008; Wondji et al. 2009, Morgan et al. 2010, Cuamba et 306 
al. 2010). However, the fold over expression for each varies depending on the origin of the test 307 
population. Further, it is recommended by WHO (WHO, 1998) that insecticide susceptibility 308 
studies be assessed using female mosquitoes aged 2-5days. As a consequence, this age cohort 309 
has also been used to identify the underlying insecticide resistance mechanisms. However, 310 
females as young as this cannot be malaria infective and are therefore not representative of 311 
that portion of a vector population responsible for malaria transmission. This is the first study 312 
to investigate variation in the frequency of resistance at different ages looking for correlations 313 
with gene transcription in a highly resistant strain of An. funestus from southern Africa. The 314 
results show clearly that there is no correlation with increase in phenotype mortality with age 315 
and P450 gene over-expression. 316 
 317 
In conclusion, this study highlighted two important genes that have previously been shown to 318 
be associated with permethrin resistance in adults of southern African An. funestus. Both these 319 
genes showed transcription variation in association with mosquito age. However, transcript 320 
analysis provided only limited information as to how the function and effect of each enzyme 321 
varies with age. Future functional genomic studies will be necessary to clarify the role of these 322 
enzymes in pyrethroid metabolism. This is likely to prove complex as these enzymes may 323 
have multiple functions and their expression can be affected by numerous environmental as 324 
well as physiological factors. A recent analysis of field-collected An. funestus samples from 325 
Mozambique showed an association between pyrethroid resistance and the up-regulation of 326 
these two genes (Cuamba et al. 2010). However, this mode of resistance may not necessarily 327 
occur in other An. funestus populations. 328 
329 
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 Figure legends 428 
 429 
Fig. 1   Percentage survival by age of pyrethroid resistant Anopheles funestus (FUMOZ-430 
R) in females (A) and males (B) 24 h post exposure to 0.75% permethrin.  Standard 431 
errors (SE) are indicated on the bars. Control: Exposure of mosquitoes to untreated 432 
papers. 433 
 434 
Fig.  2   CYP6P9 and CYP6P13 transcription analysis by age, expressed as copy number 435 
ratio, in pyrethroid resistant An. funestus FUMOZ-R females. Standard error bars are 436 
indicated.  437 
 438 
Fig. 3   CYP6P9 and CYP6P13 transcription analysis by age, expressed as copy number 439 
ratio, in pyrethroid resistant An. funestus FUMOZ-R males. Standard error bars are 440 
indicated. 441 
 442 
 443 
Table legends 444 
Table 1  Primers used in Quantitative Real Time PCR 445 
446 
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Table 1  Primers used in Quantitative Real Time PCR 446 
 447 
Gene Primer Sequence 
Fragment 
Length 
(bp) 
Annealing 
Temp (°C) 
 
Melting 
Temp (°C) 
 
CYP6P9 
*(GAN: 
EU450763) 
Fwd   5’AGA TGT GAT 
TGG CAC CTG T 3’ 
Rev   5’ TCG ATA TTC 
CAC CGT TTC CT 3’ 
232 55.00 82.00 
CYP6P13 
*(GAN: 
EF152577) 
Fwd   5’ CTG GAT CTC 
CTA ATT ATG ATG AAG 
TTT TTC 3’ 
Rev   5’ GTT CAC CGT 
CTC GCG GAC T 3’ 
132 59.10  81.00 
 rsp 7 
*(GAN: 
EF450776) 
Fwd   5’ TTA CTG CTG 
TGT ACG ATG CC 3’ 
Rev   5’ GAT GGT GGT 
CTG CTG GTT C 3’ 
135 ** 85.50 
 448 
* GAN= Gene Accession Number 449 
** Annealing temperature for the rsp 7 gene was 55°C when testing for CYP6P9 and 59.10°C for CYP6P13 450 
analysis. 451 
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a b s t r a c t
Anopheles funestus is one of the major malaria vectors in southern Africa and several populations in this
region are resistant to pyrethroids. The current study uses a microarray based approach to identify genes
up-regulated in the pyrethroid resistant population, FUMOZ, from Mozambique. As the full set of detox-
ification genes in A. funestus are unknown, this study investigated the utility of the Anopheles gambiae
‘detox chip’ to screen for differentially expressed detoxification genes in A. funestus. Differential expres-
sion of detoxification genes in 3 day old adult females and males from the FUMOZ resistant strain and the
FANG susceptible strain was identified using the A. gambiae ‘detox chip’. After optimization of the hybrid-
ization conditions, over 90% of the probes showed a positive signal. Only three genes were significantly
(p < 0.001) differentially expressed in the females, CYP6P9 (5.4-fold), COI (2.7-fold) and CYP6M7 (1.8-fold).
The same genes were also significantly differentially expressed in the adult males, CYP6P9 (6.0-fold), COI
(2.9-fold) and CYP6M3 (3.6-fold) together with an additional 21 transcripts. Quantitative PCR (qPCR)
analysis was conducted to validate the microarray results. This study demonstrated that heterologous
hybridization is a helpful tool in identifying detoxification genes differentially expressed in A. funestus
strains.
! 2011 Published by Elsevier Inc.
1. Introduction
In 2008 the World Health Organization [1] reported that an
estimated 247 million people are affected worldwide with malaria.
Most malaria deaths occur in Africa and this situation results from
both the epidemiological situation in Africa and limited control
activities during the past decades. The lack of adequate health
services often results in deficiencies in treatment and this is com-
pounded by increasing drug resistance [2]. Insecticide resistance in
the mosquito vectors is increasingly impacting on malaria control
interventions [3,4]. Malaria control in southern Africa is largely
based on the use of insecticide treated bed nets (ITNs) or indoor
residual spraying (IRS) with pyrethroids being the insecticides of
choice. There have been reports of insecticide resistance in malaria
vectors in southern Africa and these include DDT and pyrethroid
resistance in Anopheles arabiensis in South Africa [5,6] and
Anopheles funestus resistant to pyrethroids and carbamates
in South Africa and Mozambique [7,8]. The development of
pyrethroid resistance in A. funestus resulted in a malaria outbreak
in South Africa between 1996 and 2000 [7].
Two major resistance mechanisms are largely responsible for
insecticide resistance i.e. target-site resistance and metabolic resis-
tance [9]. To date there have been no reports of target-site resis-
tance to pyrethroids in A. funestus. Metabolic resistance is
characterized by increased activity of detoxifying enzymes such
as esterases, cytochrome P450 monooxygenases and glutathione-
S-transferases (GSTs) [9,10]. All three enzyme groups are encoded
by large gene families and identifying the individual genes associ-
ated with resistance is a very laborious exercise. This task was
facilitated for Anopheles gambiae by the development of a custom
microarray specifically designed to detect transcription variation
in genes associated with insecticide resistance [11]. This array
was named the ‘detoxification chip’ (‘detox chip’). The ‘detox chip’
has been utilized for screening A. gambiae populations from Kenya
and Zanzibar [11], Benin [12], Nigeria [13] and Ghana [14,15] and
has also been successfully used for A. arabiensis from Cameroon
[16] and Anopheles stephensi from Dubai [17].
Biochemical assays and synergists have been used previously to
characterize the resistance mechanisms in the FUMOZ-R
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pyrethroid resistant strain from Mozambique [8]. These studies
implicated elevated cytochrome P450 activity as the main mecha-
nism. This was later supported by qPCR [18] and genetic mapping
studies [19] which both identified the P450 gene, CYP6P9, as being
highly over-expressed in the resistant FUMOZ-R strain.
In this study, we investigated the use of the A. gambiae ‘detox
chip’ in determining potential genes associated with insecticide
resistance in a southern African A. funestus resistant strain
(FUMOZ-R) and a susceptible strain (FANG). Selected significantly
over-expressed genes from the microarray results were validated
using qPCR.
2. Materials and methods
2.1. Mosquito strains
Two A. funestus strains were used in this study. The FUMOZ-R
strain originated from Mozambique and has been maintained
under selection pressure with permethrin. FANG originates from
Angola and is susceptible to all known insecticides. Details on
the insecticide resistance status of these colonies can be found in
the study by Hunt et al. [20]. Both strains are maintained in stan-
dard insectary conditions of 25 !C with 80% relative humidity and
12 h day/night, 45 min dusk/dawn lighting cycle.
2.2. Sample preparation and microarray hybridizations
Female and male A. funestus adults were separated on day of
emergence and fed on 10% sugar solution until they were 3 days
old (without prior exposure to pyrethroids). The transcription lev-
els in the 3 day old resistant FUMOZ-R adult females were com-
pared to the susceptible females of the same age. The same was
done for the males. Each comparison in all experiments consisted
of three independent biological replicates and two technical
repeats which included dye swaps to control for dye bias. There
were four within-array replicate spots per microarray slide. Total
RNA was extracted from three batches of 15 3 day old adult
females or males using the PicoPure™ RNA Isolation kit (Arcturus)
according to manufacturer’s instructions. Amplified mRNA (amR-
NA) was synthesized using the RiboAmp™ RNA Amplification Kit
(Arcturus) according to manufacturer’s instructions. amRNA was
measured using the Nanodrop spectrophotometer (Nanodrop
Technologies, Wilmington, USA) and the quality of the RNA was as-
sessed on a 0.8% gel.
The RNA and primer mix consisting of 8 lg of amRNA for each
of the samples 2 ll mRNA spike mix (Universal Lucidea Scorecard,
Amersham), random hexamers (Invitrogen) and water was incu-
bated for 5 min at 70 !C. The RNAs mix were reverse transcribed
into Cy-labeled cDNAs using Cy3 or Cy5-dUTPs (Amersham), DTT,
dT-NTPs, RNAsin and Superscript III (Invitrogen). The samples were
incubated at 50 !C for 2½ h. A mixture of 1 M NaOH/20 mM EDTA
was added to the labeled cDNAs to stop the reaction. The Cy-la-
beled cDNAs that were to be hybridized together were pooled
and purified using the Cyscribe™GFX™ Purification kit (Amer-
sham). The concentration of the cDNAs and the binding efficiencies
of the Cy-dyes were determined using the Nanodrop spectropho-
tometer (Nanodrop Technologies, Wilmington, USA). Samples that
had a low cDNA yield (<15 ng/ll) and poor dye incorporation
(<0.1 pmol/ll of each dye) were discarded. A 5 lg of poly dA oligo
(Amersham Biosciences) were added to the purified targets to re-
duce nonspecific hybridization. The labeled samples were dried
in a speed vacuum centrifuge for 1 h at 30 !C and re-suspended
in 15.5 ll of hybridization buffer (Corning). The targets were dena-
tured by incubation at 95 !C for 5 min. The A. gambiae ‘detox chip’
was pre-treated using the Universal Hybridization kit (Corning),
according to manufacturer’s instructions. However the wash solu-
tions were made up using three times the amount of components
as stated in the protocol by David et al. [11]. The target mix was
added to the microarray chip and hybridizations were performed
at 38 !C for 16 h.
After the incubation the slides were washed using the Universal
Hybridization kit (Corning). The slides were pre-soaked in wash
solution 1 for 1–2 min at 38 !C, followed by a second wash of solu-
tion 1 for 2½min and finally incubated in wash solution 2 at ambi-
ent temperature for 5 min. The slides were subjected to three
washes in fresh wash solution 3 at ambient temperature for
1 min. Excess wash solution was removed from the slides by cen-
trifugation at 2500 rpm for two minutes.
2.3. Microarray scanning and data analysis
The slides were scanned using the Genepix 4000B scanner
(Molecular Devices, USA), where the PMT values were adjusted
to give a ratio of 1/1. The quality of spots and background intensi-
ties were examined and corrected using the Genepix Pro 6.0 soft-
ware (Axon Instruments, USA).
The raw intensity values were analyzed using the limma soft-
ware package version 2.12.0, from the BioConductor project, in
the R programming environment [21]. Image plots were generated
to inspect the variation of background values across the arrays.
Background correction was carried out using the ‘normexp’ meth-
od [22] with an offset of 50. Within array normalization was per-
formed, using the ‘control’ method in limma to fit a global loess
curve through a set of non-differentially expressed control spots.
This curve was applied to all the other spots, thereby normalizing
theM-values for each array separately [23]. Between array normal-
ization was performed using the ‘Aquantile’ method to ensure that
the A values have the same empirical distribution across arrays. To
visualize the effect of normalization, MA-plots were used. The lim-
ma package uses empirical Bayes analysis to assess differential
expression, by calculating a B-statistic, a moderated t-statistic
and an adjusted p-value for each gene [24]. A top table was gener-
ated which revealed the highly differentially expressed genes for
both the strains of interest. Genes exhibiting adjusted p values
<0.001 and fold-changesP1.5 were considered as statistically sig-
nificant over-expressed genes. The data was deposited into the
vectorbase database (https://www.vectorbase.org).
2.4. Quantitative real-time PCR (qPCR)
Quantitative PCR analysis was carried out on 3 day old FUMOZ-
R and FANG females and males to verify the results obtained from
the microarray experiments. qPCR was only carried out on the
three up-regulated genes in the females, and the same was done
for the males. The remaining up-regulated genes in the males will
be carried out in future studies. Primers were designed for genes
CYP6M7 and COI. The primer pair used for the CYP6P9 gene was
a gene-specific primer set [25] subsequent to the discovery of a
duplicate gene, CYP6P13 [26]. The cDNA probe sequence was
aligned to both the CYP6P13 (GenBank Accession No. EF152577)
and CYP6P9 (GenBank Accession No. EU450763) gene. The cDNA
probe on the microarray slide had a 81% sequence identity to both
CYP6P9 and CYP6P13. Due to sequences similarities between
CYP6P9 and CYP6P13, gene-specific primers were used for both
CYP6P13 and CYP6P9.
2.4.1. RNA Isolation
The RNA samples obtained from the extractions used in the
microarray experiments were used for the qPCR part of the study.
The samples were quantified using a Nanodrop" Spectrophotome-
ter (Nanodrop Technologies, Wilmington, DE, USA).
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2.4.2. cDNA synthesis
Total RNA was converted to cDNA using the High Capacity
RNA-to-cDNA kit (Applied Biosystems, 4387406). The quality and
quantity of cDNA was measured using the Nanodrop! Spectropho-
tometer (Nanodrop Technologies, Wilmington, DE, USA) and the
cDNA samples were stored at !70 "C until further use.
2.4.3. Primer design
Primer sequences for CYP6P9 and CYP6P13 were obtained from
the Christian et al. [25] study. Primers were designed for the
CYP6M7 (Accession No. AY729660.1) and COI (Accession No.
AY423059.1) genes using the A. funestus gene sequences. These
primers were designed using Beacon Designer 3.0 software
(Bio-rad, Hercules, CA, USA). The rsp 7 (EF450776) primers was
used as a reference gene to normalize data. Two different sets of
primers were designed for the CYP6M7 gene (Table 1).
2.4.4. Quantification of CYP6P9, CYP6P13, CYP6M7 and COI
The qPCR experiments were performed using the Bio-Rad
CFX96™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA,
USA). A total volume of 25 ll containing 12.5 ll IQ™ SYBR super-
mix (Bio-Rad, 1708882), 4 ll primer (2.5 lM), 1 ll cDNA (50 ng)
was used per reaction. A 2-fold serial dilution of cDNA was used
for the standard curve reaction. Serial dilutions of cDNA for the
standard curve were prepared.
The cycling conditions for each primer set are presented in
Table 1. Each biological sample was repeated three times on a
plate. Three biological repeats were done on different days. The
data was analyzed using the relative quantification method [27].
3. Results
A previous study [25] has shown that both females and males
from the resistant strain, FUMOZ-R, are resistant to permethrin,
although mortality rates varied between the two sexes. Therefore
gene expression was determined in both 3 day old adult females
and males of the A. funestus FUMOZ-R (resistant) and FANG (sus-
ceptible) strains using the A. gambiae ‘detox chip’. Minor adjust-
ments to the original protocol were made in order to maximize
hybridization of the targets to the chip. The hybridization tem-
perature was reduced from 42 to 38 "C and lower stringency
wash buffers and shorter washing times were used. These opti-
mized conditions were similar to those used for cross-species
hybridization to A. stephensi [17]. After optimization of the
hybridization conditions over 90% of the spots on the slide were
detected as opposed to 55% obtained when using the more strin-
gent original hybridization conditions described by David et al.
[11]. The percentage of probes detected was obtained by manu-
ally counting the number of fluorescent spots on the slides after
hybridization.
Genes were considered to be differentially expressed if they
demonstrated a P1.5-fold change in expression between the two
strains and a p-value of <0.001 over the entire experiment. Out
of a total of 254 gene probes on the A. gambiae ‘detox chip’,
1.18% of genes were significantly differentially expressed in the
females as opposed to 9.45% in males. No genes were found to be
over-expressed in both females and males from the susceptible
A. funestus, FANG, strain. In the resistant A. funestus FUMOZ-R
stain, however, three genes were differentially expressed in the
females (Fig. 1). The gene with the highest fold change in expres-
sion in the females was a cytochrome P450 gene CYP6P9 (CYP6P3
orthologous gene in A. gambiae) (5.4-fold) (Table 2). The
cytochrome oxidase I gene, COI, was 2.7-fold differentially
expressed and the third gene also a member of the cytochrome
P450 enzyme family, CYP6M7 (CYP6M3 orthologous gene in A.
gambiae) was 1.8-fold differentially expressed.
A total of 24 genes were significantly differentially expressed in
males from the resistant FUMOZ-R strain (Table 2). Fifty percent of
these genes (n = 12) belonged to the cytochrome P450 enzyme
group, 17% (n = 4) to the glutathione-S-transferase, 8% (n = 2) to
the Copper–Zinc (Cu–Zn) superoxide dismutase, 8% (n = 2) to the
thioredoxin group and the remaining 17% (n = 4) to other groups.
Three genes that were differentially expressed and common to
both sexes include the cytochrome P450 genes, CYP6P9 (6.0-fold),
CYP6M7 (3.6-fold) and cytochrome oxidase I, COI (2.9-fold) (Fig. 2).
Other differentially expressed genes in the males are shown in Ta-
ble 2.
Out of a total of 254 genes on the A. gambiae ‘detox chip’, 18
probes failed to produce any signal on the array (Table 3). Five of
these genes, CYP306A1, CYP6P4, CYP4C28, CYP305A3, and CYP6Z2
belonged to the cytochrome P450 group. Only two genes belonged
to theGSTgroup,GSTD4andGSTD3and theperoxidase (HPX) group,
HPX7andHPX5A.Howevera largenumberof genes thatdidnotbind
to the microarray slide belonged to the carboxylesterase group.
These include COEAE1G, COEJHE1E, COEunkn, COEAE1F, COEAE7G,
COEBE2O and COEBE4C. The remaining genes were superoxidase
dismutase (SOD3B) and the serine protease gene (SP21408).
Some sequence data for detoxification genes is available for
A. funestus [18] enabling the degree of identity between the A.
gambiae probes and their putative A. funestus orthologs to be
determined. The probe sequences of the genes on the A. gambiae
‘detox chip’ were aligned against the known A. funestus sequences.
The percentage identities were calculated for genes COI, CYP6M1,
CYP6M8, CYP6P4, CYP9J11, CYP9J12, CYP6P9 and CYP6M7
(Table 4). All genes had a percentage similarity of >40%. The genes
Table 1
Primers used in quantitative PCR (qPCR).
Gene Primer sequence Fragment length (bp) qPCR annealing/detection temp. ("C) Reference
COI Fwd: 50-ATG GAG CAG GAA CAG GAT GAA CAG-30 75 59.40/79.00 This paper
Rev: 50-AAT CAA CTG AAG CAC CAG CAT GAG-30
CYP6M7 Fwd1: 50-GAA GTG CTG GAA CGT CAT AAC-30 a a This paper
Rev1: 50-CGG ATA TTT ACG CAG GCT TTC-30
Fwd2: 50-TCA GAT TCC GAA AGA AAG C-30 a a
Rev2: 50-ATC ACG ATG AAT CGC ATA C-30
CYP6P9 Fwd: 50-AGA TGT GAT TGG CAC CTG T C-30 232 55/82.00 Christian et al. [25]
Rev: 50-TCG ATA TTC CAC CGT TTC CT-30
CYP6P13 Fwd: 50-CTG GAT CTC CTA ATT ATG ATG AAG TTT TTC-30 132 59.1/81.00 Christian et al. [25]
Rev : 50-GTT CAC CGT CTC GCG GAC T-30
rsp 7 Fwd: 50-TTA CTG CTG TGT ACG ATG CC-30 135 b/85.50 Amenya et al. [31]
Rev: 50-GAT GGT GGT CTG CTG GTT C-30
a No amplification.
b Annealing temperature for the rsp 7 gene is equivalent to the respective genes.
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with the highest percentage similarity were genes CYP6P9 (81%),
CYP6P13 (81%), CYP6M1 (79.4%) and CYP6P4 (75.0%). Surprisingly
no signal was detected for CYP6P4 despite the 75% sequence sim-
ilarity between the two species.
Fig. 1. Volcano plot representing genes differentially expressed in females of the A. funestus strain, FUMOZ-R. The horizontal line represents the cut off for the level of
significance a = 0.001 and vertical lines indicate cut off for the 1.5-fold change threshold.
Table 2
List of genes differentially expressed in females and males of the resistant A. funestus strain, FUMOZ-R. Gene names provided in table are as per A. gambiae naming, except for
those where the A. funestus specific name has been identified (Amenya et al. [18]) which appears in brackets behind A. gambiae names.
Gene name Group Vectorbase Accession No. Fold change Adj. P-value
Females
CYP6P3 (CYP6P9) Cytochrome P450 AGAP002865 5.4 2.84 ! 10"07
COI Cytochrome oxidase I DQ465331 (GB) 2.7 5.11 ! 10"06
CYP6M3 (CYP6M7) Cytochrome P450 AGAP008213 1.8 8.82 ! 10"04
Males
CYP6P3 (CYP6P9) Cytochrome P450 AGAP002865 6.0 3.99 ! 10"14
CYP6M3 (CYP6M7) Cytochrome P450 AGAP008213 3.6 4.13 ! 10"08
CYP6M2 (CYP6M8) Cytochrome P450 AGAP008212 3.0 8.46 ! 10"09
COI Cytochrome oxidase I DQ465331 (GB) 2.9 5.21 ! 10"12
SOD2 Superoxide dismutase AGAP005234 2.5 2.7 ! 10"06
GSTS1-1 Glutathione-S-transferase AGAP010404 2.5 5.21 ! 10"12
TRX1 Thioredoxin AGAP009584 2.4 6.74 ! 10"04
Actincytopl Actin TIGR: TC48694 2.3 5.96 ! 10"04
CYP6R1 Cytochrome P450 AGAP008205 2.2 1.30 ! 10"06
TRX3 Thioredoxin AGAP003338 2.2 6.74 ! 10"04
Cytochrome_C Cytochrome C AGAP009537 2.2 1.06 ! 10"07
CYP12f2 Cytochrome P450 AGAP008021 2.2 2.92 ! 10"04
CYP6AG1 Cytochrome P450 AY745223 (GB) 2.0 1.36 ! 10"04
CYP9J5 (CYP9J11) Cytochrome P450 AGAP012296 2.0 6.54 ! 10"06
MnSOD1 Superoxide dismutase AGAP010517 2.0 2.30 ! 10"05
SP8898 Serine protease AGAP003642 1.9 2.73 ! 10"04
CYP9M1 Cytochrome P450 AGAP009374 1.8 4.73 ! 10"05
GSTS112 Glutathione-S-transferase AF513639 (GB) 1.7 6.74 ! 10"04
CYP6Z1 Cytochrome P450 AGAP008219 1.7 1.30 ! 10"06
CYP6AG2 Cytochrome P450 AY745224 (GB) 1.6 8.50 ! 10"04
GSTMS3 Glutathione-S-transferase AGAP009946 1.6 1.01 ! 10"03
CYP6M1 (CYP6M1) Cytochrome P450 AGAP008209 1.6 5.96 ! 10"04
GSTD2 Glutathione-S-transferase AGAP004165 1.6 3.18 ! 10"05
CYP9J3 (CYP9J12) Cytochrome P450 AGAP012291 1.5 7.71 ! 10"04
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The low level of sequence identity between some of the probes
and their putative target genes in A. funestus suggests that some
care should be taken in the interpretation of the results, particu-
larly given the high level of sequence identity between some
detoxification genes in the same species [18]. The possibility that
the microarray results are confounded by cross hybridization of
probes to multiple genes cannot be excluded. Therefore qPCR
was performed to validate the results from the genes found over-
expressed in both sexes.
3.1. Validation
Quantitative PCR (qPCR) was used to validate the microarray re-
sults for the three genes over-expressed in both sexes. The up-reg-
ulation of CYP6P9 and COI in the resistant FUMOZ-R strain in both
males and females is presented in Fig. 3A and B, respectively. The
resistant males showed a fold change of 51 for the CYP6P9 gene,
15 for CYP6P13 and one for COIwhen qPCR analysis was performed.
The females also showed the highest fold change in CYP6P9 (67),
followed by CYP6P13 (8) and 4 for the COI gene.
Comparing the fold over-expression between the qPCR and
microarray analysis of the three genes within each sex shows that
only CYP6P13 and COI (females) were statistically similar (Fig. 3).
However each gene is over-expressed in the resistant strain in both
males and females although at different levels. One of the reasons
for this could be due to the effects of the low stringency hybridiza-
tion conditions for microarray analysis and this could affect fold
over-expression values. The sequence of the probes present on
the array for each gene is different to the sequence of the primers
designed for the CYP6P9 and COI genes for the A. funestus samples.
This could be another contributing factor to the differences seen.
Two sets of primers were designed for the CYP6M7 gene based
on sequence information from the partial sequence of this A. fune-
stus gene [18] (Table 1). However amplification of the product was
unsuccessful for both primers even after numerous attempts.
Fig. 2. Volcano plot representing genes differentially expressed in males of the A. funestus strain, FUMOZ-R. The horizontal line represents the cut off for the level of
significance a = 0.001 and vertical lines indicate cut off for the 1.5-fold change threshold.
Table 3
List of genes that did not hybridize onto the A. gambiae ‘detox chip’ in both the
females and males of the resistant and susceptible A. funestus strain, FUMOZ-R and
FANG.
Gene name Group Vectorbase Accession No.
CYP306A1 Cytochrome P450 AGAP004665
CYP6P4 Cytochrome P450 AGAP002867
CYP4C28 Cytochrome P450 AGAP010414
CYP305A3 Cytochrome P450 AGAP005657
CYP6Z2 Cytochrome P450 AGAP008218
SOD3B Superoxide dismutase AGAP010347
GSTD4 Glutathione-S-transferase AGAP004381
GSTD3 Glutathione-S-transferase AGAP004382
COEAE1G Carboxylesterases AGAP006700
COEJHE1E Carboxylesterases AGAP005833
COEunkn Carboxylesterases AGAP011509
COEAE1F Carboxylesterases AGAP006227
COEAE7G Carboxylesterases AGAP006728
COEBE2O Carboxylesterases AGAP001101
COEBE4C Carboxylesterases AGAP005370
HPX7 Peroxidase AGAP004036
HPX5A Peroxidase AGAP000051
SP21408 Serine protease AGAP004015
Table 4
Percentage similarity between cDNA probes on A. gambiae ‘detox chip’ and the A.
funestus genes.
A. funestus
gene name
A. gambiae
gene name
Percentage DNA
similarity (%)
A. funestus gene
Accession No.
COI COI 50.3 AY423059.1
CYP6M1 CYP6M1 79.4 AY987356.1
CYP6M8 CYP6M2 49.4 AY729660.1
CYP6P4a CYP6P4 75.0 EU852651.1
CYP9J11 CYP9J5 52.3 AY729662.1
CYP9J12 CYP9J3 43.5 AY729663.1
CYP6P9 CYP6P3 81.0 EU450763
CYP6P13 CYP6P3 81.0 EF152577
CYP6M7 CYP6M3 54.1 AY729660.1
a Indicates gene that did not produce any signal on the array.
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4. Discussion
Gene expression in 3 day old A. funestus females and males was
determined using the A. gambiae ‘detox chip’ developed by David
et al. [11]. This study used cross-species (heterologous) hybridiza-
tion of theA. funestus samples to anA. gambiaemicroarray platform
due to the fact that unlike A. gambiae, a fully sequenced genome for
A. funestus is currently unavailable. Many studies have successfully
evaluated gene expression using non-species-specific arrays due to
lack of availability of arrays. Moody et al. [28] used human micro-
arrays to study the gene expression in pigs. They found that the
reproducibility of microarray hybridization of pig cDNA to human
microarrays was high. Cross-species hybridization has also been
conductedon rhesusmacaquemonkeysusingahumanhigh-density
Affymetrix oligonucleotide array [29]. These results confirmed that
a large number of genes were differentially expressed, thereby val-
idating the use of cross-species hybridizations for non-human pri-
mate studies. Adjaye et al. [30] used human and bovine fetal brain
target samples on a human cDNA microarray. Differentially ex-
pressed geneswere obtainedand the studyproved that using tissues
from across species to identify co-expressed orthologous genes on a
human microarray platform is possible.
The A. gambiae ‘detox chip’ has been successfully used to deter-
mine the transcriptional analysis of pyrethroid resistance in A.
stephensi [17] and A. arabiensis [16]. This is the first study to
employ microarrays to determine the genetic basis of pyrethroid
resistance in A. funestus. The heterologous hybridization approach
was used successfully in this study and approximately 90% probes
were detected. Three genes were differentially expressed in both
sexes, CYP6M7, CYP6P9 and COI; COI, CYP6P9 and its duplicate
gene CYP6P13, were confirmed to be over-expressed using qPCR
analysis. Although statistically the gene expression for the COI gene
is different between the two methods for the males, the gene was
still differentially expressed in the resistant strain. Although the
over-expression of COI is not significantly high, the role of this gene
needs to be investigated.
The fact that CYP6M7 could not be amplified from A. funestus
mRNA could possibly imply that it is a pseudogene. However, the
lower hybridization stringencies can result in hybridization of
another closely related P450 gene to the CYP6M7 probe. This
hypothesis can only be validated when a full genome of A. funestus
is available. Wondji et al. [19] also attempted to amplify the
CYP6M7 gene using a different primer set from the ones used in
this study and also failed to obtain amplicons. The CYP6M7 gene
needs to be further investigated.
The CYP6P9 gene has been implicated in playing a role in insec-
ticide resistance in A. funestus. In 2008, Amenya et al. [31] found
the CYP6P9 gene to be over-expressed in the egg and adult stages
of a pyrethroid resistant laboratory strain (FUMOZ-R) originating
from southern Mozambique. Wondji et al. [32] identified a quanti-
tative trait locus (QTL) associated with pyrethroid resistance in the
same A. funestus strain. He found that these QTL markers
contained a cluster of P450 genes including CYP6P9 and that the
chromosomal position of CYP6P9 is associated with permethrin
resistance. In 2009 the same author [19] reported that the CYP6P9
gene was 25 times over-expressed in the FUMOZ-R strain in
females and that it was tandemly duplicated and this was sug-
gested to contribute to insecticide resistance. Interestingly the
CYP6P3 (A. gambiae ortholog) was also found to be differentially
expressed (2.82-fold) in field caught A. gambiae adults from Ghana
[15]. The CYP6P3 gene was also found at significantly high levels
(2.6-fold) in A. arabiensis adults from Cameroon [16].
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Fig. 3. Comparison of qPCR and microarray results for CYP6P9, CYP6P13 and COI genes in females (A) and males (B).
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The observation that additional genes were up-regulated in
males than in females in the FUMOZ-R strain was surprising given
that resistance is higher in females than males of this strain [25]. It
is possible that these 21 additional differentially expressed genes
are unrelated to the resistance phenotype. It is interesting to note
that several of them are putatively involved in the oxidative stress
response (superoxide dismutases (SOD) [33–35], thioredoxins
(TRX) [36], glutathione-S-transferases (GSTs) [37–39].
Eighteen probes did not hybridize to the RNA target. A large
portion of those probes (38%), belong to the COE group with 28%
from the P450 family. This could be due to the reduced sequence
similarity between A. gambiae and A. funestus and also these genes
may be present in the larval stages of the mosquito life cycle and
not in the adult stage. Surprisingly two P450 genes, CYP6P4 and
CYP6P1, which were significantly differentially expressed in a
study by Wondji et al. [19], did not hybridize to the array. The
CYP6P1 and CYP6P4 genes have been shown to have amino acid
identities to that of A. gambiae, 82% and 89%, respectively, on small
partial sequences analysis [18]. It is unknown why these genes did
not hybridize to the slide. This needs to be investigated further.
5. Conclusions
The A. gambiae ‘detox chip’ provided valuable information in
identifying potential genes involved in insecticide resistant in A.
funestus. We acknowledge the fact that heterologous hybridization
is most likely an under representation of the detoxifying genes that
are differentially expressed, but it is currently the only tool avail-
able to use to screen multiple probes at once. This is a useful and
an inexpensive alternative given that the development of a spe-
cies-specific array will require genome sequencing of the specific
species to be investigated and a A. funestus genome was not avail-
able at the time. This information will ultimately be used to under-
stand the underlying mechanisms involved in resistance of this
important malaria vector and hence aid in the control of effective
resistant management.
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